id	sid	tid	token	lemma	pos
dpc-3736	1	1	dermatology	dermatology	NOUN
dpc-3736	1	2	:	:	PUNCT
dpc-3736	1	3	practical	practical	ADJ
dpc-3736	1	4	and	and	CCONJ
dpc-3736	1	5	conceptual	conceptual	ADJ
dpc-3736	1	6	original	original	ADJ
dpc-3736	1	7	article	article	NOUN
dpc-3736	1	8	|	|	ADV
dpc-3736	1	9	dermatol	dermatol	ADJ
dpc-3736	1	10	pract	pract	NOUN
dpc-3736	1	11	concept	concept	NOUN
dpc-3736	1	12	.	.	PUNCT
dpc-3736	2	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	2	2	1	1	NUM
dpc-3736	2	3	comparison	comparison	NOUN
dpc-3736	2	4	of	of	ADP
dpc-3736	2	5	the	the	DET
dpc-3736	2	6	efficacies	efficacy	NOUN
dpc-3736	2	7	of	of	ADP
dpc-3736	2	8	topical	topical	ADJ
dpc-3736	2	9	liposomal	liposomal	NOUN
dpc-3736	2	10	amphotericin	amphotericin	ADP
dpc-3736	2	11	b	b	NOUN
dpc-3736	2	12	and	and	CCONJ
dpc-3736	2	13	topical	topical	ADJ
dpc-3736	2	14	clotrimazole	clotrimazole	NOUN
dpc-3736	2	15	in	in	ADP
dpc-3736	2	16	the	the	DET
dpc-3736	2	17	treatment	treatment	NOUN
dpc-3736	2	18	of	of	ADP
dpc-3736	2	19	pityriasis	pityriasis	NOUN
dpc-3736	2	20	versicolor	versicolor	NOUN
dpc-3736	2	21	mehdi	mehdi	NOUN
dpc-3736	2	22	ghahartars1	ghahartars1	PROPN
dpc-3736	2	23	,	,	PUNCT
dpc-3736	2	24	hossein	hossein	PROPN
dpc-3736	2	25	hosseini2	hosseini2	PROPN
dpc-3736	2	26	,	,	PUNCT
dpc-3736	2	27	malek	malek	PROPN
dpc-3736	2	28	khedri3	khedri3	PROPN
dpc-3736	2	29	,	,	PUNCT
dpc-3736	2	30	maryam	maryam	PROPN
dpc-3736	2	31	sadat	sadat	VERB
dpc-3736	2	32	sadati1	sadati1	PROPN
dpc-3736	2	33	1	1	NUM
dpc-3736	2	34	molecular	molecular	ADJ
dpc-3736	2	35	dermatology	dermatology	NOUN
dpc-3736	2	36	research	research	NOUN
dpc-3736	2	37	center	center	NOUN
dpc-3736	2	38	,	,	PUNCT
dpc-3736	2	39	dermatology	dermatology	NOUN
dpc-3736	2	40	department	department	NOUN
dpc-3736	2	41	,	,	PUNCT
dpc-3736	2	42	shiraz	shiraz	PROPN
dpc-3736	2	43	university	university	PROPN
dpc-3736	2	44	of	of	ADP
dpc-3736	2	45	medical	medical	ADJ
dpc-3736	2	46	sciences	sciences	PROPN
dpc-3736	2	47	,	,	PUNCT
dpc-3736	2	48	shiraz	shiraz	PROPN
dpc-3736	2	49	,	,	PUNCT
dpc-3736	2	50	iran	iran	PROPN
dpc-3736	2	51	2	2	NUM
dpc-3736	2	52	student	student	NOUN
dpc-3736	2	53	research	research	NOUN
dpc-3736	2	54	committee	committee	NOUN
dpc-3736	2	55	,	,	PUNCT
dpc-3736	2	56	shiraz	shiraz	PROPN
dpc-3736	2	57	university	university	PROPN
dpc-3736	2	58	of	of	ADP
dpc-3736	2	59	medical	medical	ADJ
dpc-3736	2	60	sciences	sciences	PROPN
dpc-3736	2	61	,	,	PUNCT
dpc-3736	2	62	shiraz	shiraz	PROPN
dpc-3736	2	63	,	,	PUNCT
dpc-3736	2	64	iran	iran	PROPN
dpc-3736	2	65	3	3	NUM
dpc-3736	2	66	molecular	molecular	ADJ
dpc-3736	2	67	dermatology	dermatology	NOUN
dpc-3736	2	68	research	research	NOUN
dpc-3736	2	69	center	center	NOUN
dpc-3736	2	70	,	,	PUNCT
dpc-3736	2	71	dermatology	dermatology	NOUN
dpc-3736	2	72	department	department	NOUN
dpc-3736	2	73	,	,	PUNCT
dpc-3736	2	74	shiraz	shiraz	PROPN
dpc-3736	2	75	university	university	PROPN
dpc-3736	2	76	of	of	ADP
dpc-3736	2	77	medical	medical	ADJ
dpc-3736	2	78	sciences	sciences	PROPN
dpc-3736	2	79	,	,	PUNCT
dpc-3736	2	80	shiraz	shiraz	PROPN
dpc-3736	2	81	,	,	PUNCT
dpc-3736	2	82	iran	iran	PROPN
dpc-3736	2	83	key	key	ADJ
dpc-3736	2	84	words	word	NOUN
dpc-3736	2	85	:	:	PUNCT
dpc-3736	2	86	amphotericin	amphotericin	ADP
dpc-3736	2	87	b	b	ADP
dpc-3736	2	88	,	,	PUNCT
dpc-3736	2	89	clotrimazole	clotrimazole	NOUN
dpc-3736	2	90	,	,	PUNCT
dpc-3736	2	91	pityriasis	pityriasis	NOUN
dpc-3736	2	92	versicolor	versicolor	NOUN
dpc-3736	2	93	,	,	PUNCT
dpc-3736	2	94	topical	topical	ADJ
dpc-3736	2	95	treatment	treatment	NOUN
dpc-3736	2	96	citation	citation	NOUN
dpc-3736	2	97	:	:	PUNCT
dpc-3736	2	98	ghahartars	ghahartars	PROPN
dpc-3736	2	99	m	m	PROPN
dpc-3736	2	100	,	,	PUNCT
dpc-3736	2	101	hosseini	hosseini	PROPN
dpc-3736	2	102	h	h	PROPN
dpc-3736	2	103	,	,	PUNCT
dpc-3736	2	104	khedri	khedri	PROPN
dpc-3736	2	105	m	m	PROPN
dpc-3736	2	106	,	,	PUNCT
dpc-3736	2	107	sadati	sadati	PROPN
dpc-3736	2	108	ms	ms	PROPN
dpc-3736	2	109	.	.	PROPN
dpc-3736	2	110	comparison	comparison	NOUN
dpc-3736	2	111	of	of	ADP
dpc-3736	2	112	the	the	DET
dpc-3736	2	113	efficacies	efficacy	NOUN
dpc-3736	2	114	of	of	ADP
dpc-3736	2	115	topical	topical	ADJ
dpc-3736	2	116	liposomal	liposomal	NOUN
dpc-3736	2	117	amphotericin	amphotericin	ADP
dpc-3736	2	118	b	b	NOUN
dpc-3736	2	119	and	and	CCONJ
dpc-3736	2	120	topical	topical	ADJ
dpc-3736	2	121	clotrimazole	clotrimazole	NOUN
dpc-3736	2	122	in	in	ADP
dpc-3736	2	123	the	the	DET
dpc-3736	2	124	treatment	treatment	NOUN
dpc-3736	2	125	of	of	ADP
dpc-3736	2	126	pityriasis	pityriasis	NOUN
dpc-3736	2	127	versicolor	versicolor	NOUN
dpc-3736	2	128	.	.	PUNCT
dpc-3736	3	1	dermatol	dermatol	NOUN
dpc-3736	3	2	pract	pract	PROPN
dpc-3736	3	3	concept	concept	NOUN
dpc-3736	3	4	.	.	PUNCT
dpc-3736	4	1	2024;14(1):e2024083	2024;14(1):e2024083	X
dpc-3736	4	2	.	.	PUNCT
dpc-3736	5	1	doi	doi	NOUN
dpc-3736	5	2	:	:	PUNCT
dpc-3736	6	1	https://doi.org/10.5826/dpc.1401a83	https://doi.org/10.5826/dpc.1401a83	NOUN
dpc-3736	6	2	accepted	accept	VERB
dpc-3736	6	3	:	:	PUNCT
dpc-3736	6	4	september	september	PROPN
dpc-3736	6	5	21	21	NUM
dpc-3736	6	6	,	,	PUNCT
dpc-3736	6	7	2023	2023	NUM
dpc-3736	6	8	;	;	PUNCT
dpc-3736	6	9	published	publish	VERB
dpc-3736	6	10	:	:	PUNCT
dpc-3736	6	11	january	january	PROPN
dpc-3736	6	12	2024	2024	NUM
dpc-3736	7	1	copyright	copyright	NOUN
dpc-3736	7	2	:	:	PUNCT
dpc-3736	7	3	©	©	PROPN
dpc-3736	7	4	2024	2024	NUM
dpc-3736	7	5	ghahartars	ghahartar	NOUN
dpc-3736	7	6	et	et	PROPN
dpc-3736	7	7	al	al	PROPN
dpc-3736	7	8	.	.	PUNCT
dpc-3736	8	1	this	this	PRON
dpc-3736	8	2	is	be	AUX
dpc-3736	8	3	an	an	DET
dpc-3736	8	4	open	open	ADJ
dpc-3736	8	5	-	-	PUNCT
dpc-3736	8	6	access	access	NOUN
dpc-3736	8	7	article	article	NOUN
dpc-3736	8	8	distributed	distribute	VERB
dpc-3736	8	9	under	under	ADP
dpc-3736	8	10	the	the	DET
dpc-3736	8	11	terms	term	NOUN
dpc-3736	8	12	of	of	ADP
dpc-3736	8	13	the	the	DET
dpc-3736	8	14	creative	creative	ADJ
dpc-3736	8	15	commons	common	NOUN
dpc-3736	8	16	attribution	attribution	NOUN
dpc-3736	8	17	-	-	PUNCT
dpc-3736	8	18	noncommercial	noncommercial	ADJ
dpc-3736	8	19	license	license	NOUN
dpc-3736	8	20	(	(	PUNCT
dpc-3736	8	21	by	by	ADP
dpc-3736	8	22	-	-	PUNCT
dpc-3736	8	23	nc-4.0	nc-4.0	NOUN
dpc-3736	8	24	)	)	PUNCT
dpc-3736	8	25	,	,	PUNCT
dpc-3736	8	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3736	8	27	,	,	PUNCT
dpc-3736	8	28	which	which	PRON
dpc-3736	8	29	permits	permit	VERB
dpc-3736	8	30	unrestricted	unrestricted	ADJ
dpc-3736	8	31	noncommercial	noncommercial	ADJ
dpc-3736	8	32	use	use	NOUN
dpc-3736	8	33	,	,	PUNCT
dpc-3736	8	34	distribution	distribution	NOUN
dpc-3736	8	35	,	,	PUNCT
dpc-3736	8	36	and	and	CCONJ
dpc-3736	8	37	reproduction	reproduction	NOUN
dpc-3736	8	38	in	in	ADP
dpc-3736	8	39	any	any	DET
dpc-3736	8	40	medium	medium	NOUN
dpc-3736	8	41	,	,	PUNCT
dpc-3736	8	42	provided	provide	VERB
dpc-3736	8	43	the	the	DET
dpc-3736	8	44	original	original	ADJ
dpc-3736	8	45	authors	author	NOUN
dpc-3736	8	46	and	and	CCONJ
dpc-3736	8	47	source	source	NOUN
dpc-3736	8	48	are	be	AUX
dpc-3736	8	49	credited	credit	VERB
dpc-3736	8	50	.	.	PUNCT
dpc-3736	9	1	funding	funding	NOUN
dpc-3736	9	2	:	:	PUNCT
dpc-3736	9	3	this	this	DET
dpc-3736	9	4	work	work	NOUN
dpc-3736	9	5	was	be	AUX
dpc-3736	9	6	supported	support	VERB
dpc-3736	9	7	by	by	ADP
dpc-3736	9	8	the	the	DET
dpc-3736	9	9	research	research	NOUN
dpc-3736	9	10	council	council	PROPN
dpc-3736	9	11	of	of	ADP
dpc-3736	9	12	shiraz	shiraz	PROPN
dpc-3736	9	13	university	university	PROPN
dpc-3736	9	14	of	of	ADP
dpc-3736	9	15	medical	medical	ADJ
dpc-3736	9	16	sciences	science	NOUN
dpc-3736	9	17	under	under	ADP
dpc-3736	9	18	grant	grant	NOUN
dpc-3736	9	19	22355	22355	NUM
dpc-3736	9	20	.	.	PUNCT
dpc-3736	10	1	competing	compete	VERB
dpc-3736	10	2	interests	interest	NOUN
dpc-3736	10	3	:	:	PUNCT
dpc-3736	10	4	none	none	NOUN
dpc-3736	10	5	.	.	PUNCT
dpc-3736	11	1	authorship	authorship	NOUN
dpc-3736	11	2	:	:	PUNCT
dpc-3736	11	3	all	all	DET
dpc-3736	11	4	authors	author	NOUN
dpc-3736	11	5	have	have	AUX
dpc-3736	11	6	contributed	contribute	VERB
dpc-3736	11	7	significantly	significantly	ADV
dpc-3736	11	8	to	to	ADP
dpc-3736	11	9	this	this	DET
dpc-3736	11	10	publication	publication	NOUN
dpc-3736	11	11	.	.	PUNCT
dpc-3736	12	1	corresponding	correspond	VERB
dpc-3736	12	2	author	author	NOUN
dpc-3736	12	3	:	:	PUNCT
dpc-3736	12	4	maryam	maryam	PROPN
dpc-3736	12	5	sadat	sadat	PROPN
dpc-3736	12	6	sadati	sadati	PROPN
dpc-3736	12	7	,	,	PUNCT
dpc-3736	12	8	molecular	molecular	ADJ
dpc-3736	12	9	dermatology	dermatology	NOUN
dpc-3736	12	10	research	research	NOUN
dpc-3736	12	11	center	center	NOUN
dpc-3736	12	12	,	,	PUNCT
dpc-3736	12	13	dermatology	dermatology	NOUN
dpc-3736	12	14	department	department	NOUN
dpc-3736	12	15	,	,	PUNCT
dpc-3736	12	16	faghihi	faghihi	PROPN
dpc-3736	12	17	hospital	hospital	PROPN
dpc-3736	12	18	,	,	PUNCT
dpc-3736	12	19	zand	zand	PROPN
dpc-3736	12	20	street	street	PROPN
dpc-3736	12	21	,	,	PUNCT
dpc-3736	12	22	shiraz	shiraz	PROPN
dpc-3736	12	23	university	university	PROPN
dpc-3736	12	24	of	of	ADP
dpc-3736	12	25	medical	medical	ADJ
dpc-3736	12	26	sciences	sciences	PROPN
dpc-3736	12	27	,	,	PUNCT
dpc-3736	12	28	shiraz	shiraz	NOUN
dpc-3736	12	29	,	,	PUNCT
dpc-3736	12	30	7134846114	7134846114	NUM
dpc-3736	12	31	,	,	PUNCT
dpc-3736	12	32	iran	iran	PROPN
dpc-3736	12	33	.	.	PUNCT
dpc-3736	13	1	orcid	orcid	NOUN
dpc-3736	13	2	:	:	PUNCT
dpc-3736	13	3	0000	0000	NUM
dpc-3736	13	4	-	-	PUNCT
dpc-3736	13	5	0002	0002	NUM
dpc-3736	13	6	-	-	PUNCT
dpc-3736	13	7	8411	8411	NUM
dpc-3736	13	8	-	-	PUNCT
dpc-3736	13	9	0228	0228	NUM
dpc-3736	13	10	tel	tel	PROPN
dpc-3736	13	11	:	:	PUNCT
dpc-3736	13	12	007132319049	007132319049	NUM
dpc-3736	13	13	email	email	NOUN
dpc-3736	13	14	:	:	PUNCT
dpc-3736	13	15	msadati63@yahoo.com	msadati63@yahoo.com	X
dpc-3736	13	16	introduction	introduction	NOUN
dpc-3736	13	17	:	:	PUNCT
dpc-3736	13	18	pityriasis	pityriasis	NOUN
dpc-3736	13	19	versicolor	versicolor	NOUN
dpc-3736	13	20	(	(	PUNCT
dpc-3736	13	21	pv	pv	NOUN
dpc-3736	13	22	)	)	PUNCT
dpc-3736	13	23	often	often	ADV
dpc-3736	13	24	exhibits	exhibit	VERB
dpc-3736	13	25	recurrence	recurrence	NOUN
dpc-3736	13	26	even	even	ADV
dpc-3736	13	27	despite	despite	SCONJ
dpc-3736	13	28	treatment	treatment	NOUN
dpc-3736	13	29	,	,	PUNCT
dpc-3736	13	30	and	and	CCONJ
dpc-3736	13	31	a	a	DET
dpc-3736	13	32	standardized	standardized	ADJ
dpc-3736	13	33	therapy	therapy	NOUN
dpc-3736	13	34	with	with	ADP
dpc-3736	13	35	a	a	DET
dpc-3736	13	36	complete	complete	ADJ
dpc-3736	13	37	cure	cure	NOUN
dpc-3736	13	38	rate	rate	NOUN
dpc-3736	13	39	remains	remain	VERB
dpc-3736	13	40	elusive	elusive	ADJ
dpc-3736	13	41	.	.	PUNCT
dpc-3736	14	1	given	give	VERB
dpc-3736	14	2	the	the	DET
dpc-3736	14	3	fungicidal	fungicidal	ADJ
dpc-3736	14	4	property	property	NOUN
dpc-3736	14	5	of	of	ADP
dpc-3736	14	6	amphotericin	amphotericin	ADP
dpc-3736	14	7	b	b	NUM
dpc-3736	14	8	,	,	PUNCT
dpc-3736	14	9	its	its	PRON
dpc-3736	14	10	potential	potential	NOUN
dpc-3736	14	11	for	for	ADP
dpc-3736	14	12	pv	pv	NOUN
dpc-3736	14	13	treatment	treatment	NOUN
dpc-3736	14	14	warrants	warrant	NOUN
dpc-3736	14	15	investigation	investigation	NOUN
dpc-3736	14	16	.	.	PUNCT
dpc-3736	15	1	objectives	objective	NOUN
dpc-3736	15	2	:	:	PUNCT
dpc-3736	15	3	this	this	DET
dpc-3736	15	4	study	study	NOUN
dpc-3736	15	5	aimed	aim	VERB
dpc-3736	15	6	to	to	PART
dpc-3736	15	7	compare	compare	VERB
dpc-3736	15	8	the	the	DET
dpc-3736	15	9	efficacy	efficacy	NOUN
dpc-3736	15	10	of	of	ADP
dpc-3736	15	11	topical	topical	ADJ
dpc-3736	15	12	liposomal	liposomal	NOUN
dpc-3736	15	13	amphotericin	amphotericin	ADP
dpc-3736	15	14	b	b	NOUN
dpc-3736	15	15	and	and	CCONJ
dpc-3736	15	16	clotrimazole	clotrimazole	NOUN
dpc-3736	15	17	cream	cream	NOUN
dpc-3736	15	18	in	in	ADP
dpc-3736	15	19	treating	treat	VERB
dpc-3736	15	20	pv	pv	NOUN
dpc-3736	15	21	.	.	PUNCT
dpc-3736	16	1	methods	method	NOUN
dpc-3736	16	2	:	:	PUNCT
dpc-3736	16	3	a	a	DET
dpc-3736	16	4	randomized	randomized	ADJ
dpc-3736	16	5	controlled	control	VERB
dpc-3736	16	6	trial	trial	NOUN
dpc-3736	16	7	was	be	AUX
dpc-3736	16	8	conducted	conduct	VERB
dpc-3736	16	9	with	with	ADP
dpc-3736	16	10	44	44	NUM
dpc-3736	16	11	pv	pv	NOUN
dpc-3736	16	12	patients	patient	NOUN
dpc-3736	16	13	,	,	PUNCT
dpc-3736	16	14	aged	age	VERB
dpc-3736	16	15	15	15	NUM
dpc-3736	16	16	to	to	PART
dpc-3736	16	17	70	70	NUM
dpc-3736	16	18	years	year	NOUN
dpc-3736	16	19	,	,	PUNCT
dpc-3736	16	20	who	who	PRON
dpc-3736	16	21	were	be	AUX
dpc-3736	16	22	equally	equally	ADV
dpc-3736	16	23	assigned	assign	VERB
dpc-3736	16	24	to	to	ADP
dpc-3736	16	25	either	either	CCONJ
dpc-3736	16	26	the	the	DET
dpc-3736	16	27	amphotericin	amphotericin	NOUN
dpc-3736	16	28	or	or	CCONJ
dpc-3736	16	29	clotrimazole	clotrimazole	NOUN
dpc-3736	16	30	group	group	NOUN
dpc-3736	16	31	.	.	PUNCT
dpc-3736	17	1	the	the	DET
dpc-3736	17	2	trial	trial	NOUN
dpc-3736	17	3	was	be	AUX
dpc-3736	17	4	registered	register	VERB
dpc-3736	17	5	at	at	ADP
dpc-3736	17	6	the	the	DET
dpc-3736	17	7	iranian	iranian	ADJ
dpc-3736	17	8	registry	registry	NOUN
dpc-3736	17	9	of	of	ADP
dpc-3736	17	10	clinical	clinical	ADJ
dpc-3736	17	11	trials	trial	NOUN
dpc-3736	17	12	on	on	ADP
dpc-3736	17	13	march	march	PROPN
dpc-3736	17	14	7th	7th	NOUN
dpc-3736	17	15	,	,	PUNCT
dpc-3736	17	16	2022	2022	NUM
dpc-3736	17	17	.	.	PUNCT
dpc-3736	18	1	pv	pv	NOUN
dpc-3736	18	2	diagnosis	diagnosis	NOUN
dpc-3736	18	3	was	be	AUX
dpc-3736	18	4	confirmed	confirm	VERB
dpc-3736	18	5	in	in	ADP
dpc-3736	18	6	all	all	DET
dpc-3736	18	7	patients	patient	NOUN
dpc-3736	18	8	through	through	ADP
dpc-3736	18	9	positive	positive	ADJ
dpc-3736	18	10	microscopic	microscopic	ADJ
dpc-3736	18	11	results	result	NOUN
dpc-3736	18	12	.	.	PUNCT
dpc-3736	19	1	the	the	DET
dpc-3736	19	2	amphotericin	amphotericin	PROPN
dpc-3736	19	3	group	group	NOUN
dpc-3736	19	4	received	receive	VERB
dpc-3736	19	5	topical	topical	ADJ
dpc-3736	19	6	gel	gel	NOUN
dpc-3736	19	7	containing	contain	VERB
dpc-3736	19	8	liposomal	liposomal	NOUN
dpc-3736	19	9	amphotericin	amphotericin	ADP
dpc-3736	19	10	b	b	PROPN
dpc-3736	19	11	0.4	0.4	NUM
dpc-3736	19	12	%	%	NOUN
dpc-3736	19	13	,	,	PUNCT
dpc-3736	19	14	while	while	SCONJ
dpc-3736	19	15	the	the	DET
dpc-3736	19	16	other	other	ADJ
dpc-3736	19	17	group	group	NOUN
dpc-3736	19	18	received	receive	VERB
dpc-3736	19	19	topical	topical	ADJ
dpc-3736	19	20	cream	cream	NOUN
dpc-3736	19	21	containing	contain	VERB
dpc-3736	19	22	clotrimazole	clotrimazole	NOUN
dpc-3736	19	23	1	1	NUM
dpc-3736	19	24	%	%	NOUN
dpc-3736	19	25	.	.	PUNCT
dpc-3736	20	1	both	both	DET
dpc-3736	20	2	treatments	treatment	NOUN
dpc-3736	20	3	were	be	AUX
dpc-3736	20	4	applied	apply	VERB
dpc-3736	20	5	twice	twice	ADV
dpc-3736	20	6	daily	daily	ADV
dpc-3736	20	7	to	to	ADP
dpc-3736	20	8	the	the	DET
dpc-3736	20	9	affected	affected	ADJ
dpc-3736	20	10	skin	skin	NOUN
dpc-3736	20	11	lesions	lesion	NOUN
dpc-3736	20	12	for	for	ADP
dpc-3736	20	13	14	14	NUM
dpc-3736	20	14	days	day	NOUN
dpc-3736	20	15	.	.	PUNCT
dpc-3736	21	1	the	the	DET
dpc-3736	21	2	primary	primary	ADJ
dpc-3736	21	3	outcomes	outcome	NOUN
dpc-3736	21	4	assessed	assess	VERB
dpc-3736	21	5	were	be	AUX
dpc-3736	21	6	mycologic	mycologic	ADJ
dpc-3736	21	7	cure	cure	NOUN
dpc-3736	21	8	,	,	PUNCT
dpc-3736	21	9	clinical	clinical	ADJ
dpc-3736	21	10	cure	cure	NOUN
dpc-3736	21	11	,	,	PUNCT
dpc-3736	21	12	and	and	CCONJ
dpc-3736	21	13	complete	complete	ADJ
dpc-3736	21	14	cure	cure	NOUN
dpc-3736	21	15	at	at	ADP
dpc-3736	21	16	day	day	NOUN
dpc-3736	21	17	14	14	NUM
dpc-3736	21	18	post	post	NOUN
dpc-3736	21	19	-	-	NOUN
dpc-3736	21	20	treatment	treatment	NOUN
dpc-3736	21	21	.	.	PUNCT
dpc-3736	22	1	results	result	NOUN
dpc-3736	22	2	:	:	PUNCT
dpc-3736	22	3	both	both	DET
dpc-3736	22	4	drugs	drug	NOUN
dpc-3736	22	5	demonstrated	demonstrate	VERB
dpc-3736	22	6	successful	successful	ADJ
dpc-3736	22	7	treatment	treatment	NOUN
dpc-3736	22	8	outcomes	outcome	NOUN
dpc-3736	22	9	,	,	PUNCT
dpc-3736	22	10	with	with	ADP
dpc-3736	22	11	comparable	comparable	ADJ
dpc-3736	22	12	rates	rate	NOUN
dpc-3736	22	13	of	of	ADP
dpc-3736	22	14	mycologic	mycologic	ADJ
dpc-3736	22	15	cure	cure	NOUN
dpc-3736	22	16	(	(	PUNCT
dpc-3736	22	17	77.3	77.3	NUM
dpc-3736	22	18	%	%	NOUN
dpc-3736	22	19	)	)	PUNCT
dpc-3736	22	20	,	,	PUNCT
dpc-3736	22	21	clinical	clinical	ADJ
dpc-3736	22	22	cure	cure	NOUN
dpc-3736	22	23	(	(	PUNCT
dpc-3736	22	24	63.6	63.6	NUM
dpc-3736	22	25	%	%	NOUN
dpc-3736	22	26	)	)	PUNCT
dpc-3736	22	27	,	,	PUNCT
dpc-3736	22	28	and	and	CCONJ
dpc-3736	22	29	complete	complete	ADJ
dpc-3736	22	30	combined	combine	VERB
dpc-3736	22	31	cure	cure	NOUN
dpc-3736	22	32	(	(	PUNCT
dpc-3736	22	33	63.6	63.6	NUM
dpc-3736	22	34	%	%	NOUN
dpc-3736	22	35	)	)	PUNCT
dpc-3736	22	36	.	.	PUNCT
dpc-3736	23	1	there	there	PRON
dpc-3736	23	2	was	be	VERB
dpc-3736	23	3	no	no	DET
dpc-3736	23	4	significant	significant	ADJ
dpc-3736	23	5	difference	difference	NOUN
dpc-3736	23	6	between	between	ADP
dpc-3736	23	7	the	the	DET
dpc-3736	23	8	groups	group	NOUN
dpc-3736	23	9	in	in	ADP
dpc-3736	23	10	terms	term	NOUN
dpc-3736	23	11	of	of	ADP
dpc-3736	23	12	the	the	DET
dpc-3736	23	13	degree	degree	NOUN
dpc-3736	23	14	of	of	ADP
dpc-3736	23	15	cure	cure	NOUN
dpc-3736	23	16	(	(	PUNCT
dpc-3736	23	17	p=0.75	p=0.75	X
dpc-3736	23	18	)	)	PUNCT
dpc-3736	23	19	.	.	PUNCT
dpc-3736	24	1	adjustments	adjustment	NOUN
dpc-3736	24	2	for	for	ADP
dpc-3736	24	3	age	age	NOUN
dpc-3736	24	4	,	,	PUNCT
dpc-3736	24	5	sex	sex	NOUN
dpc-3736	24	6	,	,	PUNCT
dpc-3736	24	7	lesion	lesion	NOUN
dpc-3736	24	8	extent	extent	NOUN
dpc-3736	24	9	,	,	PUNCT
dpc-3736	24	10	and	and	CCONJ
dpc-3736	24	11	lesion	lesion	NOUN
dpc-3736	24	12	site	site	NOUN
dpc-3736	24	13	yielded	yield	VERB
dpc-3736	24	14	insignificant	insignificant	ADJ
dpc-3736	24	15	risk	risk	NOUN
dpc-3736	24	16	ratio	ratio	NOUN
dpc-3736	24	17	and	and	CCONJ
dpc-3736	24	18	risk	risk	NOUN
dpc-3736	24	19	difference	difference	NOUN
dpc-3736	24	20	estimates	estimate	NOUN
dpc-3736	24	21	for	for	ADP
dpc-3736	24	22	the	the	DET
dpc-3736	24	23	complete	complete	ADJ
dpc-3736	24	24	cure	cure	NOUN
dpc-3736	24	25	rate	rate	NOUN
dpc-3736	24	26	(	(	PUNCT
dpc-3736	24	27	p>0.05	p>0.05	NOUN
dpc-3736	24	28	)	)	PUNCT
dpc-3736	24	29	.	.	PUNCT
dpc-3736	25	1	abstract	abstract	ADJ
dpc-3736	25	2	2	2	NUM
dpc-3736	25	3	original	original	ADJ
dpc-3736	25	4	article	article	NOUN
dpc-3736	25	5	|	|	ADV
dpc-3736	25	6	dermatol	dermatol	ADJ
dpc-3736	25	7	pract	pract	NOUN
dpc-3736	25	8	concept	concept	NOUN
dpc-3736	25	9	.	.	PUNCT
dpc-3736	26	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	26	2	introduction	introduction	NOUN
dpc-3736	26	3	pityriasis	pityriasis	NOUN
dpc-3736	26	4	versicolor	versicolor	NOUN
dpc-3736	26	5	(	(	PUNCT
dpc-3736	26	6	pv	pv	NOUN
dpc-3736	26	7	)	)	PUNCT
dpc-3736	26	8	,	,	PUNCT
dpc-3736	26	9	also	also	ADV
dpc-3736	26	10	known	know	VERB
dpc-3736	26	11	as	as	ADP
dpc-3736	26	12	tinea	tinea	PROPN
dpc-3736	26	13	versicolor	versicolor	NOUN
dpc-3736	26	14	,	,	PUNCT
dpc-3736	26	15	is	be	AUX
dpc-3736	26	16	a	a	DET
dpc-3736	26	17	prevalent	prevalent	ADJ
dpc-3736	26	18	superficial	superficial	ADJ
dpc-3736	26	19	fungal	fungal	ADJ
dpc-3736	26	20	infection	infection	NOUN
dpc-3736	26	21	of	of	ADP
dpc-3736	26	22	the	the	DET
dpc-3736	26	23	skin	skin	NOUN
dpc-3736	26	24	that	that	PRON
dpc-3736	26	25	is	be	AUX
dpc-3736	26	26	benign	benign	ADJ
dpc-3736	26	27	and	and	CCONJ
dpc-3736	26	28	noncontagious	noncontagious	ADJ
dpc-3736	26	29	[	[	X
dpc-3736	26	30	1	1	NUM
dpc-3736	26	31	]	]	PUNCT
dpc-3736	26	32	.	.	PUNCT
dpc-3736	27	1	the	the	DET
dpc-3736	27	2	treatment	treatment	NOUN
dpc-3736	27	3	of	of	ADP
dpc-3736	27	4	pv	pv	NOUN
dpc-3736	27	5	can	can	AUX
dpc-3736	27	6	be	be	AUX
dpc-3736	27	7	effectively	effectively	ADV
dpc-3736	27	8	achieved	achieve	VERB
dpc-3736	27	9	through	through	ADP
dpc-3736	27	10	the	the	DET
dpc-3736	27	11	use	use	NOUN
dpc-3736	27	12	of	of	ADP
dpc-3736	27	13	topical	topical	ADJ
dpc-3736	27	14	and/or	and/or	CCONJ
dpc-3736	27	15	systemic	systemic	ADJ
dpc-3736	27	16	agents	agent	NOUN
dpc-3736	27	17	[	[	X
dpc-3736	27	18	1,2	1,2	NUM
dpc-3736	27	19	]	]	PUNCT
dpc-3736	27	20	.	.	PUNCT
dpc-3736	28	1	topical	topical	ADJ
dpc-3736	28	2	medications	medication	NOUN
dpc-3736	28	3	are	be	AUX
dpc-3736	28	4	generally	generally	ADV
dpc-3736	28	5	considered	consider	VERB
dpc-3736	28	6	the	the	DET
dpc-3736	28	7	first	first	ADJ
dpc-3736	28	8	-	-	PUNCT
dpc-3736	28	9	line	line	NOUN
dpc-3736	28	10	therapy	therapy	NOUN
dpc-3736	28	11	for	for	ADP
dpc-3736	28	12	pv	pv	NOUN
dpc-3736	29	1	[	[	X
dpc-3736	29	2	1	1	NUM
dpc-3736	29	3	]	]	PUNCT
dpc-3736	29	4	.	.	PUNCT
dpc-3736	30	1	among	among	ADP
dpc-3736	30	2	the	the	DET
dpc-3736	30	3	various	various	ADJ
dpc-3736	30	4	topical	topical	ADJ
dpc-3736	30	5	antifungal	antifungal	ADJ
dpc-3736	30	6	agents	agent	NOUN
dpc-3736	30	7	available	available	ADJ
dpc-3736	30	8	,	,	PUNCT
dpc-3736	30	9	several	several	ADJ
dpc-3736	30	10	azole	azole	NOUN
dpc-3736	30	11	compounds	compound	VERB
dpc-3736	30	12	that	that	PRON
dpc-3736	30	13	disrupt	disrupt	ADJ
dpc-3736	30	14	ergosterol	ergosterol	NOUN
dpc-3736	30	15	biosynthesis	biosynthesis	NOUN
dpc-3736	30	16	have	have	AUX
dpc-3736	30	17	been	be	AUX
dpc-3736	30	18	extensively	extensively	ADV
dpc-3736	30	19	studied	study	VERB
dpc-3736	30	20	for	for	ADP
dpc-3736	30	21	their	their	PRON
dpc-3736	30	22	efficacy	efficacy	NOUN
dpc-3736	30	23	in	in	ADP
dpc-3736	30	24	treating	treat	VERB
dpc-3736	30	25	pv	pv	NOUN
dpc-3736	31	1	[	[	X
dpc-3736	31	2	3	3	NUM
dpc-3736	31	3	]	]	PUNCT
dpc-3736	31	4	.	.	PUNCT
dpc-3736	32	1	these	these	DET
dpc-3736	32	2	studies	study	NOUN
dpc-3736	32	3	have	have	AUX
dpc-3736	32	4	primarily	primarily	ADV
dpc-3736	32	5	focused	focus	VERB
dpc-3736	32	6	on	on	ADP
dpc-3736	32	7	comparing	compare	VERB
dpc-3736	32	8	the	the	DET
dpc-3736	32	9	effectiveness	effectiveness	NOUN
dpc-3736	32	10	of	of	ADP
dpc-3736	32	11	newer	new	ADJ
dpc-3736	32	12	topical	topical	ADJ
dpc-3736	32	13	and	and	CCONJ
dpc-3736	32	14	oral	oral	ADJ
dpc-3736	32	15	antifungal	antifungal	ADJ
dpc-3736	32	16	agents	agent	NOUN
dpc-3736	32	17	with	with	ADP
dpc-3736	32	18	well	well	ADV
dpc-3736	32	19	-	-	PUNCT
dpc-3736	32	20	established	establish	VERB
dpc-3736	32	21	clotrimazole	clotrimazole	NOUN
dpc-3736	32	22	,	,	PUNCT
dpc-3736	32	23	which	which	PRON
dpc-3736	32	24	has	have	AUX
dpc-3736	32	25	been	be	AUX
dpc-3736	32	26	widely	widely	ADV
dpc-3736	32	27	recognized	recognize	VERB
dpc-3736	32	28	for	for	ADP
dpc-3736	32	29	its	its	PRON
dpc-3736	32	30	therapeutic	therapeutic	ADJ
dpc-3736	32	31	benefits	benefit	NOUN
dpc-3736	32	32	[	[	X
dpc-3736	32	33	1	1	NUM
dpc-3736	32	34	]	]	PUNCT
dpc-3736	32	35	.	.	PUNCT
dpc-3736	33	1	however	however	ADV
dpc-3736	33	2	,	,	PUNCT
dpc-3736	33	3	there	there	PRON
dpc-3736	33	4	is	be	VERB
dpc-3736	33	5	a	a	DET
dpc-3736	33	6	noticeable	noticeable	ADJ
dpc-3736	33	7	dearth	dearth	NOUN
dpc-3736	33	8	of	of	ADP
dpc-3736	33	9	research	research	NOUN
dpc-3736	33	10	exploring	explore	VERB
dpc-3736	33	11	the	the	DET
dpc-3736	33	12	use	use	NOUN
dpc-3736	33	13	of	of	ADP
dpc-3736	33	14	amphotericin	amphotericin	ADP
dpc-3736	33	15	b	b	NOUN
dpc-3736	33	16	in	in	ADP
dpc-3736	33	17	the	the	DET
dpc-3736	33	18	treatment	treatment	NOUN
dpc-3736	33	19	of	of	ADP
dpc-3736	33	20	pv	pv	NOUN
dpc-3736	33	21	,	,	PUNCT
dpc-3736	33	22	despite	despite	SCONJ
dpc-3736	33	23	its	its	PRON
dpc-3736	33	24	lipophilic	lipophilic	ADJ
dpc-3736	33	25	properties	property	NOUN
dpc-3736	33	26	and	and	CCONJ
dpc-3736	33	27	ability	ability	NOUN
dpc-3736	33	28	to	to	PART
dpc-3736	33	29	bind	bind	VERB
dpc-3736	33	30	to	to	ADP
dpc-3736	33	31	ergosterol	ergosterol	NOUN
dpc-3736	33	32	,	,	PUNCT
dpc-3736	33	33	a	a	DET
dpc-3736	33	34	crucial	crucial	ADJ
dpc-3736	33	35	sterol	sterol	NOUN
dpc-3736	33	36	in	in	ADP
dpc-3736	33	37	the	the	DET
dpc-3736	33	38	fungal	fungal	ADJ
dpc-3736	33	39	cell	cell	NOUN
dpc-3736	33	40	wall	wall	NOUN
dpc-3736	33	41	.	.	PUNCT
dpc-3736	34	1	this	this	DET
dpc-3736	34	2	binding	bind	VERB
dpc-3736	34	3	action	action	NOUN
dpc-3736	34	4	leads	lead	VERB
dpc-3736	34	5	to	to	ADP
dpc-3736	34	6	the	the	DET
dpc-3736	34	7	leakage	leakage	NOUN
dpc-3736	34	8	of	of	ADP
dpc-3736	34	9	intracellular	intracellular	ADJ
dpc-3736	34	10	components	component	NOUN
dpc-3736	34	11	,	,	PUNCT
dpc-3736	34	12	while	while	SCONJ
dpc-3736	34	13	also	also	ADV
dpc-3736	34	14	stimulating	stimulate	VERB
dpc-3736	34	15	free	free	ADJ
dpc-3736	34	16	radical	radical	ADJ
dpc-3736	34	17	production	production	NOUN
dpc-3736	34	18	and	and	CCONJ
dpc-3736	34	19	enhancing	enhance	VERB
dpc-3736	34	20	the	the	DET
dpc-3736	34	21	body	body	NOUN
dpc-3736	34	22	’s	’s	PART
dpc-3736	34	23	phagocytic	phagocytic	ADJ
dpc-3736	34	24	system	system	NOUN
dpc-3736	34	25	for	for	ADP
dpc-3736	34	26	fungi	fungus	NOUN
dpc-3736	34	27	elimination	elimination	NOUN
dpc-3736	34	28	[	[	X
dpc-3736	34	29	3,4	3,4	NUM
dpc-3736	34	30	]	]	PUNCT
dpc-3736	34	31	.	.	PUNCT
dpc-3736	35	1	as	as	ADP
dpc-3736	35	2	a	a	DET
dpc-3736	35	3	fungicidal	fungicidal	ADJ
dpc-3736	35	4	agent	agent	NOUN
dpc-3736	35	5	,	,	PUNCT
dpc-3736	35	6	amphotericin	amphotericin	VERB
dpc-3736	35	7	b	b	NOUN
dpc-3736	35	8	is	be	AUX
dpc-3736	35	9	effective	effective	ADJ
dpc-3736	35	10	against	against	ADP
dpc-3736	35	11	a	a	DET
dpc-3736	35	12	broad	broad	ADJ
dpc-3736	35	13	range	range	NOUN
dpc-3736	35	14	of	of	ADP
dpc-3736	35	15	organisms	organism	NOUN
dpc-3736	35	16	,	,	PUNCT
dpc-3736	35	17	such	such	ADJ
dpc-3736	35	18	as	as	ADP
dpc-3736	35	19	yeast	yeast	NOUN
dpc-3736	35	20	,	,	PUNCT
dpc-3736	35	21	protozoa	protozoan	NOUN
dpc-3736	35	22	(	(	PUNCT
dpc-3736	35	23	leishmania	leishmania	NOUN
dpc-3736	35	24	)	)	PUNCT
dpc-3736	35	25	,	,	PUNCT
dpc-3736	35	26	flat	flat	ADJ
dpc-3736	35	27	worms	worm	NOUN
dpc-3736	35	28	,	,	PUNCT
dpc-3736	35	29	molds	mold	NOUN
dpc-3736	35	30	,	,	PUNCT
dpc-3736	35	31	and	and	CCONJ
dpc-3736	35	32	algae	algae	NOUN
dpc-3736	36	1	[	[	X
dpc-3736	36	2	5	5	NUM
dpc-3736	36	3	-	-	SYM
dpc-3736	36	4	7	7	NUM
dpc-3736	36	5	]	]	PUNCT
dpc-3736	36	6	.	.	PUNCT
dpc-3736	37	1	however	however	ADV
dpc-3736	37	2	,	,	PUNCT
dpc-3736	37	3	considering	consider	VERB
dpc-3736	37	4	the	the	DET
dpc-3736	37	5	unique	unique	ADJ
dpc-3736	37	6	characteristics	characteristic	NOUN
dpc-3736	37	7	and	and	CCONJ
dpc-3736	37	8	pharmacologic	pharmacologic	ADJ
dpc-3736	37	9	features	feature	NOUN
dpc-3736	37	10	of	of	ADP
dpc-3736	37	11	amphotericin	amphotericin	ADP
dpc-3736	37	12	b	b	NOUN
dpc-3736	37	13	,	,	PUNCT
dpc-3736	37	14	its	its	PRON
dpc-3736	37	15	potential	potential	NOUN
dpc-3736	37	16	as	as	ADP
dpc-3736	37	17	a	a	DET
dpc-3736	37	18	therapeutic	therapeutic	ADJ
dpc-3736	37	19	option	option	NOUN
dpc-3736	37	20	for	for	ADP
dpc-3736	37	21	treating	treat	VERB
dpc-3736	37	22	pv	pv	PROPN
dpc-3736	37	23	warrants	warrant	NOUN
dpc-3736	37	24	investigation	investigation	NOUN
dpc-3736	37	25	.	.	PUNCT
dpc-3736	38	1	therefore	therefore	ADV
dpc-3736	38	2	,	,	PUNCT
dpc-3736	38	3	we	we	PRON
dpc-3736	38	4	hypothesized	hypothesize	VERB
dpc-3736	38	5	that	that	SCONJ
dpc-3736	38	6	liposomal	liposomal	NOUN
dpc-3736	38	7	amphotericin	amphotericin	ADP
dpc-3736	38	8	b	b	NOUN
dpc-3736	38	9	could	could	AUX
dpc-3736	38	10	exhibit	exhibit	VERB
dpc-3736	38	11	favorable	favorable	ADJ
dpc-3736	38	12	therapeutic	therapeutic	ADJ
dpc-3736	38	13	effects	effect	NOUN
dpc-3736	38	14	and	and	CCONJ
dpc-3736	38	15	demonstrate	demonstrate	VERB
dpc-3736	38	16	comparable	comparable	ADJ
dpc-3736	38	17	efficacy	efficacy	NOUN
dpc-3736	38	18	to	to	ADP
dpc-3736	38	19	clotrimazole	clotrimazole	NOUN
dpc-3736	38	20	.	.	PUNCT
dpc-3736	39	1	additionally	additionally	ADV
dpc-3736	39	2	,	,	PUNCT
dpc-3736	39	3	we	we	PRON
dpc-3736	39	4	sought	seek	VERB
dpc-3736	39	5	to	to	PART
dpc-3736	39	6	explore	explore	VERB
dpc-3736	39	7	whether	whether	SCONJ
dpc-3736	39	8	factors	factor	NOUN
dpc-3736	39	9	such	such	ADJ
dpc-3736	39	10	as	as	ADP
dpc-3736	39	11	patients	patient	NOUN
dpc-3736	39	12	’	'	PUNCT
dpc-3736	39	13	age	age	NOUN
dpc-3736	39	14	,	,	PUNCT
dpc-3736	39	15	gender	gender	NOUN
dpc-3736	39	16	,	,	PUNCT
dpc-3736	39	17	and	and	CCONJ
dpc-3736	39	18	site	site	NOUN
dpc-3736	39	19	of	of	ADP
dpc-3736	39	20	lesion	lesion	NOUN
dpc-3736	39	21	would	would	AUX
dpc-3736	39	22	influence	influence	VERB
dpc-3736	39	23	treatment	treatment	NOUN
dpc-3736	39	24	success	success	NOUN
dpc-3736	39	25	.	.	PUNCT
dpc-3736	40	1	objectives	objective	NOUN
dpc-3736	40	2	in	in	ADP
dpc-3736	40	3	a	a	DET
dpc-3736	40	4	clinical	clinical	ADJ
dpc-3736	40	5	context	context	NOUN
dpc-3736	40	6	,	,	PUNCT
dpc-3736	40	7	finding	find	VERB
dpc-3736	40	8	a	a	DET
dpc-3736	40	9	medication	medication	NOUN
dpc-3736	40	10	with	with	ADP
dpc-3736	40	11	improved	improved	ADJ
dpc-3736	40	12	efficacy	efficacy	NOUN
dpc-3736	40	13	and	and	CCONJ
dpc-3736	40	14	minimal	minimal	ADJ
dpc-3736	40	15	side	side	NOUN
dpc-3736	40	16	effects	effect	NOUN
dpc-3736	40	17	for	for	ADP
dpc-3736	40	18	the	the	DET
dpc-3736	40	19	treatment	treatment	NOUN
dpc-3736	40	20	of	of	ADP
dpc-3736	40	21	pv	pv	NOUN
dpc-3736	40	22	is	be	AUX
dpc-3736	40	23	of	of	ADP
dpc-3736	40	24	significant	significant	ADJ
dpc-3736	40	25	value	value	NOUN
dpc-3736	40	26	.	.	PUNCT
dpc-3736	41	1	this	this	PRON
dpc-3736	41	2	is	be	AUX
dpc-3736	41	3	particularly	particularly	ADV
dpc-3736	41	4	crucial	crucial	ADJ
dpc-3736	41	5	due	due	ADP
dpc-3736	41	6	to	to	ADP
dpc-3736	41	7	the	the	DET
dpc-3736	41	8	common	common	ADJ
dpc-3736	41	9	recurrence	recurrence	NOUN
dpc-3736	41	10	of	of	ADP
dpc-3736	41	11	the	the	DET
dpc-3736	41	12	disease	disease	NOUN
dpc-3736	41	13	,	,	PUNCT
dpc-3736	41	14	which	which	PRON
dpc-3736	41	15	can	can	AUX
dpc-3736	41	16	adversely	adversely	ADV
dpc-3736	41	17	affect	affect	VERB
dpc-3736	41	18	a	a	DET
dpc-3736	41	19	patient	patient	NOUN
dpc-3736	41	20	’s	’s	PART
dpc-3736	41	21	quality	quality	NOUN
dpc-3736	41	22	of	of	ADP
dpc-3736	41	23	life	life	NOUN
dpc-3736	41	24	.	.	PUNCT
dpc-3736	42	1	the	the	DET
dpc-3736	42	2	primary	primary	ADJ
dpc-3736	42	3	outcomes	outcome	NOUN
dpc-3736	42	4	assessed	assess	VERB
dpc-3736	42	5	in	in	ADP
dpc-3736	42	6	this	this	DET
dpc-3736	42	7	study	study	NOUN
dpc-3736	42	8	were	be	AUX
dpc-3736	42	9	mycologic	mycologic	ADJ
dpc-3736	42	10	cure	cure	NOUN
dpc-3736	42	11	and	and	CCONJ
dpc-3736	42	12	clinical	clinical	ADJ
dpc-3736	42	13	cure	cure	NOUN
dpc-3736	42	14	at	at	ADP
dpc-3736	42	15	the	the	DET
dpc-3736	42	16	end	end	NOUN
dpc-3736	42	17	of	of	ADP
dpc-3736	42	18	the	the	DET
dpc-3736	42	19	treatment	treatment	NOUN
dpc-3736	42	20	course	course	NOUN
dpc-3736	42	21	.	.	PUNCT
dpc-3736	43	1	accordingly	accordingly	ADV
dpc-3736	43	2	,	,	PUNCT
dpc-3736	43	3	the	the	DET
dpc-3736	43	4	aim	aim	NOUN
dpc-3736	43	5	of	of	ADP
dpc-3736	43	6	this	this	DET
dpc-3736	43	7	study	study	NOUN
dpc-3736	43	8	is	be	AUX
dpc-3736	43	9	to	to	PART
dpc-3736	43	10	compare	compare	VERB
dpc-3736	43	11	the	the	DET
dpc-3736	43	12	efficacy	efficacy	NOUN
dpc-3736	43	13	of	of	ADP
dpc-3736	43	14	topical	topical	ADJ
dpc-3736	43	15	liposomal	liposomal	NOUN
dpc-3736	43	16	amphotericin	amphotericin	ADP
dpc-3736	43	17	b	b	NOUN
dpc-3736	43	18	with	with	ADP
dpc-3736	43	19	clotrimazole	clotrimazole	NOUN
dpc-3736	43	20	cream	cream	NOUN
dpc-3736	43	21	in	in	ADP
dpc-3736	43	22	the	the	DET
dpc-3736	43	23	treatment	treatment	NOUN
dpc-3736	43	24	of	of	ADP
dpc-3736	43	25	tinea	tinea	PROPN
dpc-3736	43	26	versicolor	versicolor	NOUN
dpc-3736	43	27	,	,	PUNCT
dpc-3736	43	28	with	with	ADP
dpc-3736	43	29	a	a	DET
dpc-3736	43	30	focus	focus	NOUN
dpc-3736	43	31	on	on	ADP
dpc-3736	43	32	determining	determine	VERB
dpc-3736	43	33	the	the	DET
dpc-3736	43	34	most	most	ADV
dpc-3736	43	35	effective	effective	ADJ
dpc-3736	43	36	therapeutic	therapeutic	ADJ
dpc-3736	43	37	approach	approach	NOUN
dpc-3736	43	38	for	for	ADP
dpc-3736	43	39	pv	pv	NOUN
dpc-3736	43	40	management	management	NOUN
dpc-3736	43	41	.	.	PUNCT
dpc-3736	44	1	methods	method	NOUN
dpc-3736	44	2	study	study	VERB
dpc-3736	44	3	design	design	NOUN
dpc-3736	44	4	and	and	CCONJ
dpc-3736	44	5	ethical	ethical	ADJ
dpc-3736	44	6	considerations	consideration	NOUN
dpc-3736	44	7	this	this	DET
dpc-3736	44	8	study	study	NOUN
dpc-3736	44	9	was	be	AUX
dpc-3736	44	10	conducted	conduct	VERB
dpc-3736	44	11	as	as	ADP
dpc-3736	44	12	a	a	DET
dpc-3736	44	13	single	single	ADJ
dpc-3736	44	14	-	-	PUNCT
dpc-3736	44	15	blind	blind	ADJ
dpc-3736	44	16	clinical	clinical	ADJ
dpc-3736	44	17	trial	trial	NOUN
dpc-3736	44	18	from	from	ADP
dpc-3736	44	19	march	march	PROPN
dpc-3736	44	20	7	7	NUM
dpc-3736	44	21	to	to	ADP
dpc-3736	44	22	july	july	PROPN
dpc-3736	44	23	22	22	NUM
dpc-3736	44	24	,	,	PUNCT
dpc-3736	44	25	2022	2022	NUM
dpc-3736	44	26	.	.	PUNCT
dpc-3736	45	1	the	the	DET
dpc-3736	45	2	trial	trial	NOUN
dpc-3736	45	3	utilized	utilize	VERB
dpc-3736	45	4	systematic	systematic	ADJ
dpc-3736	45	5	random	random	ADJ
dpc-3736	45	6	sampling	sampling	NOUN
dpc-3736	45	7	,	,	PUNCT
dpc-3736	45	8	and	and	CCONJ
dpc-3736	45	9	the	the	DET
dpc-3736	45	10	blinding	blind	VERB
dpc-3736	45	11	method	method	NOUN
dpc-3736	45	12	is	be	AUX
dpc-3736	45	13	described	describe	VERB
dpc-3736	45	14	in	in	ADP
dpc-3736	45	15	detail	detail	NOUN
dpc-3736	45	16	below	below	ADV
dpc-3736	45	17	.	.	PUNCT
dpc-3736	46	1	ethical	ethical	ADJ
dpc-3736	46	2	approval	approval	NOUN
dpc-3736	46	3	for	for	ADP
dpc-3736	46	4	the	the	DET
dpc-3736	46	5	study	study	NOUN
dpc-3736	46	6	was	be	AUX
dpc-3736	46	7	obtained	obtain	VERB
dpc-3736	46	8	from	from	ADP
dpc-3736	46	9	the	the	DET
dpc-3736	46	10	ethics	ethic	NOUN
dpc-3736	46	11	committee	committee	PROPN
dpc-3736	46	12	of	of	ADP
dpc-3736	46	13	shiraz	shiraz	PROPN
dpc-3736	46	14	university	university	PROPN
dpc-3736	46	15	of	of	ADP
dpc-3736	46	16	medical	medical	ADJ
dpc-3736	46	17	sciences	science	NOUN
dpc-3736	46	18	in	in	ADP
dpc-3736	46	19	february	february	PROPN
dpc-3736	46	20	2021	2021	NUM
dpc-3736	46	21	(	(	PUNCT
dpc-3736	46	22	ethical	ethical	ADJ
dpc-3736	46	23	committee	committee	NOUN
dpc-3736	46	24	approval	approval	NOUN
dpc-3736	47	1	i	i	PROPN
dpc-3736	47	2	d	d	PROPN
dpc-3736	47	3	:	:	PUNCT
dpc-3736	47	4	ir.sums.med.rec	ir.sums.med.rec	NOUN
dpc-3736	47	5	.	.	PROPN
dpc-3736	47	6	1399.543	1399.543	NUM
dpc-3736	47	7	)	)	PUNCT
dpc-3736	47	8	.	.	PUNCT
dpc-3736	48	1	the	the	DET
dpc-3736	48	2	study	study	NOUN
dpc-3736	48	3	was	be	AUX
dpc-3736	48	4	registered	register	VERB
dpc-3736	48	5	in	in	ADP
dpc-3736	48	6	the	the	DET
dpc-3736	48	7	iranian	iranian	ADJ
dpc-3736	48	8	registry	registry	NOUN
dpc-3736	48	9	of	of	ADP
dpc-3736	48	10	clinical	clinical	ADJ
dpc-3736	48	11	trials	trial	NOUN
dpc-3736	48	12	on	on	ADP
dpc-3736	48	13	march	march	PROPN
dpc-3736	48	14	7	7	NUM
dpc-3736	48	15	,	,	PUNCT
dpc-3736	48	16	2022	2022	NUM
dpc-3736	48	17	,	,	PUNCT
dpc-3736	48	18	with	with	ADP
dpc-3736	48	19	trial	trial	NOUN
dpc-3736	48	20	registration	registration	NOUN
dpc-3736	48	21	number	number	NOUN
dpc-3736	48	22	irct20220221054082n1	irct20220221054082n1	PROPN
dpc-3736	48	23	.	.	PROPN
dpc-3736	49	1	written	write	VERB
dpc-3736	49	2	informed	informed	ADJ
dpc-3736	49	3	consent	consent	NOUN
dpc-3736	49	4	was	be	AUX
dpc-3736	49	5	obtained	obtain	VERB
dpc-3736	49	6	from	from	ADP
dpc-3736	49	7	all	all	DET
dpc-3736	49	8	participants	participant	NOUN
dpc-3736	49	9	after	after	ADP
dpc-3736	49	10	explaining	explain	VERB
dpc-3736	49	11	the	the	DET
dpc-3736	49	12	study	study	NOUN
dpc-3736	49	13	purpose	purpose	NOUN
dpc-3736	49	14	,	,	PUNCT
dpc-3736	49	15	research	research	NOUN
dpc-3736	49	16	procedures	procedure	NOUN
dpc-3736	49	17	,	,	PUNCT
dpc-3736	49	18	and	and	CCONJ
dpc-3736	49	19	the	the	DET
dpc-3736	49	20	protection	protection	NOUN
dpc-3736	49	21	of	of	ADP
dpc-3736	49	22	patients	patient	NOUN
dpc-3736	49	23	privacy	privacy	NOUN
dpc-3736	49	24	.	.	PUNCT
dpc-3736	50	1	the	the	DET
dpc-3736	50	2	publication	publication	NOUN
dpc-3736	50	3	of	of	ADP
dpc-3736	50	4	skin	skin	NOUN
dpc-3736	50	5	images	image	NOUN
dpc-3736	50	6	included	include	VERB
dpc-3736	50	7	in	in	ADP
dpc-3736	50	8	the	the	DET
dpc-3736	50	9	manuscript	manuscript	NOUN
dpc-3736	50	10	was	be	AUX
dpc-3736	50	11	done	do	VERB
dpc-3736	50	12	only	only	ADV
dpc-3736	50	13	with	with	ADP
dpc-3736	50	14	the	the	DET
dpc-3736	50	15	patients	patient	NOUN
dpc-3736	50	16	’	'	PUNCT
dpc-3736	50	17	written	write	VERB
dpc-3736	50	18	informed	informed	ADJ
dpc-3736	50	19	consent	consent	NOUN
dpc-3736	50	20	.	.	PUNCT
dpc-3736	51	1	the	the	DET
dpc-3736	51	2	study	study	NOUN
dpc-3736	51	3	adhered	adhere	VERB
dpc-3736	51	4	to	to	ADP
dpc-3736	51	5	the	the	DET
dpc-3736	51	6	applicable	applicable	ADJ
dpc-3736	51	7	consort	consort	NOUN
dpc-3736	51	8	guidelines	guideline	NOUN
dpc-3736	51	9	and	and	CCONJ
dpc-3736	51	10	was	be	AUX
dpc-3736	51	11	conducted	conduct	VERB
dpc-3736	51	12	in	in	ADP
dpc-3736	51	13	accordance	accordance	NOUN
dpc-3736	51	14	with	with	ADP
dpc-3736	51	15	the	the	DET
dpc-3736	51	16	principles	principle	NOUN
dpc-3736	51	17	stated	state	VERB
dpc-3736	51	18	in	in	ADP
dpc-3736	51	19	the	the	DET
dpc-3736	51	20	declaration	declaration	NOUN
dpc-3736	51	21	of	of	ADP
dpc-3736	51	22	helsinki	helsinki	PROPN
dpc-3736	51	23	.	.	PUNCT
dpc-3736	52	1	participant	participant	ADJ
dpc-3736	52	2	selection	selection	NOUN
dpc-3736	52	3	patients	patient	NOUN
dpc-3736	52	4	with	with	ADP
dpc-3736	52	5	pityriasis	pityriasis	NOUN
dpc-3736	52	6	versicolor	versicolor	NOUN
dpc-3736	52	7	who	who	PRON
dpc-3736	52	8	visited	visit	VERB
dpc-3736	52	9	shahid	shahid	PROPN
dpc-3736	52	10	faghihi	faghihi	PROPN
dpc-3736	52	11	,	,	PUNCT
dpc-3736	52	12	dermatology	dermatology	NOUN
dpc-3736	52	13	clinic	clinic	NOUN
dpc-3736	52	14	,	,	PUNCT
dpc-3736	52	15	shiraz	shiraz	PROPN
dpc-3736	52	16	,	,	PUNCT
dpc-3736	52	17	iran	iran	PROPN
dpc-3736	52	18	,	,	PUNCT
dpc-3736	52	19	were	be	AUX
dpc-3736	52	20	included	include	VERB
dpc-3736	52	21	in	in	ADP
dpc-3736	52	22	the	the	DET
dpc-3736	52	23	study	study	NOUN
dpc-3736	52	24	.	.	PUNCT
dpc-3736	53	1	the	the	DET
dpc-3736	53	2	diagnosis	diagnosis	NOUN
dpc-3736	53	3	of	of	ADP
dpc-3736	53	4	pv	pv	PROPN
dpc-3736	53	5	was	be	AUX
dpc-3736	53	6	based	base	VERB
dpc-3736	53	7	on	on	ADP
dpc-3736	53	8	clinical	clinical	ADJ
dpc-3736	53	9	grounds	ground	NOUN
dpc-3736	53	10	and	and	CCONJ
dpc-3736	53	11	wood	wood	NOUN
dpc-3736	53	12	’s	’s	PART
dpc-3736	53	13	light	light	ADJ
dpc-3736	53	14	examination	examination	NOUN
dpc-3736	53	15	.	.	PUNCT
dpc-3736	54	1	microscopic	microscopic	ADJ
dpc-3736	54	2	confirmation	confirmation	NOUN
dpc-3736	54	3	of	of	ADP
dpc-3736	54	4	the	the	DET
dpc-3736	54	5	skin	skin	NOUN
dpc-3736	54	6	infection	infection	NOUN
dpc-3736	54	7	was	be	AUX
dpc-3736	54	8	performed	perform	VERB
dpc-3736	54	9	using	use	VERB
dpc-3736	54	10	two	two	NUM
dpc-3736	54	11	consecutive	consecutive	ADJ
dpc-3736	54	12	potassium	potassium	NOUN
dpc-3736	54	13	hydroxide	hydroxide	NOUN
dpc-3736	54	14	(	(	PUNCT
dpc-3736	54	15	koh	koh	PROPN
dpc-3736	54	16	)	)	PUNCT
dpc-3736	54	17	smear	smear	NOUN
dpc-3736	54	18	examinations	examination	NOUN
dpc-3736	54	19	,	,	PUNCT
dpc-3736	54	20	with	with	ADP
dpc-3736	54	21	a	a	DET
dpc-3736	54	22	2	2	NUM
dpc-3736	54	23	-	-	PUNCT
dpc-3736	54	24	day	day	NOUN
dpc-3736	54	25	interval	interval	NOUN
dpc-3736	54	26	between	between	ADP
dpc-3736	54	27	each	each	DET
dpc-3736	54	28	examination	examination	NOUN
dpc-3736	54	29	.	.	PUNCT
dpc-3736	55	1	the	the	DET
dpc-3736	55	2	study	study	NOUN
dpc-3736	55	3	included	include	VERB
dpc-3736	55	4	patients	patient	NOUN
dpc-3736	55	5	aged	age	VERB
dpc-3736	55	6	between	between	ADP
dpc-3736	55	7	15	15	NUM
dpc-3736	55	8	to	to	PART
dpc-3736	55	9	70	70	NUM
dpc-3736	55	10	years	year	NOUN
dpc-3736	55	11	whose	whose	DET
dpc-3736	55	12	disease	disease	NOUN
dpc-3736	55	13	extent	extent	NOUN
dpc-3736	55	14	was	be	AUX
dpc-3736	55	15	less	less	ADJ
dpc-3736	55	16	than	than	ADP
dpc-3736	55	17	10	10	NUM
dpc-3736	55	18	%	%	NOUN
dpc-3736	55	19	.	.	PUNCT
dpc-3736	56	1	exclusion	exclusion	NOUN
dpc-3736	56	2	criteria	criterion	NOUN
dpc-3736	56	3	for	for	ADP
dpc-3736	56	4	the	the	DET
dpc-3736	56	5	study	study	NOUN
dpc-3736	56	6	were	be	AUX
dpc-3736	56	7	as	as	SCONJ
dpc-3736	56	8	follows	follow	VERB
dpc-3736	56	9	:	:	PUNCT
dpc-3736	56	10	patient	patient	ADJ
dpc-3736	56	11	dissatisfaction	dissatisfaction	NOUN
dpc-3736	56	12	to	to	PART
dpc-3736	56	13	participate	participate	VERB
dpc-3736	56	14	,	,	PUNCT
dpc-3736	56	15	history	history	NOUN
dpc-3736	56	16	of	of	ADP
dpc-3736	56	17	receiving	receive	VERB
dpc-3736	56	18	topical	topical	ADJ
dpc-3736	56	19	or	or	CCONJ
dpc-3736	56	20	systemic	systemic	ADJ
dpc-3736	56	21	antifungal	antifungal	ADJ
dpc-3736	56	22	agents	agent	NOUN
dpc-3736	56	23	in	in	ADP
dpc-3736	56	24	the	the	DET
dpc-3736	56	25	past	past	ADJ
dpc-3736	56	26	month	month	NOUN
dpc-3736	56	27	,	,	PUNCT
dpc-3736	56	28	immunosuppressed	immunosuppressed	ADJ
dpc-3736	56	29	conditions	condition	NOUN
dpc-3736	56	30	,	,	PUNCT
dpc-3736	56	31	sensitivity	sensitivity	NOUN
dpc-3736	56	32	to	to	ADP
dpc-3736	56	33	antifungal	antifungal	ADJ
dpc-3736	56	34	drugs	drug	NOUN
dpc-3736	56	35	,	,	PUNCT
dpc-3736	56	36	negative	negative	ADJ
dpc-3736	56	37	result	result	NOUN
dpc-3736	56	38	in	in	ADP
dpc-3736	56	39	either	either	PRON
dpc-3736	56	40	of	of	ADP
dpc-3736	56	41	the	the	DET
dpc-3736	56	42	koh	koh	PROPN
dpc-3736	56	43	smear	smear	NOUN
dpc-3736	56	44	examinations	examination	NOUN
dpc-3736	56	45	,	,	PUNCT
dpc-3736	56	46	non	non	ADJ
dpc-3736	56	47	-	-	NOUN
dpc-3736	56	48	adherence	adherence	NOUN
dpc-3736	56	49	to	to	ADP
dpc-3736	56	50	medications	medication	NOUN
dpc-3736	56	51	,	,	PUNCT
dpc-3736	56	52	and	and	CCONJ
dpc-3736	56	53	pregnancy	pregnancy	NOUN
dpc-3736	56	54	or	or	CCONJ
dpc-3736	56	55	breastfeeding	breastfeeding	NOUN
dpc-3736	56	56	.	.	PUNCT
dpc-3736	57	1	initially	initially	ADV
dpc-3736	57	2	,	,	PUNCT
dpc-3736	57	3	80	80	NUM
dpc-3736	57	4	patients	patient	NOUN
dpc-3736	57	5	were	be	AUX
dpc-3736	57	6	recruited	recruit	VERB
dpc-3736	57	7	,	,	PUNCT
dpc-3736	57	8	but	but	CCONJ
dpc-3736	57	9	some	some	DET
dpc-3736	57	10	patients	patient	NOUN
dpc-3736	57	11	declined	decline	VERB
dpc-3736	57	12	to	to	PART
dpc-3736	57	13	participate	participate	VERB
dpc-3736	57	14	in	in	ADP
dpc-3736	57	15	the	the	DET
dpc-3736	57	16	second	second	ADJ
dpc-3736	57	17	sampling	sampling	NOUN
dpc-3736	57	18	for	for	ADP
dpc-3736	57	19	koh	koh	PROPN
dpc-3736	57	20	smear	smear	PROPN
dpc-3736	57	21	examination	examination	NOUN
dpc-3736	57	22	.	.	PUNCT
dpc-3736	58	1	ultimately	ultimately	ADV
dpc-3736	58	2	,	,	PUNCT
dpc-3736	58	3	44	44	NUM
dpc-3736	58	4	patients	patient	NOUN
dpc-3736	58	5	were	be	AUX
dpc-3736	58	6	conclusions	conclusion	NOUN
dpc-3736	58	7	:	:	PUNCT
dpc-3736	58	8	the	the	DET
dpc-3736	58	9	topical	topical	ADJ
dpc-3736	58	10	application	application	NOUN
dpc-3736	58	11	of	of	ADP
dpc-3736	58	12	liposomal	liposomal	NOUN
dpc-3736	58	13	amphotericin	amphotericin	ADP
dpc-3736	58	14	b	b	PROPN
dpc-3736	58	15	0.4	0.4	NUM
dpc-3736	58	16	%	%	NOUN
dpc-3736	58	17	is	be	AUX
dpc-3736	58	18	equally	equally	ADV
dpc-3736	58	19	effective	effective	ADJ
dpc-3736	58	20	as	as	ADP
dpc-3736	58	21	topical	topical	ADJ
dpc-3736	58	22	clotrimazole	clotrimazole	NOUN
dpc-3736	58	23	1	1	NUM
dpc-3736	58	24	%	%	NOUN
dpc-3736	58	25	in	in	ADP
dpc-3736	58	26	treating	treat	VERB
dpc-3736	58	27	pityriasis	pityriasis	NOUN
dpc-3736	58	28	versicolor	versicolor	NOUN
dpc-3736	58	29	.	.	PUNCT
dpc-3736	59	1	these	these	DET
dpc-3736	59	2	findings	finding	NOUN
dpc-3736	59	3	suggest	suggest	VERB
dpc-3736	59	4	that	that	SCONJ
dpc-3736	59	5	liposomal	liposomal	NOUN
dpc-3736	59	6	amphotericin	amphotericin	ADP
dpc-3736	59	7	b	b	NOUN
dpc-3736	59	8	could	could	AUX
dpc-3736	59	9	be	be	AUX
dpc-3736	59	10	considered	consider	VERB
dpc-3736	59	11	as	as	ADP
dpc-3736	59	12	a	a	DET
dpc-3736	59	13	viable	viable	ADJ
dpc-3736	59	14	alternative	alternative	ADJ
dpc-3736	59	15	treatment	treatment	NOUN
dpc-3736	59	16	for	for	ADP
dpc-3736	59	17	pv	pv	NOUN
dpc-3736	59	18	.	.	PUNCT
dpc-3736	60	1	further	further	ADJ
dpc-3736	60	2	research	research	NOUN
dpc-3736	60	3	is	be	AUX
dpc-3736	60	4	warranted	warrant	VERB
dpc-3736	60	5	to	to	PART
dpc-3736	60	6	explore	explore	VERB
dpc-3736	60	7	its	its	PRON
dpc-3736	60	8	long	long	ADJ
dpc-3736	60	9	-	-	PUNCT
dpc-3736	60	10	term	term	NOUN
dpc-3736	60	11	consequences	consequence	NOUN
dpc-3736	60	12	and	and	CCONJ
dpc-3736	60	13	safety	safety	NOUN
dpc-3736	60	14	profile	profile	NOUN
dpc-3736	60	15	.	.	PUNCT
dpc-3736	61	1	original	original	ADJ
dpc-3736	61	2	article	article	NOUN
dpc-3736	61	3	|	|	ADV
dpc-3736	61	4	dermatol	dermatol	ADJ
dpc-3736	61	5	pract	pract	NOUN
dpc-3736	61	6	concept	concept	NOUN
dpc-3736	61	7	.	.	PUNCT
dpc-3736	62	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	62	2	3	3	NUM
dpc-3736	62	3	randomly	randomly	ADV
dpc-3736	62	4	allocated	allocate	VERB
dpc-3736	62	5	to	to	ADP
dpc-3736	62	6	two	two	NUM
dpc-3736	62	7	groups	group	NOUN
dpc-3736	62	8	:	:	PUNCT
dpc-3736	62	9	the	the	DET
dpc-3736	62	10	amphotericin	amphotericin	ADJ
dpc-3736	62	11	group	group	NOUN
dpc-3736	62	12	(	(	PUNCT
dpc-3736	62	13	a	a	DET
dpc-3736	62	14	group	group	NOUN
dpc-3736	62	15	)	)	PUNCT
dpc-3736	62	16	and	and	CCONJ
dpc-3736	62	17	the	the	DET
dpc-3736	62	18	clotrimazole	clotrimazole	NOUN
dpc-3736	62	19	group	group	NOUN
dpc-3736	62	20	(	(	PUNCT
dpc-3736	62	21	b	b	PROPN
dpc-3736	62	22	group	group	NOUN
dpc-3736	62	23	)	)	PUNCT
dpc-3736	62	24	.	.	PUNCT
dpc-3736	63	1	figure	figure	NOUN
dpc-3736	63	2	1	1	NUM
dpc-3736	63	3	illustrates	illustrate	VERB
dpc-3736	63	4	the	the	DET
dpc-3736	63	5	patient	patient	ADJ
dpc-3736	63	6	allocation	allocation	NOUN
dpc-3736	63	7	process	process	NOUN
dpc-3736	63	8	.	.	PUNCT
dpc-3736	64	1	intervention	intervention	NOUN
dpc-3736	64	2	the	the	DET
dpc-3736	64	3	diagnosis	diagnosis	NOUN
dpc-3736	64	4	of	of	ADP
dpc-3736	64	5	pv	pv	NOUN
dpc-3736	64	6	was	be	AUX
dpc-3736	64	7	initially	initially	ADV
dpc-3736	64	8	made	make	VERB
dpc-3736	64	9	based	base	VERB
dpc-3736	64	10	on	on	ADP
dpc-3736	64	11	clinical	clinical	ADJ
dpc-3736	64	12	grounds	ground	NOUN
dpc-3736	64	13	and	and	CCONJ
dpc-3736	64	14	wood	wood	NOUN
dpc-3736	64	15	’s	’s	PART
dpc-3736	64	16	light	light	ADJ
dpc-3736	64	17	examination	examination	NOUN
dpc-3736	64	18	.	.	PUNCT
dpc-3736	65	1	mycologic	mycologic	ADJ
dpc-3736	65	2	confirmation	confirmation	NOUN
dpc-3736	65	3	was	be	AUX
dpc-3736	65	4	then	then	ADV
dpc-3736	65	5	performed	perform	VERB
dpc-3736	65	6	through	through	ADP
dpc-3736	65	7	microscopic	microscopic	ADJ
dpc-3736	65	8	examination	examination	NOUN
dpc-3736	65	9	of	of	ADP
dpc-3736	65	10	scales	scale	NOUN
dpc-3736	65	11	soaked	soak	VERB
dpc-3736	65	12	in	in	ADP
dpc-3736	65	13	10	10	NUM
dpc-3736	65	14	%	%	NOUN
dpc-3736	65	15	potassium	potassium	NOUN
dpc-3736	65	16	hydroxide	hydroxide	NOUN
dpc-3736	65	17	(	(	PUNCT
dpc-3736	65	18	koh	koh	PROPN
dpc-3736	65	19	)	)	PUNCT
dpc-3736	65	20	during	during	ADP
dpc-3736	65	21	the	the	DET
dpc-3736	65	22	first	first	ADJ
dpc-3736	65	23	visit	visit	NOUN
dpc-3736	65	24	.	.	PUNCT
dpc-3736	66	1	for	for	ADP
dpc-3736	66	2	the	the	DET
dpc-3736	66	3	subsequent	subsequent	ADJ
dpc-3736	66	4	koh	koh	PROPN
dpc-3736	66	5	examination	examination	NOUN
dpc-3736	66	6	,	,	PUNCT
dpc-3736	66	7	patients	patient	NOUN
dpc-3736	66	8	were	be	AUX
dpc-3736	66	9	instructed	instruct	VERB
dpc-3736	66	10	not	not	PART
dpc-3736	66	11	to	to	PART
dpc-3736	66	12	bathe	bathe	VERB
dpc-3736	66	13	or	or	CCONJ
dpc-3736	66	14	use	use	VERB
dpc-3736	66	15	any	any	DET
dpc-3736	66	16	antifungal	antifungal	ADJ
dpc-3736	66	17	agent	agent	NOUN
dpc-3736	66	18	for	for	ADP
dpc-3736	66	19	2	2	NUM
dpc-3736	66	20	days	day	NOUN
dpc-3736	66	21	before	before	ADP
dpc-3736	66	22	the	the	DET
dpc-3736	66	23	second	second	ADJ
dpc-3736	66	24	sampling	sampling	NOUN
dpc-3736	66	25	.	.	PUNCT
dpc-3736	67	1	patients	patient	NOUN
dpc-3736	67	2	with	with	ADP
dpc-3736	67	3	two	two	NUM
dpc-3736	67	4	positive	positive	ADJ
dpc-3736	67	5	koh	koh	PROPN
dpc-3736	67	6	smear	smear	NOUN
dpc-3736	67	7	results	result	NOUN
dpc-3736	67	8	were	be	AUX
dpc-3736	67	9	randomly	randomly	ADV
dpc-3736	67	10	assigned	assign	VERB
dpc-3736	67	11	to	to	ADP
dpc-3736	67	12	either	either	CCONJ
dpc-3736	67	13	the	the	DET
dpc-3736	67	14	intervention	intervention	NOUN
dpc-3736	67	15	group	group	NOUN
dpc-3736	67	16	or	or	CCONJ
dpc-3736	67	17	the	the	DET
dpc-3736	67	18	control	control	NOUN
dpc-3736	67	19	group	group	NOUN
dpc-3736	67	20	using	use	VERB
dpc-3736	67	21	a	a	DET
dpc-3736	67	22	permuted	permuted	ADJ
dpc-3736	67	23	block	block	NOUN
dpc-3736	67	24	technique	technique	NOUN
dpc-3736	67	25	.	.	PUNCT
dpc-3736	68	1	to	to	PART
dpc-3736	68	2	maintain	maintain	VERB
dpc-3736	68	3	blinding	blind	VERB
dpc-3736	68	4	,	,	PUNCT
dpc-3736	68	5	the	the	DET
dpc-3736	68	6	intervention	intervention	NOUN
dpc-3736	68	7	medications	medication	NOUN
dpc-3736	68	8	were	be	AUX
dpc-3736	68	9	prepared	prepare	VERB
dpc-3736	68	10	by	by	ADP
dpc-3736	68	11	a	a	DET
dpc-3736	68	12	researcher	researcher	NOUN
dpc-3736	68	13	who	who	PRON
dpc-3736	68	14	was	be	AUX
dpc-3736	68	15	not	not	PART
dpc-3736	68	16	involved	involve	VERB
dpc-3736	68	17	in	in	ADP
dpc-3736	68	18	the	the	DET
dpc-3736	68	19	study	study	NOUN
dpc-3736	68	20	and	and	CCONJ
dpc-3736	68	21	were	be	AUX
dpc-3736	68	22	directly	directly	ADV
dpc-3736	68	23	delivered	deliver	VERB
dpc-3736	68	24	to	to	ADP
dpc-3736	68	25	the	the	DET
dpc-3736	68	26	patients	patient	NOUN
dpc-3736	68	27	.	.	PUNCT
dpc-3736	69	1	the	the	DET
dpc-3736	69	2	intervention	intervention	PROPN
dpc-3736	69	3	group	group	NOUN
dpc-3736	69	4	applied	apply	VERB
dpc-3736	69	5	liposomal	liposomal	NOUN
dpc-3736	69	6	amphotericin	amphotericin	ADP
dpc-3736	69	7	b	b	NOUN
dpc-3736	69	8	topical	topical	ADJ
dpc-3736	69	9	gel	gel	NOUN
dpc-3736	69	10	(	(	PUNCT
dpc-3736	69	11	sina	sina	PROPN
dpc-3736	69	12	ampholish	ampholish	ADJ
dpc-3736	69	13	0.4	0.4	NUM
dpc-3736	69	14	%	%	NOUN
dpc-3736	69	15	,	,	PUNCT
dpc-3736	69	16	exir	exir	PROPN
dpc-3736	69	17	nano	nano	PROPN
dpc-3736	69	18	sina	sina	PROPN
dpc-3736	69	19	company	company	PROPN
dpc-3736	69	20	)	)	PUNCT
dpc-3736	69	21	,	,	PUNCT
dpc-3736	69	22	while	while	SCONJ
dpc-3736	69	23	the	the	DET
dpc-3736	69	24	control	control	PROPN
dpc-3736	69	25	group	group	NOUN
dpc-3736	69	26	applied	apply	VERB
dpc-3736	69	27	clotrimazole	clotrimazole	NOUN
dpc-3736	69	28	topical	topical	ADJ
dpc-3736	69	29	cream	cream	NOUN
dpc-3736	69	30	(	(	PUNCT
dpc-3736	69	31	clotrimazole	clotrimazole	NOUN
dpc-3736	69	32	-	-	PUNCT
dpc-3736	69	33	najo	najo	ADJ
dpc-3736	69	34	1	1	NUM
dpc-3736	69	35	%	%	NOUN
dpc-3736	69	36	cream	cream	NOUN
dpc-3736	69	37	,	,	PUNCT
dpc-3736	69	38	najo	najo	ADV
dpc-3736	69	39	company	company	NOUN
dpc-3736	69	40	)	)	PUNCT
dpc-3736	69	41	on	on	ADP
dpc-3736	69	42	their	their	PRON
dpc-3736	69	43	skin	skin	NOUN
dpc-3736	69	44	lesions	lesion	NOUN
dpc-3736	69	45	twice	twice	ADV
dpc-3736	69	46	a	a	DET
dpc-3736	69	47	day	day	NOUN
dpc-3736	69	48	for	for	ADP
dpc-3736	69	49	14	14	NUM
dpc-3736	69	50	days	day	NOUN
dpc-3736	69	51	.	.	PUNCT
dpc-3736	70	1	due	due	ADP
dpc-3736	70	2	to	to	ADP
dpc-3736	70	3	the	the	DET
dpc-3736	70	4	different	different	ADJ
dpc-3736	70	5	formulations	formulation	NOUN
dpc-3736	70	6	of	of	ADP
dpc-3736	70	7	the	the	DET
dpc-3736	70	8	antifungal	antifungal	ADJ
dpc-3736	70	9	agents	agent	NOUN
dpc-3736	70	10	(	(	PUNCT
dpc-3736	70	11	gel	gel	NOUN
dpc-3736	70	12	versus	versus	ADP
dpc-3736	70	13	cream	cream	NOUN
dpc-3736	70	14	)	)	PUNCT
dpc-3736	70	15	,	,	PUNCT
dpc-3736	70	16	the	the	DET
dpc-3736	70	17	study	study	NOUN
dpc-3736	70	18	was	be	AUX
dpc-3736	70	19	not	not	PART
dpc-3736	70	20	blinded	blind	VERB
dpc-3736	70	21	to	to	ADP
dpc-3736	70	22	the	the	DET
dpc-3736	70	23	patients	patient	NOUN
dpc-3736	70	24	.	.	PUNCT
dpc-3736	71	1	thus	thus	ADV
dpc-3736	71	2	,	,	PUNCT
dpc-3736	71	3	blinding	blinding	NOUN
dpc-3736	71	4	was	be	AUX
dpc-3736	71	5	maintained	maintain	VERB
dpc-3736	71	6	for	for	ADP
dpc-3736	71	7	the	the	DET
dpc-3736	71	8	researchers	researcher	NOUN
dpc-3736	71	9	.	.	PUNCT
dpc-3736	72	1	the	the	DET
dpc-3736	72	2	patients	patient	NOUN
dpc-3736	72	3	’	’	PART
dpc-3736	72	4	data	datum	NOUN
dpc-3736	72	5	was	be	AUX
dpc-3736	72	6	coded	code	VERB
dpc-3736	72	7	with	with	ADP
dpc-3736	72	8	the	the	DET
dpc-3736	72	9	letter	letter	NOUN
dpc-3736	72	10	a	a	DET
dpc-3736	72	11	indicating	indicate	VERB
dpc-3736	72	12	the	the	DET
dpc-3736	72	13	amphotericin	amphotericin	ADJ
dpc-3736	72	14	group	group	NOUN
dpc-3736	72	15	and	and	CCONJ
dpc-3736	72	16	the	the	DET
dpc-3736	72	17	letter	letter	NOUN
dpc-3736	72	18	b	b	NOUN
dpc-3736	72	19	representing	represent	VERB
dpc-3736	72	20	clotrimazole	clotrimazole	NOUN
dpc-3736	72	21	,	,	PUNCT
dpc-3736	72	22	followed	follow	VERB
dpc-3736	72	23	by	by	ADP
dpc-3736	72	24	a	a	DET
dpc-3736	72	25	consecutive	consecutive	ADJ
dpc-3736	72	26	numerical	numerical	ADJ
dpc-3736	72	27	assignment	assignment	NOUN
dpc-3736	72	28	(	(	PUNCT
dpc-3736	72	29	a	a	DET
dpc-3736	72	30	/	/	SYM
dpc-3736	72	31	b1	b1	NOUN
dpc-3736	72	32	,	,	PUNCT
dpc-3736	72	33	a	a	DET
dpc-3736	72	34	/	/	SYM
dpc-3736	72	35	b2	b2	NOUN
dpc-3736	72	36	,	,	PUNCT
dpc-3736	72	37	etc	etc	X
dpc-3736	72	38	.	.	X
dpc-3736	72	39	)	)	PUNCT
dpc-3736	72	40	to	to	PART
dpc-3736	72	41	conceal	conceal	VERB
dpc-3736	72	42	the	the	DET
dpc-3736	72	43	patients	patient	NOUN
dpc-3736	72	44	categorization	categorization	NOUN
dpc-3736	72	45	and	and	CCONJ
dpc-3736	72	46	the	the	DET
dpc-3736	72	47	intervention	intervention	NOUN
dpc-3736	72	48	drug	drug	NOUN
dpc-3736	72	49	used	use	VERB
dpc-3736	72	50	.	.	PUNCT
dpc-3736	73	1	data	datum	NOUN
dpc-3736	73	2	collection	collection	NOUN
dpc-3736	73	3	and	and	CCONJ
dpc-3736	73	4	clinical	clinical	ADJ
dpc-3736	73	5	assessment	assessment	NOUN
dpc-3736	73	6	during	during	ADP
dpc-3736	73	7	the	the	DET
dpc-3736	73	8	first	first	ADJ
dpc-3736	73	9	visit	visit	NOUN
dpc-3736	73	10	,	,	PUNCT
dpc-3736	73	11	a	a	DET
dpc-3736	73	12	dermatologist	dermatologist	NOUN
dpc-3736	73	13	obtained	obtain	VERB
dpc-3736	73	14	the	the	DET
dpc-3736	73	15	patient	patient	ADJ
dpc-3736	73	16	medical	medical	ADJ
dpc-3736	73	17	history	history	NOUN
dpc-3736	73	18	,	,	PUNCT
dpc-3736	73	19	performed	perform	VERB
dpc-3736	73	20	a	a	DET
dpc-3736	73	21	physical	physical	ADJ
dpc-3736	73	22	examination	examination	NOUN
dpc-3736	73	23	,	,	PUNCT
dpc-3736	73	24	evaluated	evaluate	VERB
dpc-3736	73	25	the	the	DET
dpc-3736	73	26	eligibility	eligibility	NOUN
dpc-3736	73	27	criteria	criterion	NOUN
dpc-3736	73	28	,	,	PUNCT
dpc-3736	73	29	photographed	photograph	VERB
dpc-3736	73	30	the	the	DET
dpc-3736	73	31	skin	skin	NOUN
dpc-3736	73	32	lesions	lesion	NOUN
dpc-3736	73	33	,	,	PUNCT
dpc-3736	73	34	and	and	CCONJ
dpc-3736	73	35	assessed	assess	VERB
dpc-3736	73	36	the	the	DET
dpc-3736	73	37	extent	extent	NOUN
dpc-3736	73	38	of	of	ADP
dpc-3736	73	39	the	the	DET
dpc-3736	73	40	disease	disease	NOUN
dpc-3736	73	41	.	.	PUNCT
dpc-3736	74	1	the	the	DET
dpc-3736	74	2	dermatologist	dermatologist	NOUN
dpc-3736	74	3	also	also	ADV
dpc-3736	74	4	recorded	record	VERB
dpc-3736	74	5	information	information	NOUN
dpc-3736	74	6	related	relate	VERB
dpc-3736	74	7	to	to	ADP
dpc-3736	74	8	the	the	DET
dpc-3736	74	9	skin	skin	NOUN
dpc-3736	74	10	lesions	lesion	NOUN
dpc-3736	74	11	,	,	PUNCT
dpc-3736	74	12	such	such	ADJ
dpc-3736	74	13	as	as	ADP
dpc-3736	74	14	color	color	NOUN
dpc-3736	74	15	,	,	PUNCT
dpc-3736	74	16	size	size	NOUN
dpc-3736	74	17	,	,	PUNCT
dpc-3736	74	18	site	site	NOUN
dpc-3736	74	19	of	of	ADP
dpc-3736	74	20	involvement	involvement	NOUN
dpc-3736	74	21	,	,	PUNCT
dpc-3736	74	22	time	time	NOUN
dpc-3736	74	23	of	of	ADP
dpc-3736	74	24	onset	onset	NOUN
dpc-3736	74	25	,	,	PUNCT
dpc-3736	74	26	and	and	CCONJ
dpc-3736	74	27	any	any	DET
dpc-3736	74	28	previous	previous	ADJ
dpc-3736	74	29	treatments	treatment	NOUN
dpc-3736	74	30	received	receive	VERB
dpc-3736	74	31	.	.	PUNCT
dpc-3736	75	1	demographic	demographic	ADJ
dpc-3736	75	2	information	information	NOUN
dpc-3736	75	3	,	,	PUNCT
dpc-3736	75	4	including	include	VERB
dpc-3736	75	5	age	age	NOUN
dpc-3736	75	6	,	,	PUNCT
dpc-3736	75	7	sex	sex	NOUN
dpc-3736	75	8	,	,	PUNCT
dpc-3736	75	9	height	height	NOUN
dpc-3736	75	10	,	,	PUNCT
dpc-3736	75	11	weight	weight	NOUN
dpc-3736	75	12	,	,	PUNCT
dpc-3736	75	13	and	and	CCONJ
dpc-3736	75	14	personal	personal	ADJ
dpc-3736	75	15	contact	contact	NOUN
dpc-3736	75	16	number	number	NOUN
dpc-3736	75	17	,	,	PUNCT
dpc-3736	75	18	was	be	AUX
dpc-3736	75	19	collected	collect	VERB
dpc-3736	75	20	using	use	VERB
dpc-3736	75	21	a	a	DET
dpc-3736	75	22	new	new	ADJ
dpc-3736	75	23	medical	medical	ADJ
dpc-3736	75	24	record	record	NOUN
dpc-3736	75	25	for	for	ADP
dpc-3736	75	26	each	each	DET
dpc-3736	75	27	patient	patient	NOUN
dpc-3736	75	28	.	.	PUNCT
dpc-3736	76	1	microscopic	microscopic	ADJ
dpc-3736	76	2	examination	examination	NOUN
dpc-3736	76	3	of	of	ADP
dpc-3736	76	4	specimens	specimen	NOUN
dpc-3736	76	5	in	in	ADP
dpc-3736	76	6	koh	koh	PROPN
dpc-3736	76	7	were	be	AUX
dpc-3736	76	8	performed	perform	VERB
dpc-3736	76	9	twice	twice	ADV
dpc-3736	76	10	by	by	ADP
dpc-3736	76	11	another	another	DET
dpc-3736	76	12	researcher	researcher	NOUN
dpc-3736	76	13	,	,	PUNCT
dpc-3736	76	14	and	and	CCONJ
dpc-3736	76	15	the	the	DET
dpc-3736	76	16	results	result	NOUN
dpc-3736	76	17	were	be	AUX
dpc-3736	76	18	reported	report	VERB
dpc-3736	76	19	to	to	ADP
dpc-3736	76	20	the	the	DET
dpc-3736	76	21	dermatologist	dermatologist	NOUN
dpc-3736	76	22	.	.	PUNCT
dpc-3736	77	1	patient	patient	NOUN
dpc-3736	77	2	who	who	PRON
dpc-3736	77	3	met	meet	VERB
dpc-3736	77	4	the	the	DET
dpc-3736	77	5	eligibility	eligibility	NOUN
dpc-3736	77	6	criteria	criterion	NOUN
dpc-3736	77	7	were	be	AUX
dpc-3736	77	8	randomized	randomize	VERB
dpc-3736	77	9	to	to	PART
dpc-3736	77	10	receive	receive	VERB
dpc-3736	77	11	the	the	DET
dpc-3736	77	12	intervention	intervention	NOUN
dpc-3736	77	13	figure	figure	NOUN
dpc-3736	77	14	1	1	NUM
dpc-3736	77	15	.	.	PUNCT
dpc-3736	78	1	changes	change	NOUN
dpc-3736	78	2	in	in	ADP
dpc-3736	78	3	sample	sample	NOUN
dpc-3736	78	4	size	size	NOUN
dpc-3736	78	5	at	at	ADP
dpc-3736	78	6	different	different	ADJ
dpc-3736	78	7	stages	stage	NOUN
dpc-3736	78	8	.	.	PUNCT
dpc-3736	79	1	4	4	NUM
dpc-3736	79	2	original	original	ADJ
dpc-3736	79	3	article	article	NOUN
dpc-3736	79	4	|	|	ADV
dpc-3736	79	5	dermatol	dermatol	ADJ
dpc-3736	79	6	pract	pract	NOUN
dpc-3736	79	7	concept	concept	NOUN
dpc-3736	79	8	.	.	PUNCT
dpc-3736	80	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	80	2	variables	variable	NOUN
dpc-3736	80	3	were	be	AUX
dpc-3736	80	4	reported	report	VERB
dpc-3736	80	5	as	as	ADP
dpc-3736	80	6	standardized	standardized	ADJ
dpc-3736	80	7	mean	mean	NOUN
dpc-3736	80	8	difference	difference	NOUN
dpc-3736	80	9	(	(	PUNCT
dpc-3736	80	10	smd	smd	NOUN
dpc-3736	80	11	)	)	PUNCT
dpc-3736	80	12	±	±	NOUN
dpc-3736	80	13	standard	standard	ADJ
dpc-3736	80	14	deviations	deviation	NOUN
dpc-3736	80	15	(	(	PUNCT
dpc-3736	80	16	sd	sd	NOUN
dpc-3736	80	17	)	)	PUNCT
dpc-3736	80	18	or	or	CCONJ
dpc-3736	80	19	medians	median	NOUN
dpc-3736	80	20	with	with	ADP
dpc-3736	80	21	interquartile	interquartile	NOUN
dpc-3736	80	22	ranges	range	NOUN
dpc-3736	80	23	,	,	PUNCT
dpc-3736	80	24	depending	depend	VERB
dpc-3736	80	25	on	on	ADP
dpc-3736	80	26	their	their	PRON
dpc-3736	80	27	distribution	distribution	NOUN
dpc-3736	80	28	.	.	PUNCT
dpc-3736	81	1	for	for	ADP
dpc-3736	81	2	descriptive	descriptive	ADJ
dpc-3736	81	3	analysis	analysis	NOUN
dpc-3736	81	4	,	,	PUNCT
dpc-3736	81	5	we	we	PRON
dpc-3736	81	6	used	use	VERB
dpc-3736	81	7	t	t	NOUN
dpc-3736	81	8	-	-	PUNCT
dpc-3736	81	9	test	test	NOUN
dpc-3736	81	10	,	,	PUNCT
dpc-3736	81	11	anova	anova	PROPN
dpc-3736	81	12	test	test	PROPN
dpc-3736	81	13	,	,	PUNCT
dpc-3736	81	14	mann	mann	PROPN
dpc-3736	81	15	-	-	PUNCT
dpc-3736	81	16	whitney	whitney	PROPN
dpc-3736	81	17	test	test	NOUN
dpc-3736	81	18	,	,	PUNCT
dpc-3736	81	19	paired	pair	VERB
dpc-3736	81	20	t	t	NOUN
dpc-3736	81	21	-	-	PUNCT
dpc-3736	81	22	test	test	NOUN
dpc-3736	81	23	,	,	PUNCT
dpc-3736	81	24	and	and	CCONJ
dpc-3736	81	25	independent	independent	ADJ
dpc-3736	81	26	tests	test	NOUN
dpc-3736	81	27	.	.	PUNCT
dpc-3736	82	1	using	use	VERB
dpc-3736	82	2	a	a	DET
dpc-3736	82	3	binominal	binominal	ADJ
dpc-3736	82	4	regression	regression	NOUN
dpc-3736	82	5	model	model	NOUN
dpc-3736	82	6	,	,	PUNCT
dpc-3736	82	7	we	we	PRON
dpc-3736	82	8	assumed	assume	VERB
dpc-3736	82	9	a	a	DET
dpc-3736	82	10	log	log	NOUN
dpc-3736	82	11	link	link	NOUN
dpc-3736	82	12	function	function	NOUN
dpc-3736	82	13	to	to	PART
dpc-3736	82	14	produce	produce	VERB
dpc-3736	82	15	risk	risk	NOUN
dpc-3736	82	16	ratios	ratio	NOUN
dpc-3736	82	17	,	,	PUNCT
dpc-3736	82	18	when	when	SCONJ
dpc-3736	82	19	exponentiated	exponentiate	VERB
dpc-3736	82	20	,	,	PUNCT
dpc-3736	82	21	can	can	AUX
dpc-3736	82	22	be	be	AUX
dpc-3736	82	23	directly	directly	ADV
dpc-3736	82	24	interpreted	interpret	VERB
dpc-3736	82	25	as	as	ADP
dpc-3736	82	26	risk	risk	NOUN
dpc-3736	82	27	ratios	ratio	NOUN
dpc-3736	82	28	.	.	PUNCT
dpc-3736	83	1	to	to	PART
dpc-3736	83	2	obtain	obtain	VERB
dpc-3736	83	3	risk	risk	NOUN
dpc-3736	83	4	difference	difference	NOUN
dpc-3736	83	5	,	,	PUNCT
dpc-3736	83	6	the	the	DET
dpc-3736	83	7	method	method	NOUN
dpc-3736	83	8	assumes	assume	VERB
dpc-3736	83	9	an	an	DET
dpc-3736	83	10	identity	identity	NOUN
dpc-3736	83	11	link	link	NOUN
dpc-3736	83	12	function	function	NOUN
dpc-3736	83	13	to	to	PART
dpc-3736	83	14	obtain	obtain	VERB
dpc-3736	83	15	regression	regression	NOUN
dpc-3736	83	16	coefficients	coefficient	NOUN
dpc-3736	83	17	that	that	PRON
dpc-3736	83	18	are	be	AUX
dpc-3736	83	19	risk	risk	NOUN
dpc-3736	83	20	differences	difference	NOUN
dpc-3736	83	21	.	.	PUNCT
dpc-3736	84	1	a	a	DET
dpc-3736	84	2	p	p	NOUN
dpc-3736	84	3	value	value	NOUN
dpc-3736	84	4	of	of	ADP
dpc-3736	84	5	less	less	ADJ
dpc-3736	84	6	than	than	ADP
dpc-3736	84	7	0.05	0.05	NUM
dpc-3736	84	8	was	be	AUX
dpc-3736	84	9	considered	consider	VERB
dpc-3736	84	10	statistically	statistically	ADV
dpc-3736	84	11	significant	significant	ADJ
dpc-3736	84	12	.	.	PUNCT
dpc-3736	85	1	results	result	VERB
dpc-3736	85	2	a	a	DET
dpc-3736	85	3	total	total	NOUN
dpc-3736	85	4	of	of	ADP
dpc-3736	85	5	44	44	NUM
dpc-3736	85	6	patients	patient	NOUN
dpc-3736	85	7	participated	participate	VERB
dpc-3736	85	8	in	in	ADP
dpc-3736	85	9	the	the	DET
dpc-3736	85	10	study	study	NOUN
dpc-3736	85	11	,	,	PUNCT
dpc-3736	85	12	comprising	comprise	VERB
dpc-3736	85	13	24	24	NUM
dpc-3736	85	14	female	female	NOUN
dpc-3736	85	15	(	(	PUNCT
dpc-3736	85	16	54.5	54.5	NUM
dpc-3736	85	17	%	%	NOUN
dpc-3736	85	18	)	)	PUNCT
dpc-3736	85	19	and	and	CCONJ
dpc-3736	85	20	20	20	NUM
dpc-3736	85	21	male	male	NOUN
dpc-3736	85	22	(	(	PUNCT
dpc-3736	85	23	45.5	45.5	NUM
dpc-3736	85	24	%	%	NOUN
dpc-3736	85	25	)	)	PUNCT
dpc-3736	85	26	.	.	PUNCT
dpc-3736	86	1	the	the	DET
dpc-3736	86	2	mean	mean	ADJ
dpc-3736	86	3	age	age	NOUN
dpc-3736	86	4	of	of	ADP
dpc-3736	86	5	participants	participant	NOUN
dpc-3736	86	6	in	in	ADP
dpc-3736	86	7	amphotericin	amphotericin	NOUN
dpc-3736	86	8	and	and	CCONJ
dpc-3736	86	9	clotrimazole	clotrimazole	NOUN
dpc-3736	86	10	was	be	AUX
dpc-3736	86	11	31.18±	31.18±	NUM
dpc-3736	86	12	14.94	14.94	NUM
dpc-3736	86	13	and	and	CCONJ
dpc-3736	86	14	36.77±	36.77±	NUM
dpc-3736	86	15	14.74	14.74	NUM
dpc-3736	86	16	years	year	NOUN
dpc-3736	86	17	,	,	PUNCT
dpc-3736	86	18	respectively	respectively	ADV
dpc-3736	86	19	.	.	PUNCT
dpc-3736	87	1	there	there	PRON
dpc-3736	87	2	were	be	VERB
dpc-3736	87	3	no	no	DET
dpc-3736	87	4	significant	significant	ADJ
dpc-3736	87	5	differences	difference	NOUN
dpc-3736	87	6	between	between	ADP
dpc-3736	87	7	the	the	DET
dpc-3736	87	8	groups	group	NOUN
dpc-3736	87	9	in	in	ADP
dpc-3736	87	10	terms	term	NOUN
dpc-3736	87	11	of	of	ADP
dpc-3736	87	12	sex	sex	NOUN
dpc-3736	87	13	(	(	PUNCT
dpc-3736	87	14	p	p	NOUN
dpc-3736	87	15	=	=	NOUN
dpc-3736	87	16	0.22	0.22	NUM
dpc-3736	87	17	)	)	PUNCT
dpc-3736	87	18	and	and	CCONJ
dpc-3736	87	19	age	age	NOUN
dpc-3736	87	20	(	(	PUNCT
dpc-3736	87	21	p	p	X
dpc-3736	87	22	=	=	NOUN
dpc-3736	87	23	0.21	0.21	NUM
dpc-3736	87	24	)	)	PUNCT
dpc-3736	87	25	.	.	PUNCT
dpc-3736	88	1	the	the	DET
dpc-3736	88	2	most	most	ADV
dpc-3736	88	3	common	common	ADJ
dpc-3736	88	4	form	form	NOUN
dpc-3736	88	5	of	of	ADP
dpc-3736	88	6	fungal	fungal	ADJ
dpc-3736	88	7	cutaneous	cutaneous	ADJ
dpc-3736	88	8	infection	infection	NOUN
dpc-3736	88	9	in	in	ADP
dpc-3736	88	10	both	both	DET
dpc-3736	88	11	study	study	NOUN
dpc-3736	88	12	groups	group	NOUN
dpc-3736	88	13	was	be	AUX
dpc-3736	88	14	observed	observe	VERB
dpc-3736	88	15	on	on	ADP
dpc-3736	88	16	the	the	DET
dpc-3736	88	17	head	head	NOUN
dpc-3736	88	18	,	,	PUNCT
dpc-3736	88	19	neck	neck	NOUN
dpc-3736	88	20	,	,	PUNCT
dpc-3736	88	21	extremities	extremity	NOUN
dpc-3736	88	22	,	,	PUNCT
dpc-3736	88	23	or	or	CCONJ
dpc-3736	88	24	trunk	trunk	NOUN
dpc-3736	88	25	with	with	ADP
dpc-3736	88	26	regionally	regionally	ADV
dpc-3736	88	27	isolated	isolated	ADJ
dpc-3736	88	28	lesions	lesion	NOUN
dpc-3736	88	29	,	,	PUNCT
dpc-3736	88	30	without	without	ADP
dpc-3736	88	31	a	a	DET
dpc-3736	88	32	significant	significant	ADJ
dpc-3736	88	33	difference	difference	NOUN
dpc-3736	88	34	(	(	PUNCT
dpc-3736	88	35	p	p	NOUN
dpc-3736	88	36	=	=	NOUN
dpc-3736	88	37	0.24	0.24	NUM
dpc-3736	88	38	)	)	PUNCT
dpc-3736	88	39	(	(	PUNCT
dpc-3736	88	40	table	table	NOUN
dpc-3736	88	41	1	1	NUM
dpc-3736	88	42	)	)	PUNCT
dpc-3736	88	43	.	.	PUNCT
dpc-3736	89	1	patients	patient	NOUN
dpc-3736	89	2	were	be	AUX
dpc-3736	89	3	also	also	ADV
dpc-3736	89	4	categorized	categorize	VERB
dpc-3736	89	5	based	base	VERB
dpc-3736	89	6	on	on	ADP
dpc-3736	89	7	the	the	DET
dpc-3736	89	8	extent	extent	NOUN
dpc-3736	89	9	of	of	ADP
dpc-3736	89	10	skin	skin	NOUN
dpc-3736	89	11	involvement	involvement	NOUN
dpc-3736	89	12	into	into	ADP
dpc-3736	89	13	<	<	X
dpc-3736	89	14	1	1	NUM
dpc-3736	89	15	%	%	NOUN
dpc-3736	89	16	,	,	PUNCT
dpc-3736	89	17	1	1	NUM
dpc-3736	89	18	-	-	SYM
dpc-3736	89	19	3	3	NUM
dpc-3736	89	20	%	%	NOUN
dpc-3736	89	21	,	,	PUNCT
dpc-3736	89	22	and	and	CCONJ
dpc-3736	89	23	>	>	SYM
dpc-3736	89	24	3	3	NUM
dpc-3736	89	25	%	%	NOUN
dpc-3736	89	26	groups	group	NOUN
dpc-3736	89	27	(	(	PUNCT
dpc-3736	89	28	table	table	NOUN
dpc-3736	89	29	1	1	NUM
dpc-3736	89	30	)	)	PUNCT
dpc-3736	89	31	.	.	PUNCT
dpc-3736	90	1	more	more	ADJ
dpc-3736	90	2	than	than	ADP
dpc-3736	90	3	80	80	NUM
dpc-3736	90	4	%	%	NOUN
dpc-3736	90	5	of	of	ADP
dpc-3736	90	6	patients	patient	NOUN
dpc-3736	90	7	treated	treat	VERB
dpc-3736	90	8	with	with	ADP
dpc-3736	90	9	amphotericin	amphotericin	NOUN
dpc-3736	90	10	had	have	VERB
dpc-3736	90	11	1	1	NUM
dpc-3736	90	12	-	-	SYM
dpc-3736	90	13	3	3	NUM
dpc-3736	90	14	%	%	NOUN
dpc-3736	90	15	involvement	involvement	NOUN
dpc-3736	90	16	,	,	PUNCT
dpc-3736	90	17	while	while	SCONJ
dpc-3736	90	18	50	50	NUM
dpc-3736	90	19	%	%	NOUN
dpc-3736	90	20	of	of	ADP
dpc-3736	90	21	patients	patient	NOUN
dpc-3736	90	22	treated	treat	VERB
dpc-3736	90	23	with	with	ADP
dpc-3736	90	24	clotrimazole	clotrimazole	NOUN
dpc-3736	90	25	had	have	VERB
dpc-3736	90	26	>	>	NOUN
dpc-3736	90	27	3	3	NUM
dpc-3736	90	28	%	%	NOUN
dpc-3736	90	29	involvement	involvement	NOUN
dpc-3736	90	30	.	.	PUNCT
dpc-3736	91	1	the	the	DET
dpc-3736	91	2	study	study	NOUN
dpc-3736	91	3	groups	group	NOUN
dpc-3736	91	4	differed	differ	VERB
dpc-3736	91	5	significantly	significantly	ADV
dpc-3736	91	6	in	in	ADP
dpc-3736	91	7	terms	term	NOUN
dpc-3736	91	8	of	of	ADP
dpc-3736	91	9	lesion	lesion	NOUN
dpc-3736	91	10	extent	extent	NOUN
dpc-3736	91	11	(	(	PUNCT
dpc-3736	91	12	p	p	X
dpc-3736	91	13	=	=	NOUN
dpc-3736	91	14	0.02	0.02	NUM
dpc-3736	91	15	)	)	PUNCT
dpc-3736	91	16	.	.	PUNCT
dpc-3736	92	1	the	the	DET
dpc-3736	92	2	average	average	ADJ
dpc-3736	92	3	duration	duration	NOUN
dpc-3736	92	4	of	of	ADP
dpc-3736	92	5	the	the	DET
dpc-3736	92	6	disease	disease	NOUN
dpc-3736	92	7	was	be	AUX
dpc-3736	92	8	4.27±	4.27±	NOUN
dpc-3736	92	9	3.87	3.87	NUM
dpc-3736	92	10	months	month	NOUN
dpc-3736	92	11	for	for	ADP
dpc-3736	92	12	the	the	DET
dpc-3736	92	13	amphotericin	amphotericin	ADJ
dpc-3736	92	14	group	group	NOUN
dpc-3736	92	15	and	and	CCONJ
dpc-3736	92	16	6.77	6.77	NUM
dpc-3736	92	17	±6.80	±6.80	NOUN
dpc-3736	92	18	months	month	NOUN
dpc-3736	92	19	for	for	ADP
dpc-3736	92	20	the	the	DET
dpc-3736	92	21	clotrimazole	clotrimazole	NOUN
dpc-3736	92	22	group	group	NOUN
dpc-3736	92	23	,	,	PUNCT
dpc-3736	92	24	without	without	ADP
dpc-3736	92	25	a	a	DET
dpc-3736	92	26	significant	significant	ADJ
dpc-3736	92	27	difference	difference	NOUN
dpc-3736	92	28	(	(	PUNCT
dpc-3736	92	29	p	p	NOUN
dpc-3736	92	30	=	=	NOUN
dpc-3736	92	31	0.14	0.14	NUM
dpc-3736	92	32	)	)	PUNCT
dpc-3736	92	33	.	.	PUNCT
dpc-3736	93	1	the	the	DET
dpc-3736	93	2	most	most	ADJ
dpc-3736	93	3	medication	medication	NOUN
dpc-3736	93	4	.	.	PUNCT
dpc-3736	94	1	after	after	ADP
dpc-3736	94	2	2	2	NUM
dpc-3736	94	3	weeks	week	NOUN
dpc-3736	94	4	,	,	PUNCT
dpc-3736	94	5	the	the	DET
dpc-3736	94	6	patients	patient	NOUN
dpc-3736	94	7	returned	return	VERB
dpc-3736	94	8	to	to	ADP
dpc-3736	94	9	the	the	DET
dpc-3736	94	10	clinic	clinic	NOUN
dpc-3736	94	11	without	without	ADP
dpc-3736	94	12	bathing	bathe	VERB
dpc-3736	94	13	,	,	PUNCT
dpc-3736	94	14	and	and	CCONJ
dpc-3736	94	15	another	another	DET
dpc-3736	94	16	dermatologist	dermatologist	NOUN
dpc-3736	94	17	assessed	assess	VERB
dpc-3736	94	18	the	the	DET
dpc-3736	94	19	clinical	clinical	ADJ
dpc-3736	94	20	improvement	improvement	NOUN
dpc-3736	94	21	of	of	ADP
dpc-3736	94	22	their	their	PRON
dpc-3736	94	23	lesions	lesion	NOUN
dpc-3736	94	24	compared	compare	VERB
dpc-3736	94	25	to	to	ADP
dpc-3736	94	26	the	the	DET
dpc-3736	94	27	initial	initial	ADJ
dpc-3736	94	28	visit	visit	NOUN
dpc-3736	94	29	.	.	PUNCT
dpc-3736	95	1	outcome	outcome	NOUN
dpc-3736	95	2	measures	measure	VERB
dpc-3736	95	3	the	the	DET
dpc-3736	95	4	primary	primary	ADJ
dpc-3736	95	5	time	time	NOUN
dpc-3736	95	6	point	point	NOUN
dpc-3736	95	7	for	for	ADP
dpc-3736	95	8	measurement	measurement	NOUN
dpc-3736	95	9	was	be	AUX
dpc-3736	95	10	2	2	NUM
dpc-3736	95	11	weeks	week	NOUN
dpc-3736	95	12	after	after	ADP
dpc-3736	95	13	the	the	DET
dpc-3736	95	14	start	start	NOUN
dpc-3736	95	15	of	of	ADP
dpc-3736	95	16	treatment	treatment	NOUN
dpc-3736	95	17	or	or	CCONJ
dpc-3736	95	18	when	when	SCONJ
dpc-3736	95	19	patients	patient	NOUN
dpc-3736	95	20	completed	complete	VERB
dpc-3736	95	21	a	a	DET
dpc-3736	95	22	14	14	NUM
dpc-3736	95	23	-	-	PUNCT
dpc-3736	95	24	day	day	NOUN
dpc-3736	95	25	course	course	NOUN
dpc-3736	95	26	of	of	ADP
dpc-3736	95	27	treatment	treatment	NOUN
dpc-3736	95	28	.	.	PUNCT
dpc-3736	96	1	the	the	DET
dpc-3736	96	2	proportion	proportion	NOUN
dpc-3736	96	3	of	of	ADP
dpc-3736	96	4	participants	participant	NOUN
dpc-3736	96	5	with	with	ADP
dpc-3736	96	6	mycological	mycological	ADJ
dpc-3736	96	7	cure	cure	NOUN
dpc-3736	96	8	was	be	AUX
dpc-3736	96	9	determined	determine	VERB
dpc-3736	96	10	based	base	VERB
dpc-3736	96	11	on	on	ADP
dpc-3736	96	12	a	a	DET
dpc-3736	96	13	negative	negative	ADJ
dpc-3736	96	14	result	result	NOUN
dpc-3736	96	15	in	in	ADP
dpc-3736	96	16	the	the	DET
dpc-3736	96	17	koh	koh	PROPN
dpc-3736	96	18	smear	smear	NOUN
dpc-3736	96	19	examination	examination	NOUN
dpc-3736	96	20	at	at	ADP
dpc-3736	96	21	14	14	NUM
dpc-3736	96	22	days	day	NOUN
dpc-3736	96	23	posttreatment	posttreatment	NOUN
dpc-3736	96	24	 	 	SPACE
dpc-3736	97	1	[	[	X
dpc-3736	97	2	1,8	1,8	NUM
dpc-3736	97	3	]	]	X
dpc-3736	97	4	.	.	PUNCT
dpc-3736	98	1	another	another	DET
dpc-3736	98	2	primary	primary	ADJ
dpc-3736	98	3	outcome	outcome	NOUN
dpc-3736	98	4	was	be	AUX
dpc-3736	98	5	clinical	clinical	ADJ
dpc-3736	98	6	cure	cure	NOUN
dpc-3736	98	7	after	after	ADP
dpc-3736	98	8	2	2	NUM
dpc-3736	98	9	weeks	week	NOUN
dpc-3736	98	10	of	of	ADP
dpc-3736	98	11	treatment	treatment	NOUN
dpc-3736	98	12	,	,	PUNCT
dpc-3736	98	13	which	which	PRON
dpc-3736	98	14	was	be	AUX
dpc-3736	98	15	subjectively	subjectively	ADV
dpc-3736	98	16	assessed	assess	VERB
dpc-3736	98	17	by	by	ADP
dpc-3736	98	18	a	a	DET
dpc-3736	98	19	dermatologist	dermatologist	NOUN
dpc-3736	98	20	based	base	VERB
dpc-3736	98	21	on	on	ADP
dpc-3736	98	22	the	the	DET
dpc-3736	98	23	improvement	improvement	NOUN
dpc-3736	98	24	of	of	ADP
dpc-3736	98	25	skin	skin	NOUN
dpc-3736	98	26	lesions	lesion	NOUN
dpc-3736	98	27	(	(	PUNCT
dpc-3736	98	28	absence	absence	NOUN
dpc-3736	98	29	of	of	ADP
dpc-3736	98	30	scaling	scaling	NOUN
dpc-3736	98	31	and	and	CCONJ
dpc-3736	98	32	skin	skin	NOUN
dpc-3736	98	33	lesion	lesion	NOUN
dpc-3736	98	34	removal	removal	NOUN
dpc-3736	98	35	)	)	PUNCT
dpc-3736	98	36	compared	compare	VERB
dpc-3736	98	37	to	to	ADP
dpc-3736	98	38	the	the	DET
dpc-3736	98	39	initial	initial	ADJ
dpc-3736	98	40	visit	visit	NOUN
dpc-3736	98	41	.	.	PUNCT
dpc-3736	99	1	clinical	clinical	ADJ
dpc-3736	99	2	cure	cure	NOUN
dpc-3736	99	3	also	also	ADV
dpc-3736	99	4	included	include	VERB
dpc-3736	99	5	participant	participant	ADJ
dpc-3736	99	6	-	-	PUNCT
dpc-3736	99	7	reported	report	VERB
dpc-3736	99	8	cure	cure	NOUN
dpc-3736	99	9	based	base	VERB
dpc-3736	99	10	on	on	ADP
dpc-3736	99	11	cessation	cessation	NOUN
dpc-3736	99	12	of	of	ADP
dpc-3736	99	13	symptoms	symptom	NOUN
dpc-3736	99	14	,	,	PUNCT
dpc-3736	99	15	such	such	ADJ
dpc-3736	99	16	as	as	ADP
dpc-3736	99	17	scaling	scaling	NOUN
dpc-3736	99	18	,	,	PUNCT
dpc-3736	99	19	itching	itching	NOUN
dpc-3736	99	20	and	and	CCONJ
dpc-3736	99	21	disappearance	disappearance	NOUN
dpc-3736	99	22	of	of	ADP
dpc-3736	99	23	the	the	DET
dpc-3736	99	24	lesion	lesion	NOUN
dpc-3736	99	25	.	.	PUNCT
dpc-3736	100	1	complete	complete	ADJ
dpc-3736	100	2	cure	cure	NOUN
dpc-3736	100	3	was	be	AUX
dpc-3736	100	4	defined	define	VERB
dpc-3736	100	5	as	as	ADP
dpc-3736	100	6	both	both	DET
dpc-3736	100	7	100	100	NUM
dpc-3736	100	8	%	%	NOUN
dpc-3736	100	9	clinical	clinical	ADJ
dpc-3736	100	10	cure	cure	NOUN
dpc-3736	100	11	and	and	CCONJ
dpc-3736	100	12	laboratory	laboratory	NOUN
dpc-3736	100	13	cure	cure	NOUN
dpc-3736	100	14	.	.	PUNCT
dpc-3736	101	1	incomplete	incomplete	ADJ
dpc-3736	101	2	cure	cure	NOUN
dpc-3736	101	3	was	be	AUX
dpc-3736	101	4	referred	refer	VERB
dpc-3736	101	5	to	to	ADP
dpc-3736	101	6	either	either	CCONJ
dpc-3736	101	7	clinical	clinical	ADJ
dpc-3736	101	8	cure	cure	NOUN
dpc-3736	101	9	without	without	ADP
dpc-3736	101	10	laboratory	laboratory	NOUN
dpc-3736	101	11	cure	cure	NOUN
dpc-3736	101	12	or	or	CCONJ
dpc-3736	101	13	laboratory	laboratory	NOUN
dpc-3736	101	14	cure	cure	NOUN
dpc-3736	101	15	without	without	ADP
dpc-3736	101	16	full	full	ADJ
dpc-3736	101	17	clinical	clinical	ADJ
dpc-3736	101	18	cure	cure	NOUN
dpc-3736	101	19	.	.	PUNCT
dpc-3736	102	1	the	the	DET
dpc-3736	102	2	adverse	adverse	ADJ
dpc-3736	102	3	effects	effect	NOUN
dpc-3736	102	4	assessment	assessment	NOUN
dpc-3736	102	5	included	include	VERB
dpc-3736	102	6	harms	harm	NOUN
dpc-3736	102	7	reported	report	VERB
dpc-3736	102	8	in	in	ADP
dpc-3736	102	9	the	the	DET
dpc-3736	102	10	study	study	NOUN
dpc-3736	102	11	at	at	ADP
dpc-3736	102	12	any	any	DET
dpc-3736	102	13	time	time	NOUN
dpc-3736	102	14	during	during	ADP
dpc-3736	102	15	treatment	treatment	NOUN
dpc-3736	102	16	.	.	PUNCT
dpc-3736	103	1	statistical	statistical	ADJ
dpc-3736	103	2	analysis	analysis	NOUN
dpc-3736	103	3	according	accord	VERB
dpc-3736	103	4	to	to	ADP
dpc-3736	103	5	the	the	DET
dpc-3736	103	6	study	study	NOUN
dpc-3736	103	7	conducted	conduct	VERB
dpc-3736	103	8	by	by	ADP
dpc-3736	103	9	kausar	kausar	NOUN
dpc-3736	103	10	et	et	PROPN
dpc-3736	103	11	al	al	PROPN
dpc-3736	104	1	[	[	X
dpc-3736	104	2	9	9	NUM
dpc-3736	104	3	]	]	PUNCT
dpc-3736	104	4	and	and	CCONJ
dpc-3736	104	5	using	use	VERB
dpc-3736	104	6	cochrane	cochrane	NOUN
dpc-3736	104	7	formula	formula	NOUN
dpc-3736	104	8	,	,	PUNCT
dpc-3736	104	9	we	we	PRON
dpc-3736	104	10	reached	reach	VERB
dpc-3736	104	11	a	a	DET
dpc-3736	104	12	p	p	NOUN
dpc-3736	104	13	value	value	NOUN
dpc-3736	104	14	of	of	ADP
dpc-3736	104	15	28	28	NUM
dpc-3736	104	16	%	%	NOUN
dpc-3736	104	17	and	and	CCONJ
dpc-3736	104	18	p	p	NOUN
dpc-3736	104	19	=	=	NOUN
dpc-3736	104	20	0.2	0.2	NUM
dpc-3736	104	21	(	(	PUNCT
dpc-3736	104	22	d	d	NOUN
dpc-3736	104	23	=	=	SYM
dpc-3736	104	24	0.2p	0.2p	PROPN
dpc-3736	104	25	)	)	PUNCT
dpc-3736	104	26	.	.	PUNCT
dpc-3736	105	1	the	the	DET
dpc-3736	105	2	standard	standard	ADJ
dpc-3736	105	3	error	error	NOUN
dpc-3736	105	4	obtained	obtain	VERB
dpc-3736	105	5	was	be	AUX
dpc-3736	105	6	0.05	0.05	NUM
dpc-3736	105	7	.	.	PUNCT
dpc-3736	106	1	finally	finally	ADV
dpc-3736	106	2	,	,	PUNCT
dpc-3736	106	3	a	a	DET
dpc-3736	106	4	sample	sample	NOUN
dpc-3736	106	5	size	size	NOUN
dpc-3736	106	6	of	of	ADP
dpc-3736	106	7	22	22	NUM
dpc-3736	106	8	patients	patient	NOUN
dpc-3736	106	9	was	be	AUX
dpc-3736	106	10	obtained	obtain	VERB
dpc-3736	106	11	for	for	ADP
dpc-3736	106	12	each	each	DET
dpc-3736	106	13	group	group	NOUN
dpc-3736	106	14	.	.	PUNCT
dpc-3736	107	1	data	datum	NOUN
dpc-3736	107	2	were	be	AUX
dpc-3736	107	3	analyzed	analyze	VERB
dpc-3736	107	4	using	use	VERB
dpc-3736	107	5	spss	spss	PROPN
dpc-3736	107	6	v.21	v.21	PROPN
dpc-3736	107	7	software	software	NOUN
dpc-3736	107	8	.	.	PUNCT
dpc-3736	108	1	descriptive	descriptive	ADJ
dpc-3736	108	2	statistics	statistic	NOUN
dpc-3736	108	3	were	be	AUX
dpc-3736	108	4	used	use	VERB
dpc-3736	108	5	to	to	PART
dpc-3736	108	6	summarize	summarize	VERB
dpc-3736	108	7	the	the	DET
dpc-3736	108	8	demographic	demographic	ADJ
dpc-3736	108	9	and	and	CCONJ
dpc-3736	108	10	clinical	clinical	ADJ
dpc-3736	108	11	characteristics	characteristic	NOUN
dpc-3736	108	12	of	of	ADP
dpc-3736	108	13	the	the	DET
dpc-3736	108	14	participants	participant	NOUN
dpc-3736	108	15	.	.	PUNCT
dpc-3736	109	1	continuous	continuous	ADJ
dpc-3736	109	2	table	table	NOUN
dpc-3736	109	3	1	1	NUM
dpc-3736	109	4	.	.	X
dpc-3736	109	5	baseline	baseline	VERB
dpc-3736	109	6	demographic	demographic	ADJ
dpc-3736	109	7	information	information	NOUN
dpc-3736	109	8	of	of	ADP
dpc-3736	109	9	the	the	DET
dpc-3736	109	10	study	study	NOUN
dpc-3736	109	11	population	population	NOUN
dpc-3736	109	12	and	and	CCONJ
dpc-3736	109	13	distribution	distribution	NOUN
dpc-3736	109	14	of	of	ADP
dpc-3736	109	15	patients	patient	NOUN
dpc-3736	109	16	across	across	ADP
dpc-3736	109	17	variable	variable	ADJ
dpc-3736	109	18	categories	category	NOUN
dpc-3736	109	19	.	.	PUNCT
dpc-3736	110	1	variable	variable	ADJ
dpc-3736	110	2	category	category	NOUN
dpc-3736	110	3	amphotericin	amphotericin	ADP
dpc-3736	110	4	group	group	NOUN
dpc-3736	110	5	clotrimazole	clotrimazole	NOUN
dpc-3736	110	6	group	group	NOUN
dpc-3736	110	7	p	p	NOUN
dpc-3736	110	8	-	-	PUNCT
dpc-3736	110	9	value	value	NOUN
dpc-3736	110	10	gender	gender	NOUN
dpc-3736	110	11	female	female	NOUN
dpc-3736	110	12	10	10	NUM
dpc-3736	110	13	(	(	PUNCT
dpc-3736	110	14	45.45	45.45	NUM
dpc-3736	110	15	%	%	NOUN
dpc-3736	110	16	)	)	PUNCT
dpc-3736	110	17	14	14	NUM
dpc-3736	110	18	(	(	PUNCT
dpc-3736	110	19	63.64	63.64	NUM
dpc-3736	110	20	%	%	NOUN
dpc-3736	110	21	)	)	PUNCT
dpc-3736	110	22	0.226	0.226	NUM
dpc-3736	110	23	male	male	NOUN
dpc-3736	110	24	12	12	NUM
dpc-3736	110	25	(	(	PUNCT
dpc-3736	110	26	54.55	54.55	NUM
dpc-3736	110	27	%	%	NOUN
dpc-3736	110	28	)	)	PUNCT
dpc-3736	110	29	8	8	NUM
dpc-3736	110	30	(	(	PUNCT
dpc-3736	110	31	36.36	36.36	NUM
dpc-3736	110	32	%	%	NOUN
dpc-3736	110	33	)	)	PUNCT
dpc-3736	110	34	age	age	NOUN
dpc-3736	110	35	mean	mean	NOUN
dpc-3736	110	36	(	(	PUNCT
dpc-3736	110	37	years	year	NOUN
dpc-3736	110	38	)	)	PUNCT
dpc-3736	110	39	31.18±	31.18±	NUM
dpc-3736	110	40	14.94	14.94	NUM
dpc-3736	110	41	36.77±	36.77±	NUM
dpc-3736	110	42	14.74	14.74	NUM
dpc-3736	110	43	0.218	0.218	NUM
dpc-3736	110	44	lesion	lesion	NOUN
dpc-3736	110	45	extent	extent	NOUN
dpc-3736	110	46	less	less	ADJ
dpc-3736	110	47	than	than	ADP
dpc-3736	110	48	1	1	NUM
dpc-3736	110	49	%	%	NOUN
dpc-3736	110	50	0	0	NUM
dpc-3736	111	1	(	(	PUNCT
dpc-3736	111	2	0	0	NUM
dpc-3736	111	3	%	%	NOUN
dpc-3736	111	4	)	)	PUNCT
dpc-3736	111	5	1	1	NUM
dpc-3736	111	6	(	(	PUNCT
dpc-3736	111	7	4.55	4.55	NUM
dpc-3736	111	8	%	%	NOUN
dpc-3736	111	9	)	)	PUNCT
dpc-3736	111	10	0.027	0.027	NUM
dpc-3736	111	11	1	1	NUM
dpc-3736	111	12	-	-	SYM
dpc-3736	111	13	3	3	NUM
dpc-3736	111	14	%	%	NOUN
dpc-3736	111	15	18	18	NUM
dpc-3736	111	16	(	(	PUNCT
dpc-3736	111	17	81.83	81.83	NUM
dpc-3736	111	18	%	%	NOUN
dpc-3736	111	19	)	)	PUNCT
dpc-3736	111	20	10	10	NUM
dpc-3736	111	21	(	(	PUNCT
dpc-3736	111	22	45.45	45.45	NUM
dpc-3736	111	23	%	%	NOUN
dpc-3736	111	24	)	)	PUNCT
dpc-3736	111	25	more	more	ADJ
dpc-3736	111	26	than	than	ADP
dpc-3736	111	27	3	3	NUM
dpc-3736	111	28	%	%	NOUN
dpc-3736	111	29	4	4	NUM
dpc-3736	111	30	(	(	PUNCT
dpc-3736	111	31	18.18	18.18	NUM
dpc-3736	111	32	%	%	NOUN
dpc-3736	111	33	)	)	PUNCT
dpc-3736	111	34	11	11	NUM
dpc-3736	111	35	(	(	PUNCT
dpc-3736	111	36	50.00	50.00	NUM
dpc-3736	111	37	%	%	NOUN
dpc-3736	111	38	)	)	PUNCT
dpc-3736	111	39	disease	disease	NOUN
dpc-3736	111	40	duration	duration	NOUN
dpc-3736	111	41	mean	mean	NOUN
dpc-3736	111	42	(	(	PUNCT
dpc-3736	111	43	months	month	NOUN
dpc-3736	111	44	)	)	PUNCT
dpc-3736	111	45	4.27±	4.27±	NOUN
dpc-3736	111	46	3.87	3.87	NUM
dpc-3736	111	47	6.77	6.77	NUM
dpc-3736	111	48	±6.80	±6.80	NOUN
dpc-3736	111	49	0.141	0.141	NUM
dpc-3736	111	50	lesion	lesion	NOUN
dpc-3736	111	51	color	color	NOUN
dpc-3736	111	52	brown	brown	NOUN
dpc-3736	111	53	14	14	NUM
dpc-3736	111	54	(	(	PUNCT
dpc-3736	111	55	81.82	81.82	NUM
dpc-3736	111	56	%	%	NOUN
dpc-3736	111	57	)	)	PUNCT
dpc-3736	111	58	18	18	NUM
dpc-3736	111	59	(	(	PUNCT
dpc-3736	111	60	63.64	63.64	NUM
dpc-3736	111	61	%	%	NOUN
dpc-3736	111	62	)	)	PUNCT
dpc-3736	111	63	0.16	0.16	NUM
dpc-3736	111	64	white	white	ADJ
dpc-3736	111	65	7	7	NUM
dpc-3736	111	66	(	(	PUNCT
dpc-3736	111	67	31.82	31.82	NUM
dpc-3736	111	68	%	%	NOUN
dpc-3736	111	69	)	)	PUNCT
dpc-3736	111	70	2	2	NUM
dpc-3736	111	71	(	(	PUNCT
dpc-3736	111	72	9.09	9.09	NUM
dpc-3736	111	73	%	%	NOUN
dpc-3736	111	74	)	)	PUNCT
dpc-3736	111	75	red	red	ADJ
dpc-3736	111	76	0	0	PUNCT
dpc-3736	112	1	(	(	PUNCT
dpc-3736	112	2	0	0	NUM
dpc-3736	112	3	%	%	NOUN
dpc-3736	112	4	)	)	PUNCT
dpc-3736	112	5	1	1	NUM
dpc-3736	112	6	(	(	PUNCT
dpc-3736	112	7	4.55	4.55	NUM
dpc-3736	112	8	%	%	NOUN
dpc-3736	112	9	)	)	PUNCT
dpc-3736	112	10	reddish	reddish	ADJ
dpc-3736	112	11	brown	brown	NOUN
dpc-3736	112	12	1	1	NUM
dpc-3736	112	13	(	(	PUNCT
dpc-3736	112	14	4.55	4.55	NUM
dpc-3736	112	15	%	%	NOUN
dpc-3736	112	16	)	)	PUNCT
dpc-3736	112	17	1	1	NUM
dpc-3736	112	18	(	(	PUNCT
dpc-3736	112	19	4.55	4.55	NUM
dpc-3736	112	20	%	%	NOUN
dpc-3736	112	21	)	)	PUNCT
dpc-3736	112	22	site	site	NOUN
dpc-3736	112	23	of	of	ADP
dpc-3736	112	24	lesion	lesion	NOUN
dpc-3736	112	25	head	head	NOUN
dpc-3736	112	26	,	,	PUNCT
dpc-3736	112	27	neck	neck	NOUN
dpc-3736	112	28	,	,	PUNCT
dpc-3736	112	29	or	or	CCONJ
dpc-3736	112	30	extremities	extremity	NOUN
dpc-3736	112	31	12	12	NUM
dpc-3736	112	32	(	(	PUNCT
dpc-3736	112	33	54.55	54.55	NUM
dpc-3736	112	34	%	%	NOUN
dpc-3736	112	35	)	)	PUNCT
dpc-3736	112	36	7	7	NUM
dpc-3736	112	37	(	(	PUNCT
dpc-3736	112	38	31.82	31.82	NUM
dpc-3736	112	39	%	%	NOUN
dpc-3736	112	40	)	)	PUNCT
dpc-3736	112	41	0.244	0.244	NUM
dpc-3736	112	42	trunk	trunk	NOUN
dpc-3736	112	43	8	8	NUM
dpc-3736	112	44	(	(	PUNCT
dpc-3736	112	45	36.36	36.36	NUM
dpc-3736	112	46	%	%	NOUN
dpc-3736	112	47	)	)	PUNCT
dpc-3736	112	48	10	10	NUM
dpc-3736	112	49	(	(	PUNCT
dpc-3736	112	50	45.45	45.45	NUM
dpc-3736	112	51	%	%	NOUN
dpc-3736	112	52	)	)	PUNCT
dpc-3736	112	53	multiple	multiple	ADJ
dpc-3736	112	54	sites	site	NOUN
dpc-3736	112	55	2	2	NUM
dpc-3736	112	56	(	(	PUNCT
dpc-3736	112	57	9.09	9.09	NUM
dpc-3736	112	58	%	%	NOUN
dpc-3736	112	59	)	)	PUNCT
dpc-3736	112	60	5	5	NUM
dpc-3736	112	61	(	(	PUNCT
dpc-3736	112	62	22.73	22.73	NUM
dpc-3736	112	63	%	%	NOUN
dpc-3736	112	64	)	)	PUNCT
dpc-3736	112	65	original	original	ADJ
dpc-3736	112	66	article	article	NOUN
dpc-3736	112	67	|	|	ADV
dpc-3736	112	68	dermatol	dermatol	ADJ
dpc-3736	112	69	pract	pract	NOUN
dpc-3736	112	70	concept	concept	NOUN
dpc-3736	112	71	.	.	PUNCT
dpc-3736	113	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	113	2	5	5	NUM
dpc-3736	113	3	risk	risk	NOUN
dpc-3736	113	4	difference	difference	NOUN
dpc-3736	113	5	for	for	ADP
dpc-3736	113	6	complete	complete	ADJ
dpc-3736	113	7	cure	cure	NOUN
dpc-3736	113	8	without	without	ADP
dpc-3736	113	9	any	any	DET
dpc-3736	113	10	adjustments	adjustment	NOUN
dpc-3736	113	11	were	be	AUX
dpc-3736	113	12	estimated	estimate	VERB
dpc-3736	113	13	at	at	ADP
dpc-3736	113	14	1.07	1.07	NUM
dpc-3736	113	15	(	(	PUNCT
dpc-3736	113	16	95	95	NUM
dpc-3736	113	17	%	%	NOUN
dpc-3736	113	18	ci	ci	NOUN
dpc-3736	113	19	:	:	PUNCT
dpc-3736	113	20	0.67	0.67	NUM
dpc-3736	113	21	to	to	ADP
dpc-3736	113	22	1.72	1.72	NUM
dpc-3736	113	23	)	)	PUNCT
dpc-3736	113	24	and	and	CCONJ
dpc-3736	113	25	0.04	0.04	NUM
dpc-3736	113	26	(	(	PUNCT
dpc-3736	113	27	-0.24	-0.24	NOUN
dpc-3736	113	28	to	to	ADP
dpc-3736	113	29	0.33	0.33	NUM
dpc-3736	113	30	)	)	PUNCT
dpc-3736	113	31	,	,	PUNCT
dpc-3736	113	32	respectively	respectively	ADV
dpc-3736	113	33	.	.	PUNCT
dpc-3736	114	1	in	in	ADP
dpc-3736	114	2	other	other	ADJ
dpc-3736	114	3	words	word	NOUN
dpc-3736	114	4	,	,	PUNCT
dpc-3736	114	5	the	the	DET
dpc-3736	114	6	likelihood	likelihood	NOUN
dpc-3736	114	7	of	of	ADP
dpc-3736	114	8	complete	complete	ADJ
dpc-3736	114	9	cure	cure	NOUN
dpc-3736	114	10	in	in	ADP
dpc-3736	114	11	the	the	DET
dpc-3736	114	12	amphotericin	amphotericin	NOUN
dpc-3736	114	13	group	group	NOUN
dpc-3736	114	14	increased	increase	VERB
dpc-3736	114	15	by	by	ADP
dpc-3736	114	16	only	only	ADV
dpc-3736	114	17	0.07	0.07	NUM
dpc-3736	114	18	compared	compare	VERB
dpc-3736	114	19	to	to	ADP
dpc-3736	114	20	the	the	DET
dpc-3736	114	21	clotrimazole	clotrimazole	NOUN
dpc-3736	114	22	group	group	NOUN
dpc-3736	114	23	,	,	PUNCT
dpc-3736	114	24	which	which	PRON
dpc-3736	114	25	was	be	AUX
dpc-3736	114	26	not	not	PART
dpc-3736	114	27	statistically	statistically	ADV
dpc-3736	114	28	significant	significant	ADJ
dpc-3736	114	29	(	(	PUNCT
dpc-3736	114	30	p	p	X
dpc-3736	114	31	=	=	NOUN
dpc-3736	114	32	0.75	0.75	NUM
dpc-3736	114	33	)	)	PUNCT
dpc-3736	114	34	.	.	PUNCT
dpc-3736	115	1	binomial	binomial	ADJ
dpc-3736	115	2	logistic	logistic	ADJ
dpc-3736	115	3	regression	regression	NOUN
dpc-3736	115	4	was	be	AUX
dpc-3736	115	5	used	use	VERB
dpc-3736	115	6	to	to	PART
dpc-3736	115	7	compute	compute	VERB
dpc-3736	115	8	adjusted	adjusted	ADJ
dpc-3736	115	9	estimates	estimate	NOUN
dpc-3736	115	10	of	of	ADP
dpc-3736	115	11	the	the	DET
dpc-3736	115	12	risk	risk	NOUN
dpc-3736	115	13	ratio	ratio	NOUN
dpc-3736	115	14	and	and	CCONJ
dpc-3736	115	15	risk	risk	NOUN
dpc-3736	115	16	difference	difference	NOUN
dpc-3736	115	17	.	.	PUNCT
dpc-3736	116	1	adjustments	adjustment	NOUN
dpc-3736	116	2	for	for	ADP
dpc-3736	116	3	age	age	NOUN
dpc-3736	116	4	,	,	PUNCT
dpc-3736	116	5	sex	sex	NOUN
dpc-3736	116	6	,	,	PUNCT
dpc-3736	116	7	lesion	lesion	NOUN
dpc-3736	116	8	extent	extent	NOUN
dpc-3736	116	9	,	,	PUNCT
dpc-3736	116	10	and	and	CCONJ
dpc-3736	116	11	lesion	lesion	NOUN
dpc-3736	116	12	site	site	NOUN
dpc-3736	116	13	resulted	result	VERB
dpc-3736	116	14	in	in	ADP
dpc-3736	116	15	negligible	negligible	ADJ
dpc-3736	116	16	relative	relative	ADJ
dpc-3736	116	17	and	and	CCONJ
dpc-3736	116	18	absolute	absolute	ADJ
dpc-3736	116	19	changes	change	NOUN
dpc-3736	116	20	in	in	ADP
dpc-3736	116	21	the	the	DET
dpc-3736	116	22	clinical	clinical	ADJ
dpc-3736	116	23	outcome	outcome	NOUN
dpc-3736	116	24	.	.	PUNCT
dpc-3736	117	1	therefore	therefore	ADV
dpc-3736	117	2	,	,	PUNCT
dpc-3736	117	3	regardless	regardless	ADV
dpc-3736	117	4	of	of	ADP
dpc-3736	117	5	their	their	PRON
dpc-3736	117	6	age	age	NOUN
dpc-3736	117	7	,	,	PUNCT
dpc-3736	117	8	sex	sex	NOUN
dpc-3736	117	9	,	,	PUNCT
dpc-3736	117	10	lesion	lesion	NOUN
dpc-3736	117	11	size	size	NOUN
dpc-3736	117	12	,	,	PUNCT
dpc-3736	117	13	and	and	CCONJ
dpc-3736	117	14	site	site	NOUN
dpc-3736	117	15	,	,	PUNCT
dpc-3736	117	16	patients	patient	NOUN
dpc-3736	117	17	in	in	ADP
dpc-3736	117	18	both	both	DET
dpc-3736	117	19	groups	group	NOUN
dpc-3736	117	20	showed	show	VERB
dpc-3736	117	21	almost	almost	ADV
dpc-3736	117	22	equal	equal	ADJ
dpc-3736	117	23	response	response	NOUN
dpc-3736	117	24	to	to	ADP
dpc-3736	117	25	amphotericin	amphotericin	ADP
dpc-3736	117	26	b	b	NOUN
dpc-3736	117	27	and	and	CCONJ
dpc-3736	117	28	clotrimazole	clotrimazole	NOUN
dpc-3736	117	29	.	.	PUNCT
dpc-3736	118	1	none	none	NOUN
dpc-3736	118	2	of	of	ADP
dpc-3736	118	3	these	these	DET
dpc-3736	118	4	factors	factor	NOUN
dpc-3736	118	5	had	have	VERB
dpc-3736	118	6	a	a	DET
dpc-3736	118	7	statistically	statistically	ADV
dpc-3736	118	8	significant	significant	ADJ
dpc-3736	118	9	effect	effect	NOUN
dpc-3736	118	10	on	on	ADP
dpc-3736	118	11	the	the	DET
dpc-3736	118	12	efficacy	efficacy	NOUN
dpc-3736	118	13	of	of	ADP
dpc-3736	118	14	the	the	DET
dpc-3736	118	15	drugs	drug	NOUN
dpc-3736	118	16	(	(	PUNCT
dpc-3736	118	17	p	p	X
dpc-3736	118	18	>	>	X
dpc-3736	118	19	0.05	0.05	NUM
dpc-3736	118	20	)	)	PUNCT
dpc-3736	118	21	.	.	PUNCT
dpc-3736	119	1	conclusions	conclusion	NOUN
dpc-3736	119	2	pv	pv	NOUN
dpc-3736	119	3	is	be	AUX
dpc-3736	119	4	commonly	commonly	ADV
dpc-3736	119	5	treated	treat	VERB
dpc-3736	119	6	with	with	ADP
dpc-3736	119	7	ketoconazole	ketoconazole	NOUN
dpc-3736	119	8	,	,	PUNCT
dpc-3736	119	9	a	a	DET
dpc-3736	119	10	topical	topical	ADJ
dpc-3736	119	11	antifungal	antifungal	ADJ
dpc-3736	119	12	agent	agent	NOUN
dpc-3736	119	13	[	[	X
dpc-3736	119	14	10,11	10,11	NOUN
dpc-3736	119	15	]	]	PUNCT
dpc-3736	119	16	.	.	PUNCT
dpc-3736	120	1	previous	previous	ADJ
dpc-3736	120	2	studies	study	NOUN
dpc-3736	120	3	have	have	AUX
dpc-3736	120	4	shown	show	VERB
dpc-3736	120	5	that	that	SCONJ
dpc-3736	120	6	ketoconazole	ketoconazole	PROPN
dpc-3736	120	7	cream	cream	NOUN
dpc-3736	120	8	is	be	AUX
dpc-3736	120	9	equally	equally	ADV
dpc-3736	120	10	effective	effective	ADJ
dpc-3736	120	11	as	as	ADP
dpc-3736	120	12	1	1	NUM
dpc-3736	120	13	%	%	NOUN
dpc-3736	120	14	clotrimazole	clotrimazole	NOUN
dpc-3736	120	15	and	and	CCONJ
dpc-3736	120	16	1	1	NUM
dpc-3736	120	17	%	%	NOUN
dpc-3736	120	18	terbinafine	terbinafine	NOUN
dpc-3736	120	19	cream	cream	NOUN
dpc-3736	121	1	[	[	X
dpc-3736	121	2	12,13	12,13	NUM
dpc-3736	121	3	]	]	PUNCT
dpc-3736	121	4	.	.	PUNCT
dpc-3736	122	1	although	although	SCONJ
dpc-3736	122	2	clotrimazole	clotrimazole	NOUN
dpc-3736	122	3	is	be	AUX
dpc-3736	122	4	widely	widely	ADV
dpc-3736	122	5	used	use	VERB
dpc-3736	122	6	and	and	CCONJ
dpc-3736	122	7	proven	prove	VERB
dpc-3736	122	8	effective	effective	ADJ
dpc-3736	122	9	[	[	X
dpc-3736	122	10	3	3	NUM
dpc-3736	122	11	]	]	PUNCT
dpc-3736	122	12	,	,	PUNCT
dpc-3736	122	13	there	there	PRON
dpc-3736	122	14	is	be	VERB
dpc-3736	122	15	ongoing	ongoing	ADJ
dpc-3736	122	16	research	research	NOUN
dpc-3736	122	17	to	to	PART
dpc-3736	122	18	identify	identify	VERB
dpc-3736	122	19	alternative	alternative	ADJ
dpc-3736	122	20	effective	effective	ADJ
dpc-3736	122	21	agents	agent	NOUN
dpc-3736	122	22	for	for	ADP
dpc-3736	122	23	pv	pv	NOUN
dpc-3736	122	24	treatment	treatment	NOUN
dpc-3736	122	25	,	,	PUNCT
dpc-3736	122	26	beyond	beyond	ADP
dpc-3736	122	27	the	the	DET
dpc-3736	122	28	commonly	commonly	ADV
dpc-3736	122	29	used	use	VERB
dpc-3736	122	30	azoles	azole	NOUN
dpc-3736	122	31	.	.	PUNCT
dpc-3736	123	1	several	several	ADJ
dpc-3736	123	2	studies	study	NOUN
dpc-3736	123	3	have	have	AUX
dpc-3736	123	4	explored	explore	VERB
dpc-3736	123	5	the	the	DET
dpc-3736	123	6	efficacy	efficacy	NOUN
dpc-3736	123	7	of	of	ADP
dpc-3736	123	8	different	different	ADJ
dpc-3736	123	9	treatment	treatment	NOUN
dpc-3736	123	10	options	option	NOUN
dpc-3736	123	11	for	for	ADP
dpc-3736	123	12	pv	pv	INTJ
dpc-3736	123	13	.	.	PUNCT
dpc-3736	124	1	for	for	ADP
dpc-3736	124	2	example	example	NOUN
dpc-3736	124	3	,	,	PUNCT
dpc-3736	124	4	the	the	DET
dpc-3736	124	5	effectiveness	effectiveness	NOUN
dpc-3736	124	6	common	common	ADJ
dpc-3736	124	7	lesion	lesion	NOUN
dpc-3736	124	8	color	color	NOUN
dpc-3736	124	9	was	be	AUX
dpc-3736	124	10	brownish	brownish	ADJ
dpc-3736	124	11	discoloration	discoloration	NOUN
dpc-3736	124	12	,	,	PUNCT
dpc-3736	124	13	observed	observe	VERB
dpc-3736	124	14	in	in	ADP
dpc-3736	124	15	81.82	81.82	NUM
dpc-3736	124	16	%	%	NOUN
dpc-3736	124	17	and	and	CCONJ
dpc-3736	124	18	63.64	63.64	NUM
dpc-3736	124	19	%	%	NOUN
dpc-3736	124	20	of	of	ADP
dpc-3736	124	21	the	the	DET
dpc-3736	124	22	patients	patient	NOUN
dpc-3736	124	23	in	in	ADP
dpc-3736	124	24	each	each	DET
dpc-3736	124	25	group	group	NOUN
dpc-3736	124	26	,	,	PUNCT
dpc-3736	124	27	respectively	respectively	ADV
dpc-3736	124	28	.	.	PUNCT
dpc-3736	125	1	there	there	PRON
dpc-3736	125	2	was	be	VERB
dpc-3736	125	3	no	no	DET
dpc-3736	125	4	significant	significant	ADJ
dpc-3736	125	5	difference	difference	NOUN
dpc-3736	125	6	in	in	ADP
dpc-3736	125	7	lesion	lesion	NOUN
dpc-3736	125	8	color	color	NOUN
dpc-3736	125	9	between	between	ADP
dpc-3736	125	10	the	the	DET
dpc-3736	125	11	groups	group	NOUN
dpc-3736	125	12	(	(	PUNCT
dpc-3736	125	13	p	p	X
dpc-3736	125	14	=	=	NOUN
dpc-3736	125	15	0.16	0.16	NUM
dpc-3736	125	16	)	)	PUNCT
dpc-3736	125	17	.	.	PUNCT
dpc-3736	126	1	one	one	NUM
dpc-3736	126	2	patient	patient	NOUN
dpc-3736	126	3	in	in	ADP
dpc-3736	126	4	the	the	DET
dpc-3736	126	5	topical	topical	ADJ
dpc-3736	126	6	amphotericin	amphotericin	VERB
dpc-3736	126	7	b	b	PROPN
dpc-3736	126	8	group	group	NOUN
dpc-3736	126	9	experienced	experience	VERB
dpc-3736	126	10	(	(	PUNCT
dpc-3736	126	11	irritation	irritation	NOUN
dpc-3736	126	12	and	and	CCONJ
dpc-3736	126	13	dryness	dryness	NOUN
dpc-3736	126	14	)	)	PUNCT
dpc-3736	126	15	,	,	PUNCT
dpc-3736	126	16	which	which	PRON
dpc-3736	126	17	was	be	AUX
dpc-3736	126	18	tolerable	tolerable	ADJ
dpc-3736	126	19	,	,	PUNCT
dpc-3736	126	20	and	and	CCONJ
dpc-3736	126	21	the	the	DET
dpc-3736	126	22	intervention	intervention	NOUN
dpc-3736	126	23	was	be	AUX
dpc-3736	126	24	continued	continue	VERB
dpc-3736	126	25	.	.	PUNCT
dpc-3736	127	1	no	no	DET
dpc-3736	127	2	adverse	adverse	ADJ
dpc-3736	127	3	effects	effect	NOUN
dpc-3736	127	4	were	be	AUX
dpc-3736	127	5	reported	report	VERB
dpc-3736	127	6	by	by	ADP
dpc-3736	127	7	the	the	DET
dpc-3736	127	8	patients	patient	NOUN
dpc-3736	127	9	who	who	PRON
dpc-3736	127	10	received	receive	VERB
dpc-3736	127	11	clotrimazole	clotrimazole	NOUN
dpc-3736	127	12	.	.	PUNCT
dpc-3736	128	1	the	the	DET
dpc-3736	128	2	results	result	NOUN
dpc-3736	128	3	of	of	ADP
dpc-3736	128	4	the	the	DET
dpc-3736	128	5	primary	primary	ADJ
dpc-3736	128	6	outcome	outcome	NOUN
dpc-3736	128	7	measures	measure	NOUN
dpc-3736	128	8	are	be	AUX
dpc-3736	128	9	summarized	summarize	VERB
dpc-3736	128	10	in	in	ADP
dpc-3736	128	11	table	table	NOUN
dpc-3736	128	12	2	2	NUM
dpc-3736	128	13	using	use	VERB
dpc-3736	128	14	the	the	DET
dpc-3736	128	15	chi	chi	ADJ
dpc-3736	128	16	-	-	PUNCT
dpc-3736	128	17	square	square	ADJ
dpc-3736	128	18	test	test	NOUN
dpc-3736	128	19	.	.	PUNCT
dpc-3736	129	1	both	both	DET
dpc-3736	129	2	liposomal	liposomal	ADJ
dpc-3736	129	3	amphotericin	amphotericin	ADP
dpc-3736	129	4	b	b	NOUN
dpc-3736	129	5	and	and	CCONJ
dpc-3736	129	6	clotrimazole	clotrimazole	PROPN
dpc-3736	129	7	successfully	successfully	ADV
dpc-3736	129	8	treated	treat	VERB
dpc-3736	129	9	most	most	ADJ
dpc-3736	129	10	patients	patient	NOUN
dpc-3736	129	11	(	(	PUNCT
dpc-3736	129	12	77.3	77.3	NUM
dpc-3736	129	13	%	%	NOUN
dpc-3736	129	14	)	)	PUNCT
dpc-3736	129	15	based	base	VERB
dpc-3736	129	16	on	on	ADP
dpc-3736	129	17	microscopic	microscopic	ADJ
dpc-3736	129	18	examination	examination	NOUN
dpc-3736	129	19	.	.	PUNCT
dpc-3736	130	1	there	there	PRON
dpc-3736	130	2	was	be	VERB
dpc-3736	130	3	no	no	DET
dpc-3736	130	4	significant	significant	ADJ
dpc-3736	130	5	difference	difference	NOUN
dpc-3736	130	6	in	in	ADP
dpc-3736	130	7	microscopic	microscopic	ADJ
dpc-3736	130	8	cure	cure	NOUN
dpc-3736	130	9	between	between	ADP
dpc-3736	130	10	the	the	DET
dpc-3736	130	11	two	two	NUM
dpc-3736	130	12	antifungal	antifungal	ADJ
dpc-3736	130	13	agents	agent	NOUN
dpc-3736	130	14	(	(	PUNCT
dpc-3736	130	15	p=	p=	NOUN
dpc-3736	130	16	1	1	NUM
dpc-3736	130	17	,	,	PUNCT
dpc-3736	130	18	rr=1	rr=1	NOUN
dpc-3736	130	19	,	,	PUNCT
dpc-3736	130	20	95%ci	95%ci	NUM
dpc-3736	130	21	:	:	PUNCT
dpc-3736	130	22	0.73	0.73	NUM
dpc-3736	130	23	-	-	PUNCT
dpc-3736	130	24	1.38	1.38	NUM
dpc-3736	130	25	)	)	PUNCT
dpc-3736	130	26	.	.	PUNCT
dpc-3736	131	1	regarding	regard	VERB
dpc-3736	131	2	clinical	clinical	ADJ
dpc-3736	131	3	cure	cure	NOUN
dpc-3736	131	4	,	,	PUNCT
dpc-3736	131	5	14	14	NUM
dpc-3736	131	6	(	(	PUNCT
dpc-3736	131	7	63.6	63.6	NUM
dpc-3736	131	8	%	%	NOUN
dpc-3736	131	9	)	)	PUNCT
dpc-3736	131	10	and	and	CCONJ
dpc-3736	131	11	13	13	NUM
dpc-3736	131	12	(	(	PUNCT
dpc-3736	131	13	59.1	59.1	NUM
dpc-3736	131	14	%	%	NOUN
dpc-3736	131	15	)	)	PUNCT
dpc-3736	131	16	of	of	ADP
dpc-3736	131	17	the	the	DET
dpc-3736	131	18	patients	patient	NOUN
dpc-3736	131	19	who	who	PRON
dpc-3736	131	20	received	receive	VERB
dpc-3736	131	21	amphotericin	amphotericin	ADP
dpc-3736	131	22	b	b	NOUN
dpc-3736	131	23	and	and	CCONJ
dpc-3736	131	24	clotrimazole	clotrimazole	NOUN
dpc-3736	131	25	,	,	PUNCT
dpc-3736	131	26	respectively	respectively	ADV
dpc-3736	131	27	,	,	PUNCT
dpc-3736	131	28	achieved	achieve	VERB
dpc-3736	131	29	full	full	ADJ
dpc-3736	131	30	recovery	recovery	NOUN
dpc-3736	131	31	.	.	PUNCT
dpc-3736	132	1	the	the	DET
dpc-3736	132	2	analysis	analysis	NOUN
dpc-3736	132	3	also	also	ADV
dpc-3736	132	4	showed	show	VERB
dpc-3736	132	5	similar	similar	ADJ
dpc-3736	132	6	clinical	clinical	ADJ
dpc-3736	132	7	effectiveness	effectiveness	NOUN
dpc-3736	132	8	of	of	ADP
dpc-3736	132	9	both	both	DET
dpc-3736	132	10	medications	medication	NOUN
dpc-3736	132	11	(	(	PUNCT
dpc-3736	132	12	p	p	X
dpc-3736	132	13	>	>	X
dpc-3736	132	14	0.05	0.05	NUM
dpc-3736	132	15	)	)	PUNCT
dpc-3736	132	16	.	.	PUNCT
dpc-3736	133	1	when	when	SCONJ
dpc-3736	133	2	assessing	assess	VERB
dpc-3736	133	3	mycologic	mycologic	ADJ
dpc-3736	133	4	and	and	CCONJ
dpc-3736	133	5	clinical	clinical	ADJ
dpc-3736	133	6	treatments	treatment	NOUN
dpc-3736	133	7	combined	combine	VERB
dpc-3736	133	8	,	,	PUNCT
dpc-3736	133	9	14	14	NUM
dpc-3736	133	10	(	(	PUNCT
dpc-3736	133	11	63.6	63.6	NUM
dpc-3736	133	12	%	%	NOUN
dpc-3736	133	13	)	)	PUNCT
dpc-3736	133	14	and	and	CCONJ
dpc-3736	133	15	13	13	NUM
dpc-3736	133	16	(	(	PUNCT
dpc-3736	133	17	59.1	59.1	NUM
dpc-3736	133	18	%	%	NOUN
dpc-3736	133	19	)	)	PUNCT
dpc-3736	133	20	of	of	ADP
dpc-3736	133	21	patients	patient	NOUN
dpc-3736	133	22	in	in	ADP
dpc-3736	133	23	amphotericin	amphotericin	NOUN
dpc-3736	133	24	and	and	CCONJ
dpc-3736	133	25	clotrimazole	clotrimazole	NOUN
dpc-3736	133	26	groups	group	NOUN
dpc-3736	133	27	,	,	PUNCT
dpc-3736	133	28	respectively	respectively	ADV
dpc-3736	133	29	,	,	PUNCT
dpc-3736	133	30	showed	show	VERB
dpc-3736	133	31	complete	complete	ADJ
dpc-3736	133	32	cure	cure	NOUN
dpc-3736	133	33	.	.	PUNCT
dpc-3736	134	1	no	no	DET
dpc-3736	134	2	significant	significant	ADJ
dpc-3736	134	3	difference	difference	NOUN
dpc-3736	134	4	was	be	AUX
dpc-3736	134	5	found	find	VERB
dpc-3736	134	6	between	between	ADP
dpc-3736	134	7	the	the	DET
dpc-3736	134	8	groups	group	NOUN
dpc-3736	134	9	regarding	regard	VERB
dpc-3736	134	10	the	the	DET
dpc-3736	134	11	degree	degree	NOUN
dpc-3736	134	12	of	of	ADP
dpc-3736	134	13	cure	cure	NOUN
dpc-3736	134	14	(	(	PUNCT
dpc-3736	134	15	p	p	X
dpc-3736	134	16	=	=	NOUN
dpc-3736	134	17	0.75	0.75	NUM
dpc-3736	134	18	,	,	PUNCT
dpc-3736	134	19	rr=1.08	rr=1.08	ADJ
dpc-3736	134	20	,	,	PUNCT
dpc-3736	134	21	95	95	NUM
dpc-3736	134	22	%	%	NOUN
dpc-3736	134	23	ci	ci	NOUN
dpc-3736	134	24	:	:	PUNCT
dpc-3736	134	25	 	 	SPACE
dpc-3736	134	26	0.67	0.67	NUM
dpc-3736	134	27	-	-	PUNCT
dpc-3736	134	28	1.72	1.72	NUM
dpc-3736	134	29	)	)	PUNCT
dpc-3736	134	30	.	.	PUNCT
dpc-3736	135	1	table	table	NOUN
dpc-3736	135	2	3	3	NUM
dpc-3736	135	3	presents	present	VERB
dpc-3736	135	4	the	the	DET
dpc-3736	135	5	estimation	estimation	NOUN
dpc-3736	135	6	of	of	ADP
dpc-3736	135	7	the	the	DET
dpc-3736	135	8	interventions	intervention	NOUN
dpc-3736	135	9	effect	effect	NOUN
dpc-3736	135	10	on	on	ADP
dpc-3736	135	11	complete	complete	ADJ
dpc-3736	135	12	cure	cure	NOUN
dpc-3736	135	13	as	as	ADP
dpc-3736	135	14	a	a	DET
dpc-3736	135	15	clinical	clinical	ADJ
dpc-3736	135	16	outcome	outcome	NOUN
dpc-3736	135	17	.	.	PUNCT
dpc-3736	136	1	the	the	DET
dpc-3736	136	2	risk	risk	NOUN
dpc-3736	136	3	ratio	ratio	NOUN
dpc-3736	136	4	and	and	CCONJ
dpc-3736	136	5	table	table	NOUN
dpc-3736	136	6	2	2	NUM
dpc-3736	136	7	.	.	PUNCT
dpc-3736	136	8	distribution	distribution	NOUN
dpc-3736	136	9	of	of	ADP
dpc-3736	136	10	patients	patient	NOUN
dpc-3736	136	11	across	across	ADP
dpc-3736	136	12	mycologic	mycologic	ADJ
dpc-3736	136	13	,	,	PUNCT
dpc-3736	136	14	clinical	clinical	ADJ
dpc-3736	136	15	cure	cure	NOUN
dpc-3736	136	16	,	,	PUNCT
dpc-3736	136	17	and	and	CCONJ
dpc-3736	136	18	degree	degree	NOUN
dpc-3736	136	19	of	of	ADP
dpc-3736	136	20	cure	cure	NOUN
dpc-3736	136	21	modules	module	NOUN
dpc-3736	136	22	.	.	PUNCT
dpc-3736	137	1	cure	cure	NOUN
dpc-3736	137	2	definition	definition	NOUN
dpc-3736	137	3	category	category	NOUN
dpc-3736	137	4	amphotericin	amphotericin	ADP
dpc-3736	137	5	group	group	NOUN
dpc-3736	137	6	clotrimazole	clotrimazole	NOUN
dpc-3736	137	7	group	group	NOUN
dpc-3736	137	8	p	p	NOUN
dpc-3736	137	9	-	-	PUNCT
dpc-3736	137	10	value	value	NOUN
dpc-3736	137	11	rr	rr	NOUN
dpc-3736	137	12	(	(	PUNCT
dpc-3736	137	13	95	95	NUM
dpc-3736	137	14	%	%	NOUN
dpc-3736	137	15	ci	ci	NOUN
dpc-3736	137	16	)	)	PUNCT
dpc-3736	137	17	microscopic	microscopic	ADJ
dpc-3736	137	18	cure	cure	NOUN
dpc-3736	137	19	effective	effective	ADJ
dpc-3736	137	20	17	17	NUM
dpc-3736	137	21	(	(	PUNCT
dpc-3736	137	22	77.3	77.3	NUM
dpc-3736	137	23	%	%	NOUN
dpc-3736	137	24	)	)	PUNCT
dpc-3736	137	25	17	17	NUM
dpc-3736	137	26	(	(	PUNCT
dpc-3736	137	27	77.3	77.3	NUM
dpc-3736	137	28	%	%	NOUN
dpc-3736	137	29	)	)	PUNCT
dpc-3736	137	30	1	1	NUM
dpc-3736	137	31	1	1	NUM
dpc-3736	137	32	(	(	PUNCT
dpc-3736	137	33	0.73	0.73	NUM
dpc-3736	137	34	to	to	ADP
dpc-3736	137	35	1.38	1.38	NUM
dpc-3736	137	36	)	)	PUNCT
dpc-3736	137	37	ineffective	ineffective	ADJ
dpc-3736	137	38	5	5	NUM
dpc-3736	137	39	(	(	PUNCT
dpc-3736	137	40	22.7	22.7	NUM
dpc-3736	137	41	%	%	NOUN
dpc-3736	137	42	)	)	PUNCT
dpc-3736	137	43	5	5	NUM
dpc-3736	137	44	(	(	PUNCT
dpc-3736	137	45	22.7	22.7	NUM
dpc-3736	137	46	%	%	NOUN
dpc-3736	137	47	)	)	PUNCT
dpc-3736	137	48	clinical	clinical	ADJ
dpc-3736	137	49	cure	cure	NOUN
dpc-3736	137	50	<	<	X
dpc-3736	137	51	50	50	NUM
dpc-3736	137	52	%	%	NOUN
dpc-3736	137	53	3	3	NUM
dpc-3736	137	54	(	(	PUNCT
dpc-3736	137	55	13.6	13.6	NUM
dpc-3736	137	56	%	%	NOUN
dpc-3736	137	57	)	)	PUNCT
dpc-3736	137	58	2	2	NUM
dpc-3736	137	59	(	(	PUNCT
dpc-3736	137	60	9.1	9.1	NUM
dpc-3736	137	61	%	%	NOUN
dpc-3736	137	62	)	)	PUNCT
dpc-3736	137	63	0.752	0.752	NUM
dpc-3736	137	64	reference	reference	NOUN
dpc-3736	137	65	50	50	NUM
dpc-3736	137	66	-	-	SYM
dpc-3736	137	67	99	99	NUM
dpc-3736	137	68	%	%	NOUN
dpc-3736	137	69	5	5	NUM
dpc-3736	137	70	(	(	PUNCT
dpc-3736	137	71	22.7	22.7	NUM
dpc-3736	137	72	%	%	NOUN
dpc-3736	137	73	)	)	PUNCT
dpc-3736	137	74	7	7	NUM
dpc-3736	137	75	(	(	PUNCT
dpc-3736	137	76	31.8	31.8	NUM
dpc-3736	137	77	%	%	NOUN
dpc-3736	137	78	)	)	PUNCT
dpc-3736	137	79	0.69	0.69	NUM
dpc-3736	137	80	(	(	PUNCT
dpc-3736	137	81	0.26	0.26	NUM
dpc-3736	137	82	to	to	PART
dpc-3736	137	83	1.85	1.85	NUM
dpc-3736	137	84	)	)	PUNCT
dpc-3736	137	85	100	100	NUM
dpc-3736	137	86	%	%	NOUN
dpc-3736	137	87	14	14	NUM
dpc-3736	137	88	(	(	PUNCT
dpc-3736	137	89	63.6	63.6	NUM
dpc-3736	137	90	%	%	NOUN
dpc-3736	137	91	)	)	PUNCT
dpc-3736	137	92	13	13	NUM
dpc-3736	137	93	(	(	PUNCT
dpc-3736	137	94	59.1	59.1	NUM
dpc-3736	137	95	%	%	NOUN
dpc-3736	137	96	)	)	PUNCT
dpc-3736	137	97	0.86	0.86	NUM
dpc-3736	137	98	(	(	PUNCT
dpc-3736	137	99	0.39	0.39	NUM
dpc-3736	137	100	to	to	ADP
dpc-3736	137	101	1.93	1.93	NUM
dpc-3736	137	102	)	)	PUNCT
dpc-3736	137	103	degree	degree	NOUN
dpc-3736	137	104	of	of	ADP
dpc-3736	137	105	cure	cure	NOUN
dpc-3736	137	106	complete	complete	ADJ
dpc-3736	137	107	14	14	NUM
dpc-3736	137	108	(	(	PUNCT
dpc-3736	137	109	63.6	63.6	NUM
dpc-3736	137	110	%	%	NOUN
dpc-3736	137	111	)	)	PUNCT
dpc-3736	137	112	13	13	NUM
dpc-3736	137	113	(	(	PUNCT
dpc-3736	137	114	59.1	59.1	NUM
dpc-3736	137	115	%	%	NOUN
dpc-3736	137	116	)	)	PUNCT
dpc-3736	137	117	0.757	0.757	NUM
dpc-3736	137	118	1.08	1.08	NUM
dpc-3736	137	119	(	(	PUNCT
dpc-3736	137	120	0.67	0.67	NUM
dpc-3736	137	121	to	to	PART
dpc-3736	137	122	1.72	1.72	NUM
dpc-3736	137	123	)	)	PUNCT
dpc-3736	137	124	partial	partial	ADJ
dpc-3736	137	125	8	8	NUM
dpc-3736	137	126	(	(	PUNCT
dpc-3736	137	127	36.4	36.4	NUM
dpc-3736	137	128	%	%	NOUN
dpc-3736	137	129	)	)	PUNCT
dpc-3736	137	130	9	9	NUM
dpc-3736	137	131	(	(	PUNCT
dpc-3736	137	132	40.9	40.9	NUM
dpc-3736	137	133	%	%	NOUN
dpc-3736	137	134	)	)	PUNCT
dpc-3736	137	135	ci	ci	NOUN
dpc-3736	138	1	=	=	NOUN
dpc-3736	138	2	confidence	confidence	NOUN
dpc-3736	138	3	interval	interval	NOUN
dpc-3736	138	4	.	.	PUNCT
dpc-3736	139	1	table	table	NOUN
dpc-3736	139	2	3	3	NUM
dpc-3736	139	3	.	.	PUNCT
dpc-3736	139	4	impact	impact	NOUN
dpc-3736	139	5	of	of	ADP
dpc-3736	139	6	age	age	NOUN
dpc-3736	139	7	,	,	PUNCT
dpc-3736	139	8	gender	gender	NOUN
dpc-3736	139	9	,	,	PUNCT
dpc-3736	139	10	lesion	lesion	NOUN
dpc-3736	139	11	site	site	NOUN
dpc-3736	139	12	,	,	PUNCT
dpc-3736	139	13	and	and	CCONJ
dpc-3736	139	14	size	size	NOUN
dpc-3736	139	15	on	on	ADP
dpc-3736	139	16	drug	drug	NOUN
dpc-3736	139	17	efficacy	efficacy	NOUN
dpc-3736	139	18	for	for	ADP
dpc-3736	139	19	complete	complete	ADJ
dpc-3736	139	20	cure	cure	NOUN
dpc-3736	139	21	(	(	PUNCT
dpc-3736	139	22	log	log	NOUN
dpc-3736	139	23	-	-	PUNCT
dpc-3736	139	24	binomial	binomial	ADJ
dpc-3736	139	25	logistic	logistic	ADJ
dpc-3736	139	26	regression	regression	NOUN
dpc-3736	139	27	)	)	PUNCT
dpc-3736	139	28	.	.	PUNCT
dpc-3736	140	1	complete	complete	ADJ
dpc-3736	140	2	cure	cure	NOUN
dpc-3736	140	3	risk	risk	NOUN
dpc-3736	140	4	ratio	ratio	NOUN
dpc-3736	140	5	(	(	PUNCT
dpc-3736	140	6	95	95	NUM
dpc-3736	140	7	%	%	NOUN
dpc-3736	140	8	ci	ci	NOUN
dpc-3736	140	9	)	)	PUNCT
dpc-3736	140	10	p	p	ADJ
dpc-3736	140	11	-	-	PUNCT
dpc-3736	140	12	value	value	NOUN
dpc-3736	140	13	risk	risk	NOUN
dpc-3736	140	14	difference	difference	NOUN
dpc-3736	140	15	(	(	PUNCT
dpc-3736	140	16	95	95	NUM
dpc-3736	140	17	%	%	NOUN
dpc-3736	140	18	ci	ci	NOUN
dpc-3736	140	19	)	)	PUNCT
dpc-3736	140	20	interventions	intervention	NOUN
dpc-3736	140	21	(	(	PUNCT
dpc-3736	140	22	crude	crude	NOUN
dpc-3736	140	23	)	)	PUNCT
dpc-3736	140	24	1.07	1.07	NUM
dpc-3736	140	25	(	(	PUNCT
dpc-3736	140	26	0.67	0.67	NUM
dpc-3736	140	27	to	to	ADP
dpc-3736	140	28	1.72	1.72	NUM
dpc-3736	140	29	)	)	PUNCT
dpc-3736	140	30	0.757	0.757	NUM
dpc-3736	140	31	0.04	0.04	NUM
dpc-3736	140	32	(	(	PUNCT
dpc-3736	140	33	-0.24	-0.24	NOUN
dpc-3736	140	34	to	to	PART
dpc-3736	140	35	0.33	0.33	NUM
dpc-3736	140	36	)	)	PUNCT
dpc-3736	140	37	interventions	intervention	NOUN
dpc-3736	140	38	(	(	PUNCT
dpc-3736	140	39	adjusted	adjust	VERB
dpc-3736	140	40	by	by	ADP
dpc-3736	140	41	age	age	NOUN
dpc-3736	140	42	)	)	PUNCT
dpc-3736	140	43	1.05	1.05	NUM
dpc-3736	140	44	(	(	PUNCT
dpc-3736	140	45	0.65	0.65	NUM
dpc-3736	140	46	to	to	ADP
dpc-3736	140	47	1.69	1.69	NUM
dpc-3736	140	48	)	)	PUNCT
dpc-3736	140	49	0.833	0.833	NUM
dpc-3736	140	50	0.04	0.04	NUM
dpc-3736	140	51	(	(	PUNCT
dpc-3736	140	52	-0.24	-0.24	NUM
dpc-3736	140	53	to	to	PART
dpc-3736	140	54	0.34	0.34	NUM
dpc-3736	140	55	)	)	PUNCT
dpc-3736	140	56	interventions	intervention	NOUN
dpc-3736	140	57	(	(	PUNCT
dpc-3736	140	58	adjusted	adjust	VERB
dpc-3736	140	59	by	by	ADP
dpc-3736	140	60	gender	gender	NOUN
dpc-3736	140	61	)	)	PUNCT
dpc-3736	140	62	1.30	1.30	NUM
dpc-3736	140	63	(	(	PUNCT
dpc-3736	140	64	0.87	0.87	NUM
dpc-3736	140	65	to	to	ADP
dpc-3736	140	66	1.93	1.93	NUM
dpc-3736	140	67	)	)	PUNCT
dpc-3736	140	68	0.199	0.199	NUM
dpc-3736	140	69	0.13	0.13	NUM
dpc-3736	140	70	(	(	PUNCT
dpc-3736	140	71	-0.13	-0.13	NUM
dpc-3736	140	72	to	to	ADP
dpc-3736	140	73	0.40	0.40	NUM
dpc-3736	140	74	)	)	PUNCT
dpc-3736	140	75	interventions	intervention	NOUN
dpc-3736	140	76	(	(	PUNCT
dpc-3736	140	77	adjusted	adjust	VERB
dpc-3736	140	78	by	by	ADP
dpc-3736	140	79	the	the	DET
dpc-3736	140	80	size	size	NOUN
dpc-3736	140	81	of	of	ADP
dpc-3736	140	82	the	the	DET
dpc-3736	140	83	lesion)b	lesion)b	PROPN
dpc-3736	140	84	1.08	1.08	NUM
dpc-3736	140	85	(	(	PUNCT
dpc-3736	140	86	0.68	0.68	NUM
dpc-3736	140	87	to	to	ADP
dpc-3736	140	88	1.74	1.74	NUM
dpc-3736	140	89	)	)	PUNCT
dpc-3736	140	90	0.729	0.729	NUM
dpc-3736	140	91	-0.001	-0.001	PUNCT
dpc-3736	140	92	(	(	PUNCT
dpc-3736	140	93	-0.30	-0.30	NOUN
dpc-3736	140	94	to	to	ADP
dpc-3736	140	95	0.29	0.29	NUM
dpc-3736	140	96	)	)	PUNCT
dpc-3736	140	97	interventions	intervention	NOUN
dpc-3736	140	98	(	(	PUNCT
dpc-3736	140	99	adjusted	adjust	VERB
dpc-3736	140	100	by	by	ADP
dpc-3736	140	101	the	the	DET
dpc-3736	140	102	site	site	NOUN
dpc-3736	140	103	of	of	ADP
dpc-3736	140	104	the	the	DET
dpc-3736	140	105	lesion)c	lesion)c	PROPN
dpc-3736	140	106	1.02	1.02	NUM
dpc-3736	140	107	(	(	PUNCT
dpc-3736	140	108	0.65	0.65	NUM
dpc-3736	140	109	to	to	ADP
dpc-3736	140	110	1.68	1.68	NUM
dpc-3736	140	111	)	)	PUNCT
dpc-3736	140	112	0.922	0.922	NUM
dpc-3736	140	113	0.04	0.04	NUM
dpc-3736	140	114	(	(	PUNCT
dpc-3736	140	115	-0.24	-0.24	NUM
dpc-3736	140	116	to	to	PART
dpc-3736	140	117	0.34	0.34	NUM
dpc-3736	140	118	)	)	PUNCT
dpc-3736	140	119	amen	amen	INTJ
dpc-3736	140	120	in	in	ADP
dpc-3736	140	121	comparison	comparison	NOUN
dpc-3736	140	122	with	with	ADP
dpc-3736	140	123	women	woman	NOUN
dpc-3736	140	124	;	;	PUNCT
dpc-3736	140	125	b>3	b>3	ADJ
dpc-3736	140	126	%	%	NOUN
dpc-3736	140	127	in	in	ADP
dpc-3736	140	128	comparison	comparison	NOUN
dpc-3736	140	129	with	with	ADP
dpc-3736	140	130	≤3	≤3	PROPN
dpc-3736	140	131	%	%	NOUN
dpc-3736	140	132	;	;	PUNCT
dpc-3736	140	133	cin	cin	PROPN
dpc-3736	140	134	comparison	comparison	NOUN
dpc-3736	140	135	with	with	ADP
dpc-3736	140	136	head	head	NOUN
dpc-3736	140	137	,	,	PUNCT
dpc-3736	140	138	neck	neck	NOUN
dpc-3736	140	139	,	,	PUNCT
dpc-3736	140	140	or	or	CCONJ
dpc-3736	140	141	extremities	extremity	NOUN
dpc-3736	140	142	.	.	PUNCT
dpc-3736	141	1	ci	ci	NOUN
dpc-3736	141	2	=	=	NOUN
dpc-3736	141	3	confidence	confidence	NOUN
dpc-3736	141	4	interval	interval	NOUN
dpc-3736	141	5	.	.	PUNCT
dpc-3736	142	1	6	6	NUM
dpc-3736	142	2	original	original	ADJ
dpc-3736	142	3	article	article	NOUN
dpc-3736	142	4	|	|	ADV
dpc-3736	142	5	dermatol	dermatol	ADJ
dpc-3736	142	6	pract	pract	NOUN
dpc-3736	142	7	concept	concept	NOUN
dpc-3736	142	8	.	.	PUNCT
dpc-3736	143	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	143	2	to	to	PART
dpc-3736	143	3	address	address	VERB
dpc-3736	143	4	this	this	DET
dpc-3736	143	5	gap	gap	NOUN
dpc-3736	143	6	in	in	ADP
dpc-3736	143	7	the	the	DET
dpc-3736	143	8	literature	literature	NOUN
dpc-3736	143	9	,	,	PUNCT
dpc-3736	143	10	we	we	PRON
dpc-3736	143	11	conducted	conduct	VERB
dpc-3736	143	12	a	a	DET
dpc-3736	143	13	study	study	NOUN
dpc-3736	143	14	to	to	PART
dpc-3736	143	15	investigate	investigate	VERB
dpc-3736	143	16	the	the	DET
dpc-3736	143	17	therapeutic	therapeutic	ADJ
dpc-3736	143	18	effects	effect	NOUN
dpc-3736	143	19	of	of	ADP
dpc-3736	143	20	liposomal	liposomal	NOUN
dpc-3736	143	21	amphotericin	amphotericin	ADP
dpc-3736	143	22	b	b	NOUN
dpc-3736	143	23	in	in	ADP
dpc-3736	143	24	treating	treat	VERB
dpc-3736	143	25	pv	pv	INTJ
dpc-3736	143	26	.	.	PUNCT
dpc-3736	144	1	based	base	VERB
dpc-3736	144	2	on	on	ADP
dpc-3736	144	3	its	its	PRON
dpc-3736	144	4	pharmacological	pharmacological	ADJ
dpc-3736	144	5	characteristics	characteristic	NOUN
dpc-3736	144	6	and	and	CCONJ
dpc-3736	144	7	potential	potential	ADJ
dpc-3736	144	8	advantages	advantage	NOUN
dpc-3736	144	9	,	,	PUNCT
dpc-3736	144	10	we	we	PRON
dpc-3736	144	11	hypothesized	hypothesize	VERB
dpc-3736	144	12	that	that	SCONJ
dpc-3736	144	13	amphotericin	amphotericin	ADP
dpc-3736	144	14	b	b	PROPN
dpc-3736	144	15	would	would	AUX
dpc-3736	144	16	demonstrate	demonstrate	VERB
dpc-3736	144	17	comparable	comparable	ADJ
dpc-3736	144	18	efficacy	efficacy	NOUN
dpc-3736	144	19	to	to	ADP
dpc-3736	144	20	clotrimazole	clotrimazole	NOUN
dpc-3736	144	21	in	in	ADP
dpc-3736	144	22	terms	term	NOUN
dpc-3736	144	23	of	of	ADP
dpc-3736	144	24	clinical	clinical	ADJ
dpc-3736	144	25	and	and	CCONJ
dpc-3736	144	26	microscopic	microscopic	ADJ
dpc-3736	144	27	cure	cure	NOUN
dpc-3736	144	28	rates	rate	NOUN
dpc-3736	144	29	.	.	PUNCT
dpc-3736	145	1	microscopic	microscopic	ADJ
dpc-3736	145	2	cure	cure	NOUN
dpc-3736	145	3	refers	refer	VERB
dpc-3736	145	4	to	to	ADP
dpc-3736	145	5	a	a	DET
dpc-3736	145	6	negative	negative	ADJ
dpc-3736	145	7	result	result	NOUN
dpc-3736	145	8	of	of	ADP
dpc-3736	145	9	koh	koh	PROPN
dpc-3736	145	10	smear	smear	NOUN
dpc-3736	145	11	examination	examination	NOUN
dpc-3736	145	12	of	of	ADP
dpc-3736	145	13	the	the	DET
dpc-3736	145	14	lesion	lesion	NOUN
dpc-3736	145	15	after	after	ADP
dpc-3736	145	16	the	the	DET
dpc-3736	145	17	treatment	treatment	NOUN
dpc-3736	145	18	course	course	NOUN
dpc-3736	145	19	.	.	PUNCT
dpc-3736	146	1	in	in	ADP
dpc-3736	146	2	our	our	PRON
dpc-3736	146	3	study	study	NOUN
dpc-3736	146	4	,	,	PUNCT
dpc-3736	146	5	topical	topical	ADJ
dpc-3736	146	6	liposomal	liposomal	NOUN
dpc-3736	146	7	amphotericin	amphotericin	ADP
dpc-3736	146	8	b	b	NOUN
dpc-3736	146	9	achieved	achieve	VERB
dpc-3736	146	10	microscopic	microscopic	ADJ
dpc-3736	146	11	cure	cure	NOUN
dpc-3736	146	12	in	in	ADP
dpc-3736	146	13	77.3	77.3	NUM
dpc-3736	146	14	%	%	NOUN
dpc-3736	146	15	of	of	ADP
dpc-3736	146	16	cases	case	NOUN
dpc-3736	146	17	after	after	ADP
dpc-3736	146	18	two	two	NUM
dpc-3736	146	19	weeks	week	NOUN
dpc-3736	146	20	of	of	ADP
dpc-3736	146	21	treatment	treatment	NOUN
dpc-3736	146	22	,	,	PUNCT
dpc-3736	146	23	which	which	PRON
dpc-3736	146	24	was	be	AUX
dpc-3736	146	25	comparable	comparable	ADJ
dpc-3736	146	26	to	to	ADP
dpc-3736	146	27	the	the	DET
dpc-3736	146	28	therapeutic	therapeutic	ADJ
dpc-3736	146	29	success	success	NOUN
dpc-3736	146	30	rate	rate	NOUN
dpc-3736	146	31	as	as	ADP
dpc-3736	146	32	patients	patient	NOUN
dpc-3736	146	33	treated	treat	VERB
dpc-3736	146	34	with	with	ADP
dpc-3736	146	35	topical	topical	ADJ
dpc-3736	146	36	clotrimazole	clotrimazole	NOUN
dpc-3736	146	37	cream	cream	NOUN
dpc-3736	146	38	.	.	PUNCT
dpc-3736	147	1	in	in	ADP
dpc-3736	147	2	terms	term	NOUN
dpc-3736	147	3	of	of	ADP
dpc-3736	147	4	clinical	clinical	ADJ
dpc-3736	147	5	cure	cure	NOUN
dpc-3736	147	6	,	,	PUNCT
dpc-3736	147	7	14	14	NUM
dpc-3736	147	8	(	(	PUNCT
dpc-3736	147	9	63.6	63.6	NUM
dpc-3736	147	10	%	%	NOUN
dpc-3736	147	11	)	)	PUNCT
dpc-3736	147	12	of	of	ADP
dpc-3736	147	13	the	the	DET
dpc-3736	147	14	patients	patient	NOUN
dpc-3736	147	15	who	who	PRON
dpc-3736	147	16	received	receive	VERB
dpc-3736	147	17	amphotericin	amphotericin	ADP
dpc-3736	147	18	b	b	PROPN
dpc-3736	147	19	and	and	CCONJ
dpc-3736	147	20	13	13	NUM
dpc-3736	147	21	(	(	PUNCT
dpc-3736	147	22	59.1	59.1	NUM
dpc-3736	147	23	%	%	NOUN
dpc-3736	147	24	)	)	PUNCT
dpc-3736	147	25	of	of	ADP
dpc-3736	147	26	those	those	PRON
dpc-3736	147	27	who	who	PRON
dpc-3736	147	28	received	receive	VERB
dpc-3736	147	29	clotrimazole	clotrimazole	NOUN
dpc-3736	147	30	were	be	AUX
dpc-3736	147	31	fully	fully	ADV
dpc-3736	147	32	treated	treat	VERB
dpc-3736	147	33	(	(	PUNCT
dpc-3736	147	34	p	p	X
dpc-3736	147	35	>	>	X
dpc-3736	147	36	0.05	0.05	NUM
dpc-3736	147	37	)	)	PUNCT
dpc-3736	147	38	.	.	PUNCT
dpc-3736	148	1	these	these	DET
dpc-3736	148	2	findings	finding	NOUN
dpc-3736	148	3	suggest	suggest	VERB
dpc-3736	148	4	that	that	SCONJ
dpc-3736	148	5	topical	topical	ADJ
dpc-3736	148	6	liposomal	liposomal	NOUN
dpc-3736	148	7	amphotericin	amphotericin	ADP
dpc-3736	148	8	b	b	PROPN
dpc-3736	148	9	is	be	AUX
dpc-3736	148	10	an	an	DET
dpc-3736	148	11	effective	effective	ADJ
dpc-3736	148	12	antifungal	antifungal	ADJ
dpc-3736	148	13	agent	agent	NOUN
dpc-3736	148	14	for	for	ADP
dpc-3736	148	15	both	both	CCONJ
dpc-3736	148	16	mycological	mycological	ADJ
dpc-3736	148	17	and	and	CCONJ
dpc-3736	148	18	clinical	clinical	ADJ
dpc-3736	148	19	treatments	treatment	NOUN
dpc-3736	148	20	of	of	ADP
dpc-3736	148	21	patients	patient	NOUN
dpc-3736	148	22	with	with	ADP
dpc-3736	148	23	pv	pv	NOUN
dpc-3736	148	24	.	.	PUNCT
dpc-3736	148	25	figures	figure	NOUN
dpc-3736	148	26	2	2	NUM
dpc-3736	148	27	and	and	CCONJ
dpc-3736	148	28	3	3	NUM
dpc-3736	148	29	depict	depict	NOUN
dpc-3736	148	30	the	the	DET
dpc-3736	148	31	before	before	ADV
dpc-3736	148	32	and	and	CCONJ
dpc-3736	148	33	after	after	ADP
dpc-3736	148	34	treatment	treatment	NOUN
dpc-3736	148	35	images	image	NOUN
dpc-3736	148	36	of	of	ADP
dpc-3736	148	37	a	a	DET
dpc-3736	148	38	male	male	NOUN
dpc-3736	148	39	and	and	CCONJ
dpc-3736	148	40	a	a	DET
dpc-3736	148	41	female	female	NOUN
dpc-3736	148	42	with	with	ADP
dpc-3736	148	43	pv	pv	INTJ
dpc-3736	148	44	who	who	PRON
dpc-3736	148	45	were	be	AUX
dpc-3736	148	46	treated	treat	VERB
dpc-3736	148	47	with	with	ADP
dpc-3736	148	48	amphotericin	amphotericin	ADJ
dpc-3736	148	49	b.	b.	NOUN
dpc-3736	148	50	in	in	ADP
dpc-3736	148	51	a	a	DET
dpc-3736	148	52	similar	similar	ADJ
dpc-3736	148	53	study	study	NOUN
dpc-3736	148	54	conducted	conduct	VERB
dpc-3736	148	55	by	by	ADP
dpc-3736	148	56	sepaskhah	sepaskhah	PROPN
dpc-3736	148	57	et	et	PROPN
dpc-3736	148	58	al	al	PROPN
dpc-3736	148	59	in	in	ADP
dpc-3736	148	60	2017	2017	NUM
dpc-3736	148	61	  	  	SPACE
dpc-3736	149	1	[	[	PUNCT
dpc-3736	149	2	18	18	NUM
dpc-3736	149	3	]	]	PUNCT
dpc-3736	149	4	,	,	PUNCT
dpc-3736	149	5	topical	topical	ADJ
dpc-3736	149	6	tacrolimus	tacrolimus	NOUN
dpc-3736	149	7	was	be	AUX
dpc-3736	149	8	compared	compare	VERB
dpc-3736	149	9	to	to	ADP
dpc-3736	149	10	topical	topical	ADJ
dpc-3736	149	11	clotrimazole	clotrimazole	NOUN
dpc-3736	149	12	in	in	ADP
dpc-3736	149	13	50	50	NUM
dpc-3736	149	14	patients	patient	NOUN
dpc-3736	149	15	.	.	PUNCT
dpc-3736	150	1	clinical	clinical	ADJ
dpc-3736	150	2	and	and	CCONJ
dpc-3736	150	3	microscopic	microscopic	ADJ
dpc-3736	150	4	assessments	assessment	NOUN
dpc-3736	150	5	were	be	AUX
dpc-3736	150	6	performed	perform	VERB
dpc-3736	150	7	at	at	ADP
dpc-3736	150	8	the	the	DET
dpc-3736	150	9	beginning	beginning	NOUN
dpc-3736	150	10	of	of	ADP
dpc-3736	150	11	the	the	DET
dpc-3736	150	12	study	study	NOUN
dpc-3736	150	13	,	,	PUNCT
dpc-3736	150	14	as	as	ADV
dpc-3736	150	15	well	well	ADV
dpc-3736	150	16	as	as	ADP
dpc-3736	150	17	at	at	ADP
dpc-3736	150	18	the	the	DET
dpc-3736	150	19	end	end	NOUN
dpc-3736	150	20	of	of	ADP
dpc-3736	150	21	3rd	3rd	ADJ
dpc-3736	150	22	and	and	CCONJ
dpc-3736	150	23	5th	5th	ADJ
dpc-3736	150	24	weeks	week	NOUN
dpc-3736	150	25	of	of	ADP
dpc-3736	150	26	treatment	treatment	NOUN
dpc-3736	150	27	.	.	PUNCT
dpc-3736	151	1	the	the	DET
dpc-3736	151	2	results	result	NOUN
dpc-3736	151	3	showed	show	VERB
dpc-3736	151	4	no	no	DET
dpc-3736	151	5	significant	significant	ADJ
dpc-3736	151	6	differences	difference	NOUN
dpc-3736	151	7	were	be	AUX
dpc-3736	151	8	observed	observe	VERB
dpc-3736	151	9	in	in	ADP
dpc-3736	151	10	laboratory	laboratory	NOUN
dpc-3736	151	11	and	and	CCONJ
dpc-3736	151	12	clinical	clinical	ADJ
dpc-3736	151	13	cure	cure	NOUN
dpc-3736	151	14	rates	rate	NOUN
dpc-3736	151	15	between	between	ADP
dpc-3736	151	16	the	the	DET
dpc-3736	151	17	two	two	NUM
dpc-3736	151	18	groups	group	NOUN
dpc-3736	151	19	.	.	PUNCT
dpc-3736	152	1	however	however	ADV
dpc-3736	152	2	,	,	PUNCT
dpc-3736	152	3	the	the	DET
dpc-3736	152	4	5	5	NUM
dpc-3736	152	5	-	-	PUNCT
dpc-3736	152	6	week	week	NOUN
dpc-3736	152	7	treatment	treatment	NOUN
dpc-3736	152	8	with	with	ADP
dpc-3736	152	9	tacrolimus	tacrolimus	NOUN
dpc-3736	152	10	did	do	AUX
dpc-3736	152	11	not	not	PART
dpc-3736	152	12	significantly	significantly	ADV
dpc-3736	152	13	affect	affect	VERB
dpc-3736	152	14	the	the	DET
dpc-3736	152	15	hypopigmentation	hypopigmentation	NOUN
dpc-3736	152	16	of	of	ADP
dpc-3736	152	17	the	the	DET
dpc-3736	152	18	lesions	lesion	NOUN
dpc-3736	152	19	.	.	PUNCT
dpc-3736	153	1	of	of	ADP
dpc-3736	153	2	oral	oral	ADJ
dpc-3736	153	3	griseoflovin	griseoflovin	NOUN
dpc-3736	153	4	[	[	X
dpc-3736	153	5	14	14	NUM
dpc-3736	153	6	]	]	X
dpc-3736	153	7	,	,	PUNCT
dpc-3736	153	8	1	1	NUM
dpc-3736	153	9	%	%	NOUN
dpc-3736	153	10	diclophenac	diclophenac	ADJ
dpc-3736	153	11	gel	gel	NOUN
dpc-3736	154	1	[	[	X
dpc-3736	154	2	15	15	NUM
dpc-3736	154	3	]	]	X
dpc-3736	154	4	,	,	PUNCT
dpc-3736	154	5	a	a	DET
dpc-3736	154	6	single	single	ADJ
dpc-3736	154	7	400	400	NUM
dpc-3736	154	8	mg	mg	NOUN
dpc-3736	154	9	dose	dose	PROPN
dpc-3736	154	10	of	of	ADP
dpc-3736	154	11	itraconazole	itraconazole	NOUN
dpc-3736	155	1	[	[	X
dpc-3736	155	2	16	16	NUM
dpc-3736	155	3	]	]	PUNCT
dpc-3736	155	4	,	,	PUNCT
dpc-3736	155	5	and	and	CCONJ
dpc-3736	155	6	fluconazole	fluconazole	NOUN
dpc-3736	155	7	[	[	X
dpc-3736	155	8	17	17	NUM
dpc-3736	155	9	]	]	PUNCT
dpc-3736	155	10	were	be	AUX
dpc-3736	155	11	found	find	VERB
dpc-3736	155	12	to	to	PART
dpc-3736	155	13	be	be	AUX
dpc-3736	155	14	lower	low	ADJ
dpc-3736	155	15	than	than	ADP
dpc-3736	155	16	that	that	PRON
dpc-3736	155	17	of	of	ADP
dpc-3736	155	18	topical	topical	ADJ
dpc-3736	155	19	clotrimazole	clotrimazole	NOUN
dpc-3736	156	1	[	[	X
dpc-3736	156	2	18	18	NUM
dpc-3736	156	3	]	]	PUNCT
dpc-3736	156	4	.	.	PUNCT
dpc-3736	157	1	other	other	ADJ
dpc-3736	157	2	antifungal	antifungal	ADJ
dpc-3736	157	3	agents	agent	NOUN
dpc-3736	157	4	,	,	PUNCT
dpc-3736	157	5	such	such	ADJ
dpc-3736	157	6	as	as	ADP
dpc-3736	157	7	mycoderm	mycoderm	NOUN
dpc-3736	157	8	lotion	lotion	NOUN
dpc-3736	157	9	[	[	X
dpc-3736	157	10	19	19	NUM
dpc-3736	157	11	]	]	PUNCT
dpc-3736	157	12	,	,	PUNCT
dpc-3736	157	13	topical	topical	ADJ
dpc-3736	157	14	terbinafine	terbinafine	NOUN
dpc-3736	157	15	[	[	X
dpc-3736	157	16	20,21	20,21	NUM
dpc-3736	157	17	]	]	PUNCT
dpc-3736	157	18	,	,	PUNCT
dpc-3736	157	19	and	and	CCONJ
dpc-3736	157	20	sertaconazole	sertaconazole	NOUN
dpc-3736	157	21	cream	cream	NOUN
dpc-3736	158	1	[	[	X
dpc-3736	158	2	22	22	NUM
dpc-3736	158	3	]	]	PUNCT
dpc-3736	158	4	,	,	PUNCT
dpc-3736	158	5	have	have	AUX
dpc-3736	158	6	demonstrated	demonstrate	VERB
dpc-3736	158	7	even	even	ADV
dpc-3736	158	8	better	well	ADJ
dpc-3736	158	9	efficacy	efficacy	NOUN
dpc-3736	158	10	compared	compare	VERB
dpc-3736	158	11	to	to	ADP
dpc-3736	158	12	topical	topical	ADJ
dpc-3736	158	13	clotrimazole	clotrimazole	NOUN
dpc-3736	158	14	.	.	PUNCT
dpc-3736	159	1	in	in	ADP
dpc-3736	159	2	a	a	DET
dpc-3736	159	3	study	study	NOUN
dpc-3736	159	4	by	by	ADP
dpc-3736	159	5	khosravi	khosravi	NOUN
dpc-3736	159	6	et	et	PROPN
dpc-3736	159	7	al	al	PROPN
dpc-3736	160	1	[	[	X
dpc-3736	160	2	19	19	NUM
dpc-3736	160	3	]	]	PUNCT
dpc-3736	160	4	,	,	PUNCT
dpc-3736	160	5	the	the	DET
dpc-3736	160	6	therapeutic	therapeutic	ADJ
dpc-3736	160	7	effects	effect	NOUN
dpc-3736	160	8	of	of	ADP
dpc-3736	160	9	a	a	DET
dpc-3736	160	10	new	new	ADJ
dpc-3736	160	11	antifungal	antifungal	ADJ
dpc-3736	160	12	lotion	lotion	NOUN
dpc-3736	160	13	(	(	PUNCT
dpc-3736	160	14	mycoderm	mycoderm	NOUN
dpc-3736	160	15	)	)	PUNCT
dpc-3736	160	16	were	be	AUX
dpc-3736	160	17	compared	compare	VERB
dpc-3736	160	18	to	to	ADP
dpc-3736	160	19	clotrimazole	clotrimazole	NOUN
dpc-3736	160	20	lotion	lotion	NOUN
dpc-3736	160	21	in	in	ADP
dpc-3736	160	22	68	68	NUM
dpc-3736	160	23	patients	patient	NOUN
dpc-3736	160	24	.	.	PUNCT
dpc-3736	161	1	the	the	DET
dpc-3736	161	2	patients	patient	NOUN
dpc-3736	161	3	applied	apply	VERB
dpc-3736	161	4	the	the	DET
dpc-3736	161	5	lotions	lotion	NOUN
dpc-3736	161	6	twice	twice	DET
dpc-3736	161	7	a	a	DET
dpc-3736	161	8	day	day	NOUN
dpc-3736	161	9	for	for	ADP
dpc-3736	161	10	two	two	NUM
dpc-3736	161	11	weeks	week	NOUN
dpc-3736	161	12	.	.	PUNCT
dpc-3736	162	1	the	the	DET
dpc-3736	162	2	cure	cure	NOUN
dpc-3736	162	3	rates	rate	NOUN
dpc-3736	162	4	reported	report	VERB
dpc-3736	162	5	by	by	ADP
dpc-3736	162	6	patients	patient	NOUN
dpc-3736	162	7	in	in	ADP
dpc-3736	162	8	the	the	DET
dpc-3736	162	9	clotrimazole	clotrimazole	NOUN
dpc-3736	162	10	and	and	CCONJ
dpc-3736	162	11	mycoderm	mycoderm	NOUN
dpc-3736	162	12	groups	group	NOUN
dpc-3736	162	13	were	be	AUX
dpc-3736	162	14	71	71	NUM
dpc-3736	162	15	%	%	NOUN
dpc-3736	162	16	and	and	CCONJ
dpc-3736	162	17	91.9	91.9	NUM
dpc-3736	162	18	%	%	NOUN
dpc-3736	162	19	,	,	PUNCT
dpc-3736	162	20	respectively	respectively	ADV
dpc-3736	162	21	,	,	PUNCT
dpc-3736	162	22	with	with	ADP
dpc-3736	162	23	a	a	DET
dpc-3736	162	24	statistically	statistically	ADV
dpc-3736	162	25	significant	significant	ADJ
dpc-3736	162	26	difference	difference	NOUN
dpc-3736	162	27	(	(	PUNCT
dpc-3736	162	28	p	p	X
dpc-3736	162	29	<	<	X
dpc-3736	162	30	0.05	0.05	NUM
dpc-3736	162	31	)	)	PUNCT
dpc-3736	162	32	.	.	PUNCT
dpc-3736	163	1	the	the	DET
dpc-3736	163	2	rate	rate	NOUN
dpc-3736	163	3	of	of	ADP
dpc-3736	163	4	full	full	ADJ
dpc-3736	163	5	clinical	clinical	ADJ
dpc-3736	163	6	cure	cure	NOUN
dpc-3736	163	7	was	be	AUX
dpc-3736	163	8	observed	observe	VERB
dpc-3736	163	9	in	in	ADP
dpc-3736	163	10	51.6	51.6	NUM
dpc-3736	163	11	%	%	NOUN
dpc-3736	163	12	and	and	CCONJ
dpc-3736	163	13	70.3	70.3	NUM
dpc-3736	163	14	%	%	NOUN
dpc-3736	163	15	of	of	ADP
dpc-3736	163	16	the	the	DET
dpc-3736	163	17	clotrimazole	clotrimazole	NOUN
dpc-3736	163	18	and	and	CCONJ
dpc-3736	163	19	mycoderm	mycoderm	NOUN
dpc-3736	163	20	groups	group	NOUN
dpc-3736	163	21	,	,	PUNCT
dpc-3736	163	22	respectively	respectively	ADV
dpc-3736	163	23	.	.	PUNCT
dpc-3736	164	1	amphotericin	amphotericin	ADP
dpc-3736	164	2	b	b	NUM
dpc-3736	164	3	,	,	PUNCT
dpc-3736	164	4	a	a	DET
dpc-3736	164	5	polyene	polyene	ADJ
dpc-3736	164	6	antifungal	antifungal	ADJ
dpc-3736	164	7	agent	agent	NOUN
dpc-3736	164	8	,	,	PUNCT
dpc-3736	164	9	exhibits	exhibit	VERB
dpc-3736	164	10	broad	broad	ADJ
dpc-3736	164	11	-	-	PUNCT
dpc-3736	164	12	spectrum	spectrum	NOUN
dpc-3736	164	13	activity	activity	NOUN
dpc-3736	164	14	against	against	ADP
dpc-3736	164	15	various	various	ADJ
dpc-3736	164	16	fungal	fungal	ADJ
dpc-3736	164	17	organisms	organism	NOUN
dpc-3736	164	18	.	.	PUNCT
dpc-3736	165	1	it	it	PRON
dpc-3736	165	2	binds	bind	VERB
dpc-3736	165	3	to	to	ADP
dpc-3736	165	4	ergosterol	ergosterol	NOUN
dpc-3736	165	5	,	,	PUNCT
dpc-3736	165	6	disrupting	disrupt	VERB
dpc-3736	165	7	the	the	DET
dpc-3736	165	8	fungal	fungal	ADJ
dpc-3736	165	9	cell	cell	NOUN
dpc-3736	165	10	wall	wall	NOUN
dpc-3736	165	11	and	and	CCONJ
dpc-3736	165	12	causing	cause	VERB
dpc-3736	165	13	leakage	leakage	NOUN
dpc-3736	165	14	of	of	ADP
dpc-3736	165	15	intracellular	intracellular	ADJ
dpc-3736	165	16	contents	content	NOUN
dpc-3736	165	17	[	[	X
dpc-3736	165	18	4	4	NUM
dpc-3736	165	19	]	]	PUNCT
dpc-3736	165	20	.	.	PUNCT
dpc-3736	166	1	additionally	additionally	ADV
dpc-3736	166	2	,	,	PUNCT
dpc-3736	166	3	amphotericin	amphotericin	ADP
dpc-3736	166	4	b	b	NOUN
dpc-3736	166	5	stimulates	stimulate	VERB
dpc-3736	166	6	the	the	DET
dpc-3736	166	7	body	body	NOUN
dpc-3736	166	8	immune	immune	ADJ
dpc-3736	166	9	response	response	NOUN
dpc-3736	166	10	against	against	ADP
dpc-3736	166	11	fungi	fungus	NOUN
dpc-3736	166	12	by	by	ADP
dpc-3736	166	13	inducing	induce	VERB
dpc-3736	166	14	the	the	DET
dpc-3736	166	15	production	production	NOUN
dpc-3736	166	16	of	of	ADP
dpc-3736	166	17	free	free	ADJ
dpc-3736	166	18	radicals	radical	NOUN
dpc-3736	166	19	[	[	X
dpc-3736	166	20	3	3	NUM
dpc-3736	166	21	]	]	PUNCT
dpc-3736	166	22	.	.	PUNCT
dpc-3736	167	1	while	while	SCONJ
dpc-3736	167	2	amphotericin	amphotericin	ADP
dpc-3736	167	3	b	b	NOUN
dpc-3736	167	4	is	be	AUX
dpc-3736	167	5	commonly	commonly	ADV
dpc-3736	167	6	used	use	VERB
dpc-3736	167	7	for	for	ADP
dpc-3736	167	8	systemic	systemic	ADJ
dpc-3736	167	9	fungal	fungal	ADJ
dpc-3736	167	10	infections	infection	NOUN
dpc-3736	167	11	[	[	X
dpc-3736	167	12	4	4	NUM
dpc-3736	167	13	]	]	PUNCT
dpc-3736	167	14	,	,	PUNCT
dpc-3736	167	15	its	its	PRON
dpc-3736	167	16	topical	topical	ADJ
dpc-3736	167	17	formulation	formulation	NOUN
dpc-3736	167	18	,	,	PUNCT
dpc-3736	167	19	specifically	specifically	ADV
dpc-3736	167	20	liposomal	liposomal	ADJ
dpc-3736	167	21	amphotericin	amphotericin	ADP
dpc-3736	167	22	b	b	PROPN
dpc-3736	167	23	,	,	PUNCT
dpc-3736	167	24	has	have	AUX
dpc-3736	167	25	been	be	AUX
dpc-3736	167	26	primarily	primarily	ADV
dpc-3736	167	27	investigated	investigate	VERB
dpc-3736	167	28	for	for	ADP
dpc-3736	167	29	the	the	DET
dpc-3736	167	30	treatment	treatment	NOUN
dpc-3736	167	31	of	of	ADP
dpc-3736	167	32	other	other	ADJ
dpc-3736	167	33	fungal	fungal	ADJ
dpc-3736	167	34	conditions	condition	NOUN
dpc-3736	167	35	such	such	ADJ
dpc-3736	167	36	as	as	ADP
dpc-3736	167	37	cutaneous	cutaneous	ADJ
dpc-3736	167	38	leishmaniosis	leishmaniosis	NOUN
dpc-3736	167	39	,	,	PUNCT
dpc-3736	167	40	cutaneous	cutaneous	ADJ
dpc-3736	167	41	candidiasis	candidiasis	NOUN
dpc-3736	167	42	,	,	PUNCT
dpc-3736	167	43	vaginal	vaginal	ADJ
dpc-3736	167	44	mucormycosis	mucormycosis	NOUN
dpc-3736	167	45	,	,	PUNCT
dpc-3736	167	46	and	and	CCONJ
dpc-3736	167	47	onychomycosis	onychomycosis	NOUN
dpc-3736	167	48	[	[	X
dpc-3736	167	49	5	5	NUM
dpc-3736	167	50	-	-	SYM
dpc-3736	167	51	7	7	NUM
dpc-3736	167	52	]	]	PUNCT
dpc-3736	167	53	.	.	PUNCT
dpc-3736	168	1	the	the	DET
dpc-3736	168	2	potential	potential	NOUN
dpc-3736	168	3	of	of	ADP
dpc-3736	168	4	liposomal	liposomal	NOUN
dpc-3736	168	5	amphotericin	amphotericin	ADP
dpc-3736	168	6	b	b	NOUN
dpc-3736	168	7	in	in	ADP
dpc-3736	168	8	the	the	DET
dpc-3736	168	9	topical	topical	ADJ
dpc-3736	168	10	treatment	treatment	NOUN
dpc-3736	168	11	of	of	ADP
dpc-3736	168	12	pv	pv	NOUN
dpc-3736	168	13	remains	remain	VERB
dpc-3736	168	14	largely	largely	ADV
dpc-3736	168	15	unexplored	unexplored	ADJ
dpc-3736	168	16	.	.	PUNCT
dpc-3736	169	1	figure	figure	NOUN
dpc-3736	169	2	2	2	NUM
dpc-3736	169	3	.	.	PUNCT
dpc-3736	170	1	(	(	PUNCT
dpc-3736	170	2	a	a	X
dpc-3736	170	3	)	)	PUNCT
dpc-3736	170	4	a	a	DET
dpc-3736	170	5	37	37	NUM
dpc-3736	170	6	-	-	PUNCT
dpc-3736	170	7	year	year	NOUN
dpc-3736	170	8	-	-	PUNCT
dpc-3736	170	9	old	old	ADJ
dpc-3736	170	10	man	man	NOUN
dpc-3736	170	11	from	from	ADP
dpc-3736	170	12	shiraz	shiraz	PROPN
dpc-3736	170	13	with	with	ADP
dpc-3736	170	14	a	a	DET
dpc-3736	170	15	whitish	whitish	ADJ
dpc-3736	170	16	neck	neck	NOUN
dpc-3736	170	17	lesion	lesion	NOUN
dpc-3736	170	18	for	for	ADP
dpc-3736	170	19	5	5	NUM
dpc-3736	170	20	months	month	NOUN
dpc-3736	170	21	,	,	PUNCT
dpc-3736	170	22	with	with	ADP
dpc-3736	170	23	<	<	X
dpc-3736	170	24	1	1	NUM
dpc-3736	170	25	%	%	NOUN
dpc-3736	170	26	skin	skin	NOUN
dpc-3736	170	27	involvement	involvement	NOUN
dpc-3736	170	28	.	.	PUNCT
dpc-3736	171	1	(	(	PUNCT
dpc-3736	171	2	b	b	X
dpc-3736	171	3	)	)	PUNCT
dpc-3736	171	4	complete	complete	ADJ
dpc-3736	171	5	clinical	clinical	ADJ
dpc-3736	171	6	and	and	CCONJ
dpc-3736	171	7	mycological	mycological	ADJ
dpc-3736	171	8	cure	cure	NOUN
dpc-3736	171	9	of	of	ADP
dpc-3736	171	10	the	the	DET
dpc-3736	171	11	same	same	ADJ
dpc-3736	171	12	patient	patient	NOUN
dpc-3736	171	13	after	after	ADP
dpc-3736	171	14	14	14	NUM
dpc-3736	171	15	days	day	NOUN
dpc-3736	171	16	of	of	ADP
dpc-3736	171	17	topical	topical	NOUN
dpc-3736	171	18	amphotericin	amphotericin	ADP
dpc-3736	171	19	b	b	NOUN
dpc-3736	171	20	treatment	treatment	NOUN
dpc-3736	171	21	.	.	PUNCT
dpc-3736	172	1	original	original	ADJ
dpc-3736	172	2	article	article	NOUN
dpc-3736	172	3	|	|	ADV
dpc-3736	172	4	dermatol	dermatol	ADJ
dpc-3736	172	5	pract	pract	NOUN
dpc-3736	172	6	concept	concept	NOUN
dpc-3736	172	7	.	.	PUNCT
dpc-3736	173	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	173	2	7	7	NUM
dpc-3736	173	3	clotrimazole	clotrimazole	NOUN
dpc-3736	173	4	reported	report	VERB
dpc-3736	173	5	any	any	DET
dpc-3736	173	6	side	side	NOUN
dpc-3736	173	7	effects	effect	NOUN
dpc-3736	173	8	.	.	PUNCT
dpc-3736	174	1	however	however	ADV
dpc-3736	174	2	,	,	PUNCT
dpc-3736	174	3	it	it	PRON
dpc-3736	174	4	is	be	AUX
dpc-3736	174	5	possible	possible	ADJ
dpc-3736	174	6	for	for	SCONJ
dpc-3736	174	7	some	some	DET
dpc-3736	174	8	individuals	individual	NOUN
dpc-3736	174	9	to	to	PART
dpc-3736	174	10	experience	experience	VERB
dpc-3736	174	11	local	local	ADJ
dpc-3736	174	12	side	side	NOUN
dpc-3736	174	13	effects	effect	NOUN
dpc-3736	174	14	such	such	ADJ
dpc-3736	174	15	as	as	ADP
dpc-3736	174	16	skin	skin	NOUN
dpc-3736	174	17	irritation	irritation	NOUN
dpc-3736	174	18	,	,	PUNCT
dpc-3736	174	19	dryness	dryness	NOUN
dpc-3736	174	20	,	,	PUNCT
dpc-3736	174	21	and	and	CCONJ
dpc-3736	174	22	allergic	allergic	ADJ
dpc-3736	174	23	reactions	reaction	NOUN
dpc-3736	174	24	[	[	X
dpc-3736	174	25	25	25	NUM
dpc-3736	174	26	]	]	PUNCT
dpc-3736	174	27	.	.	PUNCT
dpc-3736	175	1	serious	serious	ADJ
dpc-3736	175	2	systemic	systemic	ADJ
dpc-3736	175	3	side	side	NOUN
dpc-3736	175	4	effects	effect	NOUN
dpc-3736	175	5	with	with	ADP
dpc-3736	175	6	topical	topical	ADJ
dpc-3736	175	7	clotrimazole	clotrimazole	NOUN
dpc-3736	175	8	are	be	AUX
dpc-3736	175	9	extremely	extremely	ADV
dpc-3736	175	10	rare	rare	ADJ
dpc-3736	175	11	.	.	PUNCT
dpc-3736	176	1	topical	topical	ADJ
dpc-3736	176	2	amphotericin	amphotericin	ADP
dpc-3736	176	3	b	b	NOUN
dpc-3736	176	4	is	be	AUX
dpc-3736	176	5	generally	generally	ADV
dpc-3736	176	6	considered	consider	VERB
dpc-3736	176	7	safe	safe	ADJ
dpc-3736	176	8	,	,	PUNCT
dpc-3736	176	9	although	although	SCONJ
dpc-3736	176	10	there	there	PRON
dpc-3736	176	11	is	be	VERB
dpc-3736	176	12	a	a	DET
dpc-3736	176	13	potential	potential	NOUN
dpc-3736	176	14	for	for	ADP
dpc-3736	176	15	dose	dose	NOUN
dpc-3736	176	16	-	-	PUNCT
dpc-3736	176	17	dependent	dependent	ADJ
dpc-3736	176	18	adverse	adverse	ADJ
dpc-3736	176	19	reactions	reaction	NOUN
dpc-3736	176	20	,	,	PUNCT
dpc-3736	176	21	particularly	particularly	ADV
dpc-3736	176	22	with	with	ADP
dpc-3736	176	23	higher	high	ADJ
dpc-3736	176	24	concentrations	concentration	NOUN
dpc-3736	176	25	or	or	CCONJ
dpc-3736	176	26	prolonged	prolonged	ADJ
dpc-3736	176	27	use	use	NOUN
dpc-3736	176	28	[	[	X
dpc-3736	176	29	26	26	NUM
dpc-3736	176	30	]	]	PUNCT
dpc-3736	176	31	.	.	PUNCT
dpc-3736	177	1	one	one	NUM
dpc-3736	177	2	case	case	NOUN
dpc-3736	177	3	in	in	ADP
dpc-3736	177	4	our	our	PRON
dpc-3736	177	5	study	study	NOUN
dpc-3736	177	6	experienced	experience	VERB
dpc-3736	177	7	tolerable	tolerable	ADJ
dpc-3736	177	8	skin	skin	NOUN
dpc-3736	177	9	sensitivity	sensitivity	NOUN
dpc-3736	177	10	while	while	SCONJ
dpc-3736	177	11	receiving	receive	VERB
dpc-3736	177	12	topical	topical	ADJ
dpc-3736	177	13	liposomal	liposomal	NOUN
dpc-3736	177	14	amphotericin	amphotericin	AUX
dpc-3736	177	15	b.	b.	VERB
dpc-3736	177	16	the	the	DET
dpc-3736	177	17	appropriate	appropriate	ADJ
dpc-3736	177	18	concentrations	concentration	NOUN
dpc-3736	177	19	for	for	ADP
dpc-3736	177	20	topical	topical	ADJ
dpc-3736	177	21	amphotericin	amphotericin	VERB
dpc-3736	177	22	b	b	NOUN
dpc-3736	177	23	range	range	NOUN
dpc-3736	177	24	from	from	ADP
dpc-3736	177	25	0.1	0.1	NUM
dpc-3736	177	26	%	%	NOUN
dpc-3736	177	27	to	to	PART
dpc-3736	177	28	0.4	0.4	NUM
dpc-3736	177	29	%	%	NOUN
dpc-3736	177	30	,	,	PUNCT
dpc-3736	177	31	and	and	CCONJ
dpc-3736	177	32	treatment	treatment	NOUN
dpc-3736	177	33	typically	typically	ADV
dpc-3736	177	34	lasts	last	VERB
dpc-3736	177	35	2	2	NUM
dpc-3736	177	36	to	to	PART
dpc-3736	177	37	4	4	NUM
dpc-3736	177	38	weeks	week	NOUN
dpc-3736	177	39	,	,	PUNCT
dpc-3736	177	40	depending	depend	VERB
dpc-3736	177	41	on	on	ADP
dpc-3736	177	42	the	the	DET
dpc-3736	177	43	formulation	formulation	NOUN
dpc-3736	177	44	and	and	CCONJ
dpc-3736	177	45	severity	severity	NOUN
dpc-3736	177	46	of	of	ADP
dpc-3736	177	47	the	the	DET
dpc-3736	177	48	condition	condition	NOUN
dpc-3736	177	49	[	[	X
dpc-3736	177	50	27	27	NUM
dpc-3736	177	51	]	]	PUNCT
dpc-3736	177	52	.	.	PUNCT
dpc-3736	178	1	prolonged	prolonged	ADJ
dpc-3736	178	2	use	use	NOUN
dpc-3736	178	3	,	,	PUNCT
dpc-3736	178	4	however	however	ADV
dpc-3736	178	5	,	,	PUNCT
dpc-3736	178	6	is	be	AUX
dpc-3736	178	7	not	not	PART
dpc-3736	178	8	recommended	recommend	VERB
dpc-3736	178	9	.	.	PUNCT
dpc-3736	179	1	it	it	PRON
dpc-3736	179	2	is	be	AUX
dpc-3736	179	3	worth	worth	ADJ
dpc-3736	179	4	noting	note	VERB
dpc-3736	179	5	that	that	SCONJ
dpc-3736	179	6	liposomal	liposomal	ADJ
dpc-3736	179	7	formulations	formulation	NOUN
dpc-3736	179	8	of	of	ADP
dpc-3736	179	9	amphotericin	amphotericin	ADP
dpc-3736	179	10	b	b	AUX
dpc-3736	179	11	improve	improve	VERB
dpc-3736	179	12	drug	drug	NOUN
dpc-3736	179	13	delivery	delivery	NOUN
dpc-3736	179	14	and	and	CCONJ
dpc-3736	179	15	enhance	enhance	VERB
dpc-3736	179	16	efficacy	efficacy	NOUN
dpc-3736	179	17	and	and	CCONJ
dpc-3736	179	18	safety	safety	NOUN
dpc-3736	180	1	[	[	X
dpc-3736	180	2	26	26	NUM
dpc-3736	180	3	]	]	PUNCT
dpc-3736	180	4	.	.	PUNCT
dpc-3736	181	1	on	on	ADP
dpc-3736	181	2	the	the	DET
dpc-3736	181	3	other	other	ADJ
dpc-3736	181	4	hand	hand	NOUN
dpc-3736	181	5	,	,	PUNCT
dpc-3736	181	6	the	the	DET
dpc-3736	181	7	intravenous	intravenous	ADJ
dpc-3736	181	8	use	use	NOUN
dpc-3736	181	9	of	of	ADP
dpc-3736	181	10	liposomal	liposomal	NOUN
dpc-3736	181	11	amphotericin	amphotericin	ADP
dpc-3736	181	12	b	b	PROPN
dpc-3736	181	13	is	be	AUX
dpc-3736	181	14	associated	associate	VERB
dpc-3736	181	15	with	with	ADP
dpc-3736	181	16	side	side	NOUN
dpc-3736	181	17	effects	effect	NOUN
dpc-3736	181	18	such	such	ADJ
dpc-3736	181	19	as	as	ADP
dpc-3736	181	20	hyperpyrexia	hyperpyrexia	NOUN
dpc-3736	181	21	,	,	PUNCT
dpc-3736	181	22	hypotension	hypotension	NOUN
dpc-3736	181	23	,	,	PUNCT
dpc-3736	181	24	renal	renal	ADJ
dpc-3736	181	25	damage	damage	NOUN
dpc-3736	181	26	,	,	PUNCT
dpc-3736	181	27	and	and	CCONJ
dpc-3736	181	28	hypokalemia	hypokalemia	NOUN
dpc-3736	182	1	[	[	X
dpc-3736	182	2	4	4	NUM
dpc-3736	182	3	]	]	PUNCT
dpc-3736	182	4	.	.	PUNCT
dpc-3736	183	1	for	for	ADP
dpc-3736	183	2	severe	severe	ADJ
dpc-3736	183	3	or	or	CCONJ
dpc-3736	183	4	recurrent	recurrent	ADJ
dpc-3736	183	5	cases	case	NOUN
dpc-3736	183	6	,	,	PUNCT
dpc-3736	183	7	oral	oral	ADJ
dpc-3736	183	8	medications	medication	NOUN
dpc-3736	183	9	such	such	ADJ
dpc-3736	183	10	as	as	ADP
dpc-3736	183	11	itraconazole	itraconazole	NOUN
dpc-3736	183	12	and	and	CCONJ
dpc-3736	183	13	fluconazole	fluconazole	NOUN
dpc-3736	183	14	are	be	AUX
dpc-3736	183	15	considered	consider	VERB
dpc-3736	183	16	second	second	ADJ
dpc-3736	183	17	-	-	PUNCT
dpc-3736	183	18	line	line	NOUN
dpc-3736	183	19	treatments	treatment	NOUN
dpc-3736	183	20	[	[	X
dpc-3736	183	21	28	28	NUM
dpc-3736	183	22	]	]	PUNCT
dpc-3736	183	23	.	.	PUNCT
dpc-3736	184	1	while	while	SCONJ
dpc-3736	184	2	polyene	polyene	VERB
dpc-3736	184	3	antifungals	antifungal	NOUN
dpc-3736	184	4	like	like	ADP
dpc-3736	184	5	amphotericin	amphotericin	ADP
dpc-3736	184	6	b	b	AUX
dpc-3736	184	7	provide	provide	VERB
dpc-3736	184	8	broad	broad	ADJ
dpc-3736	184	9	-	-	PUNCT
dpc-3736	184	10	spectrum	spectrum	NOUN
dpc-3736	184	11	coverage	coverage	NOUN
dpc-3736	184	12	against	against	ADP
dpc-3736	184	13	most	most	ADJ
dpc-3736	184	14	pathogenic	pathogenic	ADJ
dpc-3736	184	15	fungi	fungus	NOUN
dpc-3736	184	16	,	,	PUNCT
dpc-3736	184	17	they	they	PRON
dpc-3736	184	18	are	be	AUX
dpc-3736	184	19	generally	generally	ADV
dpc-3736	184	20	less	less	ADV
dpc-3736	184	21	effective	effective	ADJ
dpc-3736	184	22	against	against	ADP
dpc-3736	184	23	dermatophytes	dermatophyte	NOUN
dpc-3736	184	24	[	[	X
dpc-3736	184	25	4	4	NUM
dpc-3736	184	26	]	]	PUNCT
dpc-3736	184	27	.	.	PUNCT
dpc-3736	185	1	as	as	ADP
dpc-3736	185	2	a	a	DET
dpc-3736	185	3	result	result	NOUN
dpc-3736	185	4	,	,	PUNCT
dpc-3736	185	5	azoles	azole	NOUN
dpc-3736	185	6	,	,	PUNCT
dpc-3736	185	7	which	which	PRON
dpc-3736	185	8	primarily	primarily	ADV
dpc-3736	185	9	target	target	VERB
dpc-3736	185	10	superficial	superficial	ADJ
dpc-3736	185	11	infections	infection	NOUN
dpc-3736	185	12	caused	cause	VERB
dpc-3736	185	13	by	by	ADP
dpc-3736	185	14	dermatophytes	dermatophyte	NOUN
dpc-3736	185	15	,	,	PUNCT
dpc-3736	185	16	are	be	AUX
dpc-3736	185	17	recommended	recommend	VERB
dpc-3736	185	18	as	as	ADP
dpc-3736	185	19	the	the	DET
dpc-3736	185	20	first	first	ADJ
dpc-3736	185	21	-	-	PUNCT
dpc-3736	185	22	line	line	NOUN
dpc-3736	185	23	treatment	treatment	NOUN
dpc-3736	185	24	,	,	PUNCT
dpc-3736	185	25	while	while	SCONJ
dpc-3736	185	26	polyene	polyene	NOUN
dpc-3736	185	27	antifungals	antifungal	NOUN
dpc-3736	185	28	should	should	AUX
dpc-3736	185	29	be	be	AUX
dpc-3736	185	30	reserved	reserve	VERB
dpc-3736	185	31	for	for	ADP
dpc-3736	185	32	severe	severe	ADJ
dpc-3736	185	33	fungal	fungal	ADJ
dpc-3736	185	34	infections	infection	NOUN
dpc-3736	185	35	.	.	PUNCT
dpc-3736	186	1	we	we	PRON
dpc-3736	186	2	also	also	ADV
dpc-3736	186	3	hypothesized	hypothesize	VERB
dpc-3736	186	4	that	that	SCONJ
dpc-3736	186	5	the	the	DET
dpc-3736	186	6	therapeutic	therapeutic	ADJ
dpc-3736	186	7	efficacy	efficacy	NOUN
dpc-3736	186	8	of	of	ADP
dpc-3736	186	9	our	our	PRON
dpc-3736	186	10	intervention	intervention	NOUN
dpc-3736	186	11	would	would	AUX
dpc-3736	186	12	not	not	PART
dpc-3736	186	13	be	be	AUX
dpc-3736	186	14	influenced	influence	VERB
dpc-3736	186	15	by	by	ADP
dpc-3736	186	16	patients	patient	NOUN
dpc-3736	186	17	’	'	PUNCT
dpc-3736	186	18	demographic	demographic	ADJ
dpc-3736	186	19	and	and	CCONJ
dpc-3736	186	20	baseline	baseline	ADJ
dpc-3736	186	21	characteristics	characteristic	NOUN
dpc-3736	186	22	.	.	PUNCT
dpc-3736	187	1	the	the	DET
dpc-3736	187	2	statistical	statistical	ADJ
dpc-3736	187	3	analysis	analysis	NOUN
dpc-3736	187	4	the	the	DET
dpc-3736	187	5	 	 	SPACE
dpc-3736	187	6	hypopigmentation	hypopigmentation	NOUN
dpc-3736	187	7	observed	observe	VERB
dpc-3736	187	8	in	in	ADP
dpc-3736	187	9	pityriasis	pityriasis	NOUN
dpc-3736	187	10	versicolor	versicolor	NOUN
dpc-3736	187	11	may	may	AUX
dpc-3736	187	12	be	be	AUX
dpc-3736	187	13	attributed	attribute	VERB
dpc-3736	187	14	to	to	ADP
dpc-3736	187	15	the	the	DET
dpc-3736	187	16	inhibitory	inhibitory	ADJ
dpc-3736	187	17	effect	effect	NOUN
dpc-3736	187	18	of	of	ADP
dpc-3736	187	19	azelaic	azelaic	PROPN
dpc-3736	187	20	acid	acid	NOUN
dpc-3736	187	21	,	,	PUNCT
dpc-3736	187	22	produced	produce	VERB
dpc-3736	187	23	by	by	ADP
dpc-3736	187	24	malassezia	malassezia	NOUN
dpc-3736	187	25	species	specie	NOUN
dpc-3736	187	26	,	,	PUNCT
dpc-3736	187	27	on	on	ADP
dpc-3736	187	28	tyrosinase	tyrosinase	NOUN
dpc-3736	187	29	,	,	PUNCT
dpc-3736	187	30	an	an	DET
dpc-3736	187	31	enzyme	enzyme	NOUN
dpc-3736	187	32	involved	involve	VERB
dpc-3736	187	33	in	in	ADP
dpc-3736	187	34	melanogenesis	melanogenesis	NOUN
dpc-3736	187	35	[	[	X
dpc-3736	187	36	23	23	NUM
dpc-3736	187	37	]	]	PUNCT
dpc-3736	187	38	.	.	PUNCT
dpc-3736	188	1	additionally	additionally	ADV
dpc-3736	188	2	,	,	PUNCT
dpc-3736	188	3	the	the	DET
dpc-3736	188	4	production	production	NOUN
dpc-3736	188	5	of	of	ADP
dpc-3736	188	6	free	free	ADJ
dpc-3736	188	7	radicals	radical	NOUN
dpc-3736	188	8	by	by	ADP
dpc-3736	188	9	lipoperoxidase	lipoperoxidase	NOUN
dpc-3736	188	10	can	can	AUX
dpc-3736	188	11	lead	lead	VERB
dpc-3736	188	12	to	to	ADP
dpc-3736	188	13	skin	skin	NOUN
dpc-3736	188	14	damage	damage	NOUN
dpc-3736	188	15	and	and	CCONJ
dpc-3736	188	16	impaired	impaired	ADJ
dpc-3736	188	17	pigmentation	pigmentation	NOUN
dpc-3736	188	18	[	[	X
dpc-3736	188	19	23	23	NUM
dpc-3736	188	20	]	]	PUNCT
dpc-3736	188	21	.	.	PUNCT
dpc-3736	189	1	it	it	PRON
dpc-3736	189	2	is	be	AUX
dpc-3736	189	3	important	important	ADJ
dpc-3736	189	4	to	to	PART
dpc-3736	189	5	note	note	VERB
dpc-3736	189	6	that	that	SCONJ
dpc-3736	189	7	pigmentary	pigmentary	ADJ
dpc-3736	189	8	changes	change	NOUN
dpc-3736	189	9	may	may	AUX
dpc-3736	189	10	take	take	VERB
dpc-3736	189	11	weeks	week	NOUN
dpc-3736	189	12	to	to	ADP
dpc-3736	189	13	months	month	NOUN
dpc-3736	189	14	to	to	PART
dpc-3736	189	15	resolve	resolve	VERB
dpc-3736	189	16	,	,	PUNCT
dpc-3736	189	17	even	even	ADV
dpc-3736	189	18	after	after	ADP
dpc-3736	189	19	successful	successful	ADJ
dpc-3736	189	20	eradication	eradication	NOUN
dpc-3736	189	21	of	of	ADP
dpc-3736	189	22	the	the	DET
dpc-3736	189	23	fungus	fungus	NOUN
dpc-3736	190	1	[	[	X
dpc-3736	190	2	1	1	NUM
dpc-3736	190	3	]	]	PUNCT
dpc-3736	190	4	.	.	PUNCT
dpc-3736	191	1	in	in	ADP
dpc-3736	191	2	our	our	PRON
dpc-3736	191	3	study	study	NOUN
dpc-3736	191	4	,	,	PUNCT
dpc-3736	191	5	when	when	SCONJ
dpc-3736	191	6	considering	consider	VERB
dpc-3736	191	7	both	both	CCONJ
dpc-3736	191	8	mycologic	mycologic	ADJ
dpc-3736	191	9	and	and	CCONJ
dpc-3736	191	10	clinical	clinical	ADJ
dpc-3736	191	11	treatments	treatment	NOUN
dpc-3736	191	12	combined	combine	VERB
dpc-3736	191	13	,	,	PUNCT
dpc-3736	191	14	14	14	NUM
dpc-3736	191	15	(	(	PUNCT
dpc-3736	191	16	63.6	63.6	NUM
dpc-3736	191	17	%	%	NOUN
dpc-3736	191	18	)	)	PUNCT
dpc-3736	191	19	and	and	CCONJ
dpc-3736	191	20	13	13	NUM
dpc-3736	191	21	(	(	PUNCT
dpc-3736	191	22	59.1	59.1	NUM
dpc-3736	191	23	%	%	NOUN
dpc-3736	191	24	)	)	PUNCT
dpc-3736	191	25	of	of	ADP
dpc-3736	191	26	patients	patient	NOUN
dpc-3736	191	27	in	in	ADP
dpc-3736	191	28	the	the	DET
dpc-3736	191	29	amphotericin	amphotericin	NOUN
dpc-3736	191	30	and	and	CCONJ
dpc-3736	191	31	clotrimazole	clotrimazole	NOUN
dpc-3736	191	32	groups	group	NOUN
dpc-3736	191	33	,	,	PUNCT
dpc-3736	191	34	respectively	respectively	ADV
dpc-3736	191	35	,	,	PUNCT
dpc-3736	191	36	achieved	achieve	VERB
dpc-3736	191	37	complete	complete	ADJ
dpc-3736	191	38	cure	cure	NOUN
dpc-3736	191	39	.	.	PUNCT
dpc-3736	192	1	although	although	SCONJ
dpc-3736	192	2	there	there	PRON
dpc-3736	192	3	was	be	VERB
dpc-3736	192	4	no	no	DET
dpc-3736	192	5	statistically	statistically	ADV
dpc-3736	192	6	significant	significant	ADJ
dpc-3736	192	7	difference	difference	NOUN
dpc-3736	192	8	in	in	ADP
dpc-3736	192	9	the	the	DET
dpc-3736	192	10	complete	complete	ADJ
dpc-3736	192	11	cure	cure	NOUN
dpc-3736	192	12	rates	rate	NOUN
dpc-3736	192	13	between	between	ADP
dpc-3736	192	14	the	the	DET
dpc-3736	192	15	two	two	NUM
dpc-3736	192	16	groups	group	NOUN
dpc-3736	192	17	,	,	PUNCT
dpc-3736	192	18	liposomal	liposomal	NOUN
dpc-3736	192	19	amphotericin	amphotericin	ADP
dpc-3736	192	20	b	b	PROPN
dpc-3736	192	21	showed	show	VERB
dpc-3736	192	22	a	a	DET
dpc-3736	192	23	slight	slight	ADJ
dpc-3736	192	24	numerical	numerical	ADJ
dpc-3736	192	25	advantage	advantage	NOUN
dpc-3736	192	26	(	(	PUNCT
dpc-3736	192	27	rr	rr	NOUN
dpc-3736	192	28	=	=	SYM
dpc-3736	192	29	1.07	1.07	NUM
dpc-3736	192	30	;	;	PUNCT
dpc-3736	192	31	95	95	NUM
dpc-3736	192	32	%	%	NOUN
dpc-3736	192	33	ci	ci	NOUN
dpc-3736	192	34	:	:	PUNCT
dpc-3736	192	35	0.67	0.67	NUM
dpc-3736	192	36	-	-	SYM
dpc-3736	192	37	1.72	1.72	NUM
dpc-3736	192	38	)	)	PUNCT
dpc-3736	192	39	.	.	PUNCT
dpc-3736	193	1	however	however	ADV
dpc-3736	193	2	,	,	PUNCT
dpc-3736	193	3	this	this	DET
dpc-3736	193	4	difference	difference	NOUN
dpc-3736	193	5	was	be	AUX
dpc-3736	193	6	not	not	PART
dpc-3736	193	7	statistically	statistically	ADV
dpc-3736	193	8	significant	significant	ADJ
dpc-3736	193	9	(	(	PUNCT
dpc-3736	193	10	p	p	X
dpc-3736	193	11	>	>	X
dpc-3736	193	12	0.7	0.7	NUM
dpc-3736	193	13	)	)	PUNCT
dpc-3736	193	14	.	.	PUNCT
dpc-3736	194	1	azoles	azole	NOUN
dpc-3736	194	2	are	be	AUX
dpc-3736	194	3	known	know	VERB
dpc-3736	194	4	to	to	PART
dpc-3736	194	5	possess	possess	VERB
dpc-3736	194	6	anti	anti	ADJ
dpc-3736	194	7	-	-	ADJ
dpc-3736	194	8	inflammatory	inflammatory	ADJ
dpc-3736	194	9	properties	property	NOUN
dpc-3736	194	10	and	and	CCONJ
dpc-3736	194	11	have	have	VERB
dpc-3736	194	12	fungistatic	fungistatic	ADJ
dpc-3736	194	13	effects	effect	NOUN
dpc-3736	194	14	[	[	X
dpc-3736	194	15	24	24	NUM
dpc-3736	194	16	]	]	PUNCT
dpc-3736	194	17	.	.	PUNCT
dpc-3736	195	1	in	in	ADP
dpc-3736	195	2	contrast	contrast	NOUN
dpc-3736	195	3	,	,	PUNCT
dpc-3736	195	4	topical	topical	ADJ
dpc-3736	195	5	liposomal	liposomal	NOUN
dpc-3736	195	6	amphotericin	amphotericin	ADP
dpc-3736	195	7	b	b	PROPN
dpc-3736	195	8	has	have	VERB
dpc-3736	195	9	fungicidal	fungicidal	ADJ
dpc-3736	195	10	properties	property	NOUN
dpc-3736	195	11	and	and	CCONJ
dpc-3736	195	12	may	may	AUX
dpc-3736	195	13	theoretically	theoretically	ADV
dpc-3736	195	14	lead	lead	VERB
dpc-3736	195	15	to	to	ADP
dpc-3736	195	16	better	well	ADJ
dpc-3736	195	17	treatment	treatment	NOUN
dpc-3736	195	18	outcomes	outcome	NOUN
dpc-3736	195	19	.	.	PUNCT
dpc-3736	196	1	the	the	DET
dpc-3736	196	2	lack	lack	NOUN
dpc-3736	196	3	of	of	ADP
dpc-3736	196	4	a	a	DET
dpc-3736	196	5	significant	significant	ADJ
dpc-3736	196	6	difference	difference	NOUN
dpc-3736	196	7	in	in	ADP
dpc-3736	196	8	complete	complete	ADJ
dpc-3736	196	9	cure	cure	NOUN
dpc-3736	196	10	rates	rate	NOUN
dpc-3736	196	11	observed	observe	VERB
dpc-3736	196	12	between	between	ADP
dpc-3736	196	13	the	the	DET
dpc-3736	196	14	two	two	NUM
dpc-3736	196	15	groups	group	NOUN
dpc-3736	196	16	may	may	AUX
dpc-3736	196	17	be	be	AUX
dpc-3736	196	18	attributed	attribute	VERB
dpc-3736	196	19	to	to	ADP
dpc-3736	196	20	the	the	DET
dpc-3736	196	21	limited	limited	ADJ
dpc-3736	196	22	statistical	statistical	ADJ
dpc-3736	196	23	power	power	NOUN
dpc-3736	196	24	of	of	ADP
dpc-3736	196	25	the	the	DET
dpc-3736	196	26	study	study	NOUN
dpc-3736	196	27	,	,	PUNCT
dpc-3736	196	28	raising	raise	VERB
dpc-3736	196	29	the	the	DET
dpc-3736	196	30	possibility	possibility	NOUN
dpc-3736	196	31	that	that	SCONJ
dpc-3736	196	32	the	the	DET
dpc-3736	196	33	benefits	benefit	NOUN
dpc-3736	196	34	of	of	ADP
dpc-3736	196	35	amphotericin	amphotericin	ADP
dpc-3736	196	36	b	b	NOUN
dpc-3736	196	37	may	may	AUX
dpc-3736	196	38	have	have	AUX
dpc-3736	196	39	been	be	AUX
dpc-3736	196	40	underestimated	underestimate	VERB
dpc-3736	196	41	.	.	PUNCT
dpc-3736	197	1	further	further	ADJ
dpc-3736	197	2	studies	study	NOUN
dpc-3736	197	3	with	with	ADP
dpc-3736	197	4	larger	large	ADJ
dpc-3736	197	5	sample	sample	NOUN
dpc-3736	197	6	sizes	size	NOUN
dpc-3736	197	7	should	should	AUX
dpc-3736	197	8	be	be	AUX
dpc-3736	197	9	conducted	conduct	VERB
dpc-3736	197	10	to	to	PART
dpc-3736	197	11	confirm	confirm	VERB
dpc-3736	197	12	these	these	DET
dpc-3736	197	13	findings	finding	NOUN
dpc-3736	197	14	.	.	PUNCT
dpc-3736	198	1	nevertheless	nevertheless	ADV
dpc-3736	198	2	,	,	PUNCT
dpc-3736	198	3	it	it	PRON
dpc-3736	198	4	is	be	AUX
dpc-3736	198	5	worth	worth	ADJ
dpc-3736	198	6	noting	note	VERB
dpc-3736	198	7	that	that	SCONJ
dpc-3736	198	8	all	all	DET
dpc-3736	198	9	patients	patient	NOUN
dpc-3736	198	10	who	who	PRON
dpc-3736	198	11	achieved	achieve	VERB
dpc-3736	198	12	full	full	ADJ
dpc-3736	198	13	clinical	clinical	ADJ
dpc-3736	198	14	cure	cure	NOUN
dpc-3736	198	15	were	be	AUX
dpc-3736	198	16	also	also	ADV
dpc-3736	198	17	found	find	VERB
dpc-3736	198	18	to	to	PART
dpc-3736	198	19	be	be	AUX
dpc-3736	198	20	microscopically	microscopically	ADV
dpc-3736	198	21	free	free	ADJ
dpc-3736	198	22	of	of	ADP
dpc-3736	198	23	pv	pv	NOUN
dpc-3736	198	24	at	at	ADP
dpc-3736	198	25	the	the	DET
dpc-3736	198	26	end	end	NOUN
dpc-3736	198	27	of	of	ADP
dpc-3736	198	28	the	the	DET
dpc-3736	198	29	study	study	NOUN
dpc-3736	198	30	,	,	PUNCT
dpc-3736	198	31	irrespective	irrespective	ADV
dpc-3736	198	32	of	of	ADP
dpc-3736	198	33	the	the	DET
dpc-3736	198	34	treatment	treatment	NOUN
dpc-3736	198	35	received	receive	VERB
dpc-3736	198	36	.	.	PUNCT
dpc-3736	199	1	in	in	ADP
dpc-3736	199	2	the	the	DET
dpc-3736	199	3	present	present	ADJ
dpc-3736	199	4	study	study	NOUN
dpc-3736	199	5	,	,	PUNCT
dpc-3736	199	6	we	we	PRON
dpc-3736	199	7	found	find	VERB
dpc-3736	199	8	that	that	SCONJ
dpc-3736	199	9	topical	topical	ADJ
dpc-3736	199	10	clotrimazole	clotrimazole	NOUN
dpc-3736	199	11	was	be	AUX
dpc-3736	199	12	well	well	ADV
dpc-3736	199	13	-	-	PUNCT
dpc-3736	199	14	tolerated	tolerate	VERB
dpc-3736	199	15	,	,	PUNCT
dpc-3736	199	16	and	and	CCONJ
dpc-3736	199	17	none	none	NOUN
dpc-3736	199	18	of	of	ADP
dpc-3736	199	19	the	the	DET
dpc-3736	199	20	patients	patient	NOUN
dpc-3736	199	21	treated	treat	VERB
dpc-3736	199	22	with	with	ADP
dpc-3736	199	23	figure	figure	NOUN
dpc-3736	199	24	3	3	NUM
dpc-3736	199	25	.	.	PUNCT
dpc-3736	200	1	(	(	PUNCT
dpc-3736	200	2	a	a	X
dpc-3736	200	3	)	)	PUNCT
dpc-3736	200	4	a	a	DET
dpc-3736	200	5	17	17	NUM
dpc-3736	200	6	-	-	PUNCT
dpc-3736	200	7	year	year	NOUN
dpc-3736	200	8	-	-	PUNCT
dpc-3736	200	9	old	old	ADJ
dpc-3736	200	10	girl	girl	NOUN
dpc-3736	200	11	from	from	ADP
dpc-3736	200	12	shiraz	shiraz	PROPN
dpc-3736	200	13	with	with	ADP
dpc-3736	200	14	lesions	lesion	NOUN
dpc-3736	200	15	on	on	ADP
dpc-3736	200	16	the	the	DET
dpc-3736	200	17	lower	low	ADJ
dpc-3736	200	18	abdominal	abdominal	ADJ
dpc-3736	200	19	area	area	NOUN
dpc-3736	200	20	for	for	ADP
dpc-3736	200	21	3	3	NUM
dpc-3736	200	22	weeks	week	NOUN
dpc-3736	200	23	,	,	PUNCT
dpc-3736	200	24	with	with	ADP
dpc-3736	200	25	<	<	X
dpc-3736	200	26	1	1	NUM
dpc-3736	200	27	%	%	NOUN
dpc-3736	200	28	skin	skin	NOUN
dpc-3736	200	29	involvement	involvement	NOUN
dpc-3736	200	30	.	.	PUNCT
dpc-3736	201	1	she	she	PRON
dpc-3736	201	2	was	be	AUX
dpc-3736	201	3	advised	advise	VERB
dpc-3736	201	4	to	to	PART
dpc-3736	201	5	apply	apply	VERB
dpc-3736	201	6	amphotericin	amphotericin	ADP
dpc-3736	201	7	gel	gel	NOUN
dpc-3736	201	8	twice	twice	ADV
dpc-3736	201	9	daily	daily	ADV
dpc-3736	201	10	for	for	ADP
dpc-3736	201	11	2	2	NUM
dpc-3736	201	12	weeks	week	NOUN
dpc-3736	201	13	.	.	PUNCT
dpc-3736	202	1	(	(	PUNCT
dpc-3736	202	2	b	b	X
dpc-3736	202	3	)	)	PUNCT
dpc-3736	202	4	complete	complete	ADJ
dpc-3736	202	5	cure	cure	NOUN
dpc-3736	202	6	observed	observe	VERB
dpc-3736	202	7	two	two	NUM
dpc-3736	202	8	weeks	week	NOUN
dpc-3736	202	9	after	after	ADP
dpc-3736	202	10	treatment	treatment	NOUN
dpc-3736	202	11	.	.	PUNCT
dpc-3736	203	1	8	8	NUM
dpc-3736	203	2	original	original	ADJ
dpc-3736	203	3	article	article	NOUN
dpc-3736	203	4	|	|	ADV
dpc-3736	203	5	dermatol	dermatol	ADJ
dpc-3736	203	6	pract	pract	NOUN
dpc-3736	203	7	concept	concept	NOUN
dpc-3736	203	8	.	.	PUNCT
dpc-3736	204	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	205	1	3	3	X
dpc-3736	205	2	.	.	PUNCT
dpc-3736	205	3	gupta	gupta	PROPN
dpc-3736	205	4	a	a	DET
dpc-3736	205	5	k	k	PROPN
dpc-3736	205	6	,	,	PUNCT
dpc-3736	205	7	kogan	kogan	PROPN
dpc-3736	205	8	n	n	CCONJ
dpc-3736	205	9	,	,	PUNCT
dpc-3736	205	10	batra	batra	PROPN
dpc-3736	205	11	r.	r.	PROPN
dpc-3736	205	12	pityriasis	pityriasis	PROPN
dpc-3736	205	13	versicolor	versicolor	PROPN
dpc-3736	205	14	:	:	PUNCT
dpc-3736	205	15	a	a	DET
dpc-3736	205	16	review	review	NOUN
dpc-3736	205	17	of	of	ADP
dpc-3736	205	18	pharmacological	pharmacological	ADJ
dpc-3736	205	19	treatment	treatment	NOUN
dpc-3736	205	20	options	option	NOUN
dpc-3736	205	21	.	.	PUNCT
dpc-3736	206	1	expert	expert	NOUN
dpc-3736	206	2	opin	opin	NOUN
dpc-3736	206	3	pharmacother	pharmacother	NOUN
dpc-3736	206	4	.	.	PUNCT
dpc-3736	207	1	2005;6(2):165	2005;6(2):165	NUM
dpc-3736	207	2	-	-	SYM
dpc-3736	207	3	178	178	NUM
dpc-3736	207	4	doi:10.1517/14656566.6.2.165	doi:10.1517/14656566.6.2.165	PROPN
dpc-3736	207	5	.	.	PUNCT
dpc-3736	208	1	pmid	pmid	NOUN
dpc-3736	208	2	:	:	PUNCT
dpc-3736	208	3	15757415	15757415	NUM
dpc-3736	208	4	.	.	PUNCT
dpc-3736	209	1	4	4	X
dpc-3736	209	2	.	.	X
dpc-3736	209	3	hay	hay	PROPN
dpc-3736	209	4	r.	r.	PROPN
dpc-3736	209	5	antifungal	antifungal	PROPN
dpc-3736	209	6	drugs	drug	NOUN
dpc-3736	209	7	-	-	PUNCT
dpc-3736	209	8	an	an	DET
dpc-3736	209	9	introduction	introduction	NOUN
dpc-3736	209	10	.	.	PUNCT
dpc-3736	210	1	j	j	PROPN
dpc-3736	210	2	dermatolog	dermatolog	PROPN
dpc-3736	210	3	treat	treat	NOUN
dpc-3736	210	4	.	.	PUNCT
dpc-3736	211	1	1990;1(sup2):1	1990;1(sup2):1	NUM
dpc-3736	211	2	-	-	SYM
dpc-3736	211	3	3	3	NUM
dpc-3736	211	4	.	.	PUNCT
dpc-3736	211	5	doi:10.3109/09546639009089020	doi:10.3109/09546639009089020	NOUN
dpc-3736	211	6	.	.	PUNCT
dpc-3736	212	1	5	5	X
dpc-3736	212	2	.	.	X
dpc-3736	212	3	carlile	carlile	PROPN
dpc-3736	212	4	m	m	PROPN
dpc-3736	212	5	j	j	PROPN
dpc-3736	212	6	,	,	PUNCT
dpc-3736	212	7	watkinson	watkinson	PROPN
dpc-3736	212	8	s	s	PART
dpc-3736	212	9	c	c	NOUN
dpc-3736	212	10	,	,	PUNCT
dpc-3736	212	11	gooday	gooday	NOUN
dpc-3736	212	12	g	g	PROPN
dpc-3736	212	13	w.	w.	PROPN
dpc-3736	212	14	the	the	DET
dpc-3736	212	15	fungi	fungi	PROPN
dpc-3736	212	16	.	.	PUNCT
dpc-3736	213	1	elsevier	elsevier	PROPN
dpc-3736	213	2	science	science	PROPN
dpc-3736	213	3	;	;	PUNCT
dpc-3736	213	4	2001;3:179	2001;3:179	NUM
dpc-3736	213	5	.	.	PUNCT
dpc-3736	214	1	6	6	NUM
dpc-3736	214	2	.	.	NOUN
dpc-3736	214	3	pazouki	pazouki	PROPN
dpc-3736	214	4	m	m	PROPN
dpc-3736	214	5	,	,	PUNCT
dpc-3736	214	6	panda	panda	NOUN
dpc-3736	214	7	t.	t.	NOUN
dpc-3736	214	8	understanding	understand	VERB
dpc-3736	214	9	the	the	DET
dpc-3736	214	10	morphology	morphology	NOUN
dpc-3736	214	11	of	of	ADP
dpc-3736	214	12	fungi	fungi	PROPN
dpc-3736	214	13	.	.	PUNCT
dpc-3736	215	1	bioprocess	bioprocess	PROPN
dpc-3736	215	2	biosyst	biosyst	PROPN
dpc-3736	215	3	eng	eng	PROPN
dpc-3736	215	4	.	.	PUNCT
dpc-3736	216	1	2000;22:127	2000;22:127	NUM
dpc-3736	216	2	-	-	SYM
dpc-3736	216	3	143	143	NUM
dpc-3736	216	4	.	.	PUNCT
dpc-3736	217	1	doi:10.1007	doi:10.1007	PROPN
dpc-3736	217	2	/s004490050022	/s004490050022	NOUN
dpc-3736	217	3	.	.	PUNCT
dpc-3736	218	1	7	7	X
dpc-3736	218	2	.	.	X
dpc-3736	218	3	heitman	heitman	PROPN
dpc-3736	218	4	j	j	PROPN
dpc-3736	218	5	,	,	PUNCT
dpc-3736	218	6	carter	carter	PROPN
dpc-3736	218	7	d	d	PROPN
dpc-3736	218	8	a	a	PROPN
dpc-3736	218	9	,	,	PUNCT
dpc-3736	218	10	dyer	dyer	NOUN
dpc-3736	218	11	p	p	PROPN
dpc-3736	218	12	s	s	PROPN
dpc-3736	218	13	,	,	PUNCT
dpc-3736	218	14	soll	soll	PROPN
dpc-3736	218	15	d	d	PROPN
dpc-3736	218	16	r.	r.	PROPN
dpc-3736	218	17	sexual	sexual	ADJ
dpc-3736	218	18	reproduction	reproduction	NOUN
dpc-3736	218	19	of	of	ADP
dpc-3736	218	20	human	human	ADJ
dpc-3736	218	21	fungal	fungal	ADJ
dpc-3736	218	22	pathogens	pathogen	NOUN
dpc-3736	218	23	.	.	PUNCT
dpc-3736	219	1	cold	cold	ADJ
dpc-3736	219	2	spring	spring	NOUN
dpc-3736	219	3	harb	harb	PROPN
dpc-3736	219	4	perspect	perspect	PROPN
dpc-3736	219	5	med	med	PROPN
dpc-3736	219	6	.	.	PUNCT
dpc-3736	220	1	2014;4(8):a019281	2014;4(8):a019281	X
dpc-3736	220	2	.	.	PUNCT
dpc-3736	220	3	doi:10.1101	doi:10.1101	NOUN
dpc-3736	220	4	/	/	SYM
dpc-3736	220	5	cshperspect.a019281	cshperspect.a019281	X
dpc-3736	220	6	.	.	PUNCT
dpc-3736	221	1	pmid	pmid	NOUN
dpc-3736	221	2	:	:	PUNCT
dpc-3736	221	3	25085958	25085958	NUM
dpc-3736	221	4	.	.	PUNCT
dpc-3736	222	1	pmcid	pmcid	ADJ
dpc-3736	222	2	:	:	PUNCT
dpc-3736	222	3	pmc4109574	pmc4109574	ADJ
dpc-3736	222	4	.	.	PUNCT
dpc-3736	223	1	8	8	X
dpc-3736	223	2	.	.	X
dpc-3736	223	3	bamford	bamford	PROPN
dpc-3736	223	4	jtm	jtm	PROPN
dpc-3736	223	5	,	,	PUNCT
dpc-3736	223	6	flores	flore	NOUN
dpc-3736	223	7	-	-	PUNCT
dpc-3736	223	8	genuino	genuino	NOUN
dpc-3736	223	9	rns	rn	NOUN
dpc-3736	223	10	,	,	PUNCT
dpc-3736	223	11	ray	ray	NOUN
dpc-3736	223	12	s	s	PROPN
dpc-3736	223	13	,	,	PUNCT
dpc-3736	223	14	et	et	PROPN
dpc-3736	223	15	al	al	PROPN
dpc-3736	223	16	.	.	PUNCT
dpc-3736	223	17	interventions	intervention	NOUN
dpc-3736	223	18	for	for	ADP
dpc-3736	223	19	the	the	DET
dpc-3736	223	20	treatment	treatment	NOUN
dpc-3736	223	21	of	of	ADP
dpc-3736	223	22	pityriasis	pityriasis	NOUN
dpc-3736	223	23	versicolor	versicolor	NOUN
dpc-3736	223	24	.	.	PUNCT
dpc-3736	224	1	cochrane	cochrane	NOUN
dpc-3736	224	2	database	database	PROPN
dpc-3736	224	3	syst	syst	PROPN
dpc-3736	224	4	rev	rev	PROPN
dpc-3736	224	5	.	.	PROPN
dpc-3736	224	6	2018;2018(6):cd011208	2018;2018(6):cd011208	NUM
dpc-3736	224	7	.	.	PUNCT
dpc-3736	225	1	doi	doi	NOUN
dpc-3736	225	2	:	:	PUNCT
dpc-3736	225	3	10.1002/14651858	10.1002/14651858	NUM
dpc-3736	225	4	.cd011208.pub2	.cd011208.pub2	NOUN
dpc-3736	225	5	.	.	PUNCT
dpc-3736	226	1	pmcid	pmcid	NOUN
dpc-3736	226	2	:	:	PUNCT
dpc-3736	226	3	pmc6513390	pmc6513390	ADJ
dpc-3736	226	4	.	.	PUNCT
dpc-3736	227	1	9	9	X
dpc-3736	227	2	.	.	X
dpc-3736	227	3	ahmed	ahmed	PROPN
dpc-3736	227	4	n	n	PROPN
dpc-3736	227	5	,	,	PUNCT
dpc-3736	227	6	kausar	kausar	VERB
dpc-3736	227	7	s	s	PROPN
dpc-3736	227	8	,	,	PUNCT
dpc-3736	227	9	shaikh	shaikh	PROPN
dpc-3736	227	10	z	z	PROPN
dpc-3736	227	11	,	,	PUNCT
dpc-3736	227	12	malik	malik	PROPN
dpc-3736	227	13	s.	s.	PROPN
dpc-3736	227	14	comparison	comparison	NOUN
dpc-3736	227	15	of	of	ADP
dpc-3736	227	16	oral	oral	ADJ
dpc-3736	227	17	itraconazole	itraconazole	NOUN
dpc-3736	227	18	versus	versus	ADP
dpc-3736	227	19	topical	topical	ADJ
dpc-3736	227	20	clotrimazole	clotrimazole	NOUN
dpc-3736	227	21	in	in	ADP
dpc-3736	227	22	treatment	treatment	NOUN
dpc-3736	227	23	of	of	ADP
dpc-3736	227	24	pityriasis	pityriasis	NOUN
dpc-3736	227	25	versicolor	versicolor	NOUN
dpc-3736	227	26	.	.	PUNCT
dpc-3736	228	1	pak	pak	NOUN
dpc-3736	228	2	armed	armed	ADJ
dpc-3736	228	3	forces	force	NOUN
dpc-3736	228	4	med	me	VERB
dpc-3736	228	5	j.	j.	PROPN
dpc-3736	228	6	2017;67:458	2017;67:458	PROPN
dpc-3736	228	7	-	-	PUNCT
dpc-3736	228	8	461	461	NUM
dpc-3736	228	9	.	.	PUNCT
dpc-3736	229	1	10	10	NUM
dpc-3736	229	2	.	.	PUNCT
dpc-3736	230	1	shi	shi	PROPN
dpc-3736	230	2	t	t	PROPN
dpc-3736	230	3	-	-	PUNCT
dpc-3736	230	4	w	w	PROPN
dpc-3736	230	5	,	,	PUNCT
dpc-3736	230	6	zhang	zhang	PROPN
dpc-3736	230	7	j	j	PROPN
dpc-3736	230	8	-	-	PUNCT
dpc-3736	230	9	a	a	PROPN
dpc-3736	230	10	,	,	PUNCT
dpc-3736	230	11	tang	tang	PROPN
dpc-3736	230	12	y	y	PROPN
dpc-3736	230	13	-	-	PUNCT
dpc-3736	230	14	b	b	PROPN
dpc-3736	230	15	,	,	PUNCT
dpc-3736	230	16	yu	yu	PROPN
dpc-3736	230	17	h	h	PROPN
dpc-3736	230	18	-	-	PUNCT
dpc-3736	230	19	x	x	PROPN
dpc-3736	230	20	,	,	PUNCT
dpc-3736	230	21	li	li	PROPN
dpc-3736	230	22	z	z	PROPN
dpc-3736	230	23	-	-	PUNCT
dpc-3736	230	24	g	g	PROPN
dpc-3736	230	25	,	,	PUNCT
dpc-3736	230	26	yu	yu	PROPN
dpc-3736	230	27	j	j	PROPN
dpc-3736	230	28	-	-	PROPN
dpc-3736	230	29	b.	b.	PROPN
dpc-3736	230	30	a	a	DET
dpc-3736	230	31	randomized	randomized	ADJ
dpc-3736	230	32	controlled	control	VERB
dpc-3736	230	33	trial	trial	NOUN
dpc-3736	230	34	of	of	ADP
dpc-3736	230	35	combination	combination	NOUN
dpc-3736	230	36	treatment	treatment	NOUN
dpc-3736	230	37	with	with	ADP
dpc-3736	230	38	ketoconazole	ketoconazole	NOUN
dpc-3736	230	39	2	2	NUM
dpc-3736	230	40	%	%	NOUN
dpc-3736	230	41	cream	cream	NOUN
dpc-3736	230	42	and	and	CCONJ
dpc-3736	230	43	adapalene	adapalene	NOUN
dpc-3736	230	44	0.1	0.1	NUM
dpc-3736	230	45	%	%	NOUN
dpc-3736	230	46	gel	gel	NOUN
dpc-3736	230	47	in	in	ADP
dpc-3736	230	48	pityriasis	pityriasis	NOUN
dpc-3736	230	49	versicolor	versicolor	NOUN
dpc-3736	230	50	.	.	PUNCT
dpc-3736	231	1	j	j	PROPN
dpc-3736	231	2	dermatolog	dermatolog	PROPN
dpc-3736	231	3	treat	treat	NOUN
dpc-3736	231	4	.	.	PUNCT
dpc-3736	232	1	2015;26(2):143	2015;26(2):143	PROPN
dpc-3736	232	2	-	-	SYM
dpc-3736	232	3	146	146	NUM
dpc-3736	232	4	.	.	PUNCT
dpc-3736	233	1	doi:10.3109	doi:10.3109	PROPN
dpc-3736	234	1	/09546634.2014.921661	/09546634.2014.921661	PROPN
dpc-3736	234	2	.	.	PUNCT
dpc-3736	235	1	pmid	pmid	NOUN
dpc-3736	235	2	:	:	PUNCT
dpc-3736	235	3	24802530	24802530	NUM
dpc-3736	235	4	.	.	PUNCT
dpc-3736	236	1	11	11	NUM
dpc-3736	236	2	.	.	PUNCT
dpc-3736	237	1	mellen	mellen	PROPN
dpc-3736	237	2	l	l	PROPN
dpc-3736	237	3	a	a	PROPN
dpc-3736	237	4	,	,	PUNCT
dpc-3736	237	5	vallee	vallee	PROPN
dpc-3736	237	6	j	j	PROPN
dpc-3736	237	7	,	,	PUNCT
dpc-3736	237	8	feldman	feldman	PROPN
dpc-3736	237	9	s	s	PART
dpc-3736	237	10	r	r	PROPN
dpc-3736	237	11	,	,	PUNCT
dpc-3736	237	12	fleischer	fleischer	NOUN
dpc-3736	237	13	a	a	DET
dpc-3736	237	14	b.	b.	PROPN
dpc-3736	237	15	treatment	treatment	NOUN
dpc-3736	237	16	of	of	ADP
dpc-3736	237	17	pityriasis	pityriasis	NOUN
dpc-3736	237	18	versicolor	versicolor	NOUN
dpc-3736	237	19	in	in	ADP
dpc-3736	237	20	the	the	DET
dpc-3736	237	21	united	united	PROPN
dpc-3736	237	22	states	states	PROPN
dpc-3736	237	23	.	.	PUNCT
dpc-3736	238	1	j	j	PROPN
dpc-3736	238	2	dermatolog	dermatolog	PROPN
dpc-3736	238	3	treat	treat	NOUN
dpc-3736	238	4	.	.	PUNCT
dpc-3736	238	5	  	  	SPACE
dpc-3736	239	1	2004;15(3):189	2004;15(3):189	NUM
dpc-3736	239	2	-	-	PUNCT
dpc-3736	239	3	192	192	NUM
dpc-3736	239	4	.	.	PUNCT
dpc-3736	240	1	doi:10.1080/09546630410032421	doi:10.1080/09546630410032421	PROPN
dpc-3736	240	2	.	.	PUNCT
dpc-3736	241	1	pmid	pmid	NOUN
dpc-3736	241	2	:	:	PUNCT
dpc-3736	241	3	15204154	15204154	NUM
dpc-3736	241	4	.	.	PUNCT
dpc-3736	242	1	12	12	NUM
dpc-3736	242	2	.	.	PUNCT
dpc-3736	243	1	balwada	balwada	NOUN
dpc-3736	243	2	r	r	NOUN
dpc-3736	243	3	p	p	PROPN
dpc-3736	243	4	,	,	PUNCT
dpc-3736	243	5	jain	jain	PROPN
dpc-3736	243	6	v	v	ADP
dpc-3736	243	7	k	k	PROPN
dpc-3736	243	8	,	,	PUNCT
dpc-3736	243	9	dayal	dayal	PROPN
dpc-3736	243	10	s.	s.	PROPN
dpc-3736	244	1	a	a	DET
dpc-3736	244	2	double	double	ADJ
dpc-3736	244	3	-	-	PUNCT
dpc-3736	244	4	blind	blind	ADJ
dpc-3736	244	5	comparison	comparison	NOUN
dpc-3736	244	6	of	of	ADP
dpc-3736	244	7	2	2	NUM
dpc-3736	244	8	%	%	NOUN
dpc-3736	244	9	ketoconazole	ketoconazole	NOUN
dpc-3736	244	10	and	and	CCONJ
dpc-3736	244	11	1	1	NUM
dpc-3736	244	12	%	%	NOUN
dpc-3736	244	13	clotrimazole	clotrimazole	NOUN
dpc-3736	244	14	in	in	ADP
dpc-3736	244	15	the	the	DET
dpc-3736	244	16	treatment	treatment	NOUN
dpc-3736	244	17	of	of	ADP
dpc-3736	244	18	pityriasis	pityriasis	NOUN
dpc-3736	244	19	versicolor	versicolor	NOUN
dpc-3736	244	20	.	.	PUNCT
dpc-3736	245	1	indian	indian	PROPN
dpc-3736	245	2	j	j	PROPN
dpc-3736	245	3	dermatol	dermatol	PROPN
dpc-3736	245	4	venereol	venereol	PROPN
dpc-3736	245	5	leprol	leprol	PROPN
dpc-3736	245	6	.	.	PUNCT
dpc-3736	246	1	1996;62(5):298	1996;62(5):298	NUM
dpc-3736	246	2	-	-	SYM
dpc-3736	246	3	300	300	NUM
dpc-3736	246	4	.	.	PUNCT
dpc-3736	247	1	pmid	pmid	NOUN
dpc-3736	247	2	:	:	PUNCT
dpc-3736	247	3	20948094	20948094	NUM
dpc-3736	247	4	.	.	PUNCT
dpc-3736	248	1	13	13	NUM
dpc-3736	248	2	.	.	PUNCT
dpc-3736	249	1	chopra	chopra	PROPN
dpc-3736	249	2	v	v	PROPN
dpc-3736	249	3	,	,	PUNCT
dpc-3736	249	4	jain	jain	PROPN
dpc-3736	249	5	v	v	PROPN
dpc-3736	249	6	k.	k.	PROPN
dpc-3736	249	7	comparative	comparative	PROPN
dpc-3736	249	8	study	study	NOUN
dpc-3736	249	9	of	of	ADP
dpc-3736	249	10	topical	topical	ADJ
dpc-3736	249	11	terbinafine	terbinafine	NOUN
dpc-3736	249	12	and	and	CCONJ
dpc-3736	249	13	topical	topical	ADJ
dpc-3736	249	14	ketoconazole	ketoconazole	NOUN
dpc-3736	249	15	in	in	ADP
dpc-3736	249	16	pityriasis	pityriasis	NOUN
dpc-3736	249	17	versicolor	versicolor	NOUN
dpc-3736	249	18	.	.	PUNCT
dpc-3736	250	1	indian	indian	PROPN
dpc-3736	250	2	j	j	PROPN
dpc-3736	250	3	dermatol	dermatol	PROPN
dpc-3736	250	4	venereol	venereol	ADJ
dpc-3736	250	5	leprol	leprol	NOUN
dpc-3736	250	6	.	.	PUNCT
dpc-3736	251	1	2000;66(6):299	2000;66(6):299	NUM
dpc-3736	251	2	-	-	SYM
dpc-3736	251	3	300	300	NUM
dpc-3736	251	4	.	.	PUNCT
dpc-3736	252	1	pmid	pmid	NOUN
dpc-3736	252	2	:	:	PUNCT
dpc-3736	252	3	20877107	20877107	NUM
dpc-3736	252	4	.	.	PUNCT
dpc-3736	253	1	14	14	NUM
dpc-3736	253	2	.	.	PUNCT
dpc-3736	254	1	mansoori	mansoori	PROPN
dpc-3736	254	2	p	p	NOUN
dpc-3736	254	3	,	,	PUNCT
dpc-3736	254	4	mortazavi	mortazavi	ADJ
dpc-3736	254	5	m.	m.	NOUN
dpc-3736	254	6	a	a	DET
dpc-3736	254	7	comparison	comparison	NOUN
dpc-3736	254	8	between	between	ADP
dpc-3736	254	9	topical	topical	ADJ
dpc-3736	254	10	griseofulvin	griseofulvin	NOUN
dpc-3736	254	11	and	and	CCONJ
dpc-3736	254	12	topical	topical	ADJ
dpc-3736	254	13	clotrimazole	clotrimazole	NOUN
dpc-3736	254	14	in	in	ADP
dpc-3736	254	15	tinea	tinea	PROPN
dpc-3736	254	16	versicolor	versicolor	PROPN
dpc-3736	254	17	.	.	PUNCT
dpc-3736	255	1	tehran	tehran	PROPN
dpc-3736	255	2	univ	univ	PROPN
dpc-3736	255	3	medical	medical	PROPN
dpc-3736	255	4	j.	j.	PROPN
dpc-3736	255	5	1998;56(2):35	1998;56(2):35	PROPN
dpc-3736	255	6	-	-	SYM
dpc-3736	255	7	37	37	NUM
dpc-3736	255	8	.	.	PUNCT
dpc-3736	255	9	15	15	NUM
dpc-3736	255	10	.	.	PUNCT
dpc-3736	256	1	sharquie	sharquie	NOUN
dpc-3736	256	2	k	k	PROPN
dpc-3736	257	1	e	e	PROPN
dpc-3736	257	2	,	,	PUNCT
dpc-3736	257	3	al	al	PROPN
dpc-3736	257	4	-	-	PUNCT
dpc-3736	257	5	hamamy	hamamy	PROPN
dpc-3736	257	6	h	h	NOUN
dpc-3736	257	7	m	m	PROPN
dpc-3736	257	8	,	,	PUNCT
dpc-3736	257	9	noaimi	noaimi	ADV
dpc-3736	257	10	a	a	DET
dpc-3736	257	11	a	a	PROPN
dpc-3736	257	12	,	,	PUNCT
dpc-3736	257	13	al	al	PROPN
dpc-3736	257	14	-	-	PUNCT
dpc-3736	257	15	shawi	shawi	PROPN
dpc-3736	257	16	i	i	PRON
dpc-3736	257	17	a.	a.	NOUN
dpc-3736	257	18	treatment	treatment	NOUN
dpc-3736	257	19	of	of	ADP
dpc-3736	257	20	pityriasis	pityriasis	NOUN
dpc-3736	257	21	versicolor	versicolor	NOUN
dpc-3736	257	22	using	use	VERB
dpc-3736	257	23	1	1	NUM
dpc-3736	257	24	%	%	NOUN
dpc-3736	257	25	diclofenac	diclofenac	NOUN
dpc-3736	257	26	gel	gel	NOUN
dpc-3736	257	27	and	and	CCONJ
dpc-3736	257	28	clotrimazole	clotrimazole	NOUN
dpc-3736	257	29	cream	cream	NOUN
dpc-3736	257	30	(	(	PUNCT
dpc-3736	257	31	comparative	comparative	ADJ
dpc-3736	257	32	therapeutic	therapeutic	ADJ
dpc-3736	257	33	study	study	NOUN
dpc-3736	257	34	)	)	PUNCT
dpc-3736	257	35	.	.	PUNCT
dpc-3736	258	1	journal	journal	NOUN
dpc-3736	258	2	of	of	ADP
dpc-3736	258	3	the	the	DET
dpc-3736	258	4	saudi	saudi	ADJ
dpc-3736	258	5	society	society	NOUN
dpc-3736	258	6	of	of	ADP
dpc-3736	258	7	dermatology	dermatology	NOUN
dpc-3736	258	8	&	&	CCONJ
dpc-3736	258	9	dermatologic	dermatologic	ADJ
dpc-3736	258	10	surgery	surgery	NOUN
dpc-3736	258	11	.	.	PUNCT
dpc-3736	259	1	2011;15(1):19	2011;15(1):19	NUM
dpc-3736	259	2	-	-	SYM
dpc-3736	259	3	23.doi	23.doi	PROPN
dpc-3736	259	4	:	:	PUNCT
dpc-3736	259	5	10.1016	10.1016	NUM
dpc-3736	259	6	/	/	SYM
dpc-3736	259	7	j.jssdds.2010.10.004	j.jssdds.2010.10.004	PROPN
dpc-3736	259	8	.	.	PUNCT
dpc-3736	260	1	16	16	NUM
dpc-3736	260	2	.	.	PUNCT
dpc-3736	261	1	köse	köse	PROPN
dpc-3736	261	2	o	o	PROPN
dpc-3736	261	3	,	,	PUNCT
dpc-3736	261	4	taştan	taştan	PROPN
dpc-3736	261	5	h	h	PROPN
dpc-3736	261	6	b	b	PROPN
dpc-3736	261	7	,	,	PUNCT
dpc-3736	261	8	gür	gür	VERB
dpc-3736	261	9	a	a	DET
dpc-3736	261	10	r	r	NOUN
dpc-3736	261	11	,	,	PUNCT
dpc-3736	261	12	kurumlu	kurumlu	PROPN
dpc-3736	261	13	z.	z.	PROPN
dpc-3736	261	14	comparison	comparison	NOUN
dpc-3736	261	15	of	of	ADP
dpc-3736	261	16	a	a	DET
dpc-3736	261	17	single	single	ADJ
dpc-3736	261	18	400	400	NUM
dpc-3736	261	19	mg	mg	NOUN
dpc-3736	261	20	dose	dose	NOUN
dpc-3736	261	21	versus	versus	ADP
dpc-3736	261	22	a	a	DET
dpc-3736	261	23	7	7	NUM
dpc-3736	261	24	-	-	PUNCT
dpc-3736	261	25	day	day	NOUN
dpc-3736	261	26	200	200	NUM
dpc-3736	261	27	mg	mg	NOUN
dpc-3736	261	28	daily	daily	ADJ
dpc-3736	261	29	dose	dose	PROPN
dpc-3736	261	30	of	of	ADP
dpc-3736	261	31	itraconazole	itraconazole	NOUN
dpc-3736	261	32	in	in	ADP
dpc-3736	261	33	the	the	DET
dpc-3736	261	34	treatment	treatment	NOUN
dpc-3736	261	35	of	of	ADP
dpc-3736	261	36	tinea	tinea	PROPN
dpc-3736	261	37	versicolor	versicolor	NOUN
dpc-3736	261	38	.	.	PUNCT
dpc-3736	262	1	j	j	PROPN
dpc-3736	262	2	dermatolog	dermatolog	PROPN
dpc-3736	262	3	treat	treat	NOUN
dpc-3736	262	4	.	.	PUNCT
dpc-3736	263	1	2002;13(2	2002;13(2	NUM
dpc-3736	263	2	):	):	PUNCT
dpc-3736	263	3	77	77	NUM
dpc-3736	263	4	-	-	SYM
dpc-3736	263	5	79	79	NUM
dpc-3736	263	6	.	.	PUNCT
dpc-3736	264	1	doi:10.1080/095466302317584430	doi:10.1080/095466302317584430	PROPN
dpc-3736	264	2	.	.	PUNCT
dpc-3736	265	1	pmid	pmid	NOUN
dpc-3736	265	2	:	:	PUNCT
dpc-3736	265	3	12060506	12060506	NUM
dpc-3736	265	4	.	.	PUNCT
dpc-3736	266	1	17	17	NUM
dpc-3736	266	2	.	.	PUNCT
dpc-3736	267	1	dehghan	dehghan	PROPN
dpc-3736	267	2	m	m	PROPN
dpc-3736	267	3	,	,	PUNCT
dpc-3736	267	4	akbari	akbari	PROPN
dpc-3736	267	5	n	n	CCONJ
dpc-3736	267	6	,	,	PUNCT
dpc-3736	267	7	alborzi	alborzi	NOUN
dpc-3736	267	8	n	n	CCONJ
dpc-3736	267	9	,	,	PUNCT
dpc-3736	267	10	sadani	sadani	PROPN
dpc-3736	267	11	s	s	PROPN
dpc-3736	267	12	,	,	PUNCT
dpc-3736	267	13	keshtkar	keshtkar	PROPN
dpc-3736	267	14	a	a	DET
dpc-3736	267	15	a.	a.	NOUN
dpc-3736	267	16	single	single	ADV
dpc-3736	267	17	-	-	PUNCT
dpc-3736	267	18	dose	dose	VERB
dpc-3736	267	19	oral	oral	ADJ
dpc-3736	267	20	fluconazole	fluconazole	NOUN
dpc-3736	267	21	versus	versus	ADP
dpc-3736	267	22	topical	topical	ADJ
dpc-3736	267	23	clotrimazole	clotrimazole	NOUN
dpc-3736	267	24	in	in	ADP
dpc-3736	267	25	patients	patient	NOUN
dpc-3736	267	26	with	with	ADP
dpc-3736	267	27	pityriasis	pityriasis	NOUN
dpc-3736	267	28	versicolor	versicolor	NOUN
dpc-3736	267	29	:	:	PUNCT
dpc-3736	267	30	a	a	DET
dpc-3736	267	31	double	double	ADJ
dpc-3736	267	32	-	-	PUNCT
dpc-3736	267	33	blind	blind	ADJ
dpc-3736	267	34	randomized	randomize	VERB
dpc-3736	267	35	controlled	control	VERB
dpc-3736	267	36	trial	trial	NOUN
dpc-3736	267	37	.	.	PUNCT
dpc-3736	268	1	j	j	PROPN
dpc-3736	268	2	dermatol	dermatol	NOUN
dpc-3736	268	3	.	.	PUNCT
dpc-3736	269	1	2010;37(8):699	2010;37(8):699	NUM
dpc-3736	269	2	-	-	PUNCT
dpc-3736	269	3	702	702	NUM
dpc-3736	269	4	.	.	PUNCT
dpc-3736	270	1	doi:10.1111	doi:10.1111	NOUN
dpc-3736	270	2	/j.1346	/j.1346	NOUN
dpc-3736	270	3	-	-	PUNCT
dpc-3736	270	4	8138.2010.00908.x	8138.2010.00908.x	NUM
dpc-3736	270	5	.	.	PUNCT
dpc-3736	271	1	pmid	pmid	NOUN
dpc-3736	271	2	:	:	PUNCT
dpc-3736	271	3	20649710	20649710	NUM
dpc-3736	271	4	.	.	PUNCT
dpc-3736	272	1	18	18	NUM
dpc-3736	272	2	.	.	PUNCT
dpc-3736	273	1	sepaskhah	sepaskhah	PROPN
dpc-3736	273	2	m	m	PROPN
dpc-3736	273	3	,	,	PUNCT
dpc-3736	273	4	sadat	sadat	PROPN
dpc-3736	273	5	m	m	PROPN
dpc-3736	273	6	s	s	NOUN
dpc-3736	273	7	,	,	PUNCT
dpc-3736	273	8	pakshir	pakshir	NOUN
dpc-3736	273	9	k	k	PROPN
dpc-3736	273	10	,	,	PUNCT
dpc-3736	273	11	bagheri	bagheri	PROPN
dpc-3736	273	12	z.	z.	PROPN
dpc-3736	273	13	comparative	comparative	PROPN
dpc-3736	273	14	efficacy	efficacy	PROPN
dpc-3736	273	15	of	of	ADP
dpc-3736	273	16	topical	topical	ADJ
dpc-3736	273	17	application	application	NOUN
dpc-3736	273	18	of	of	ADP
dpc-3736	273	19	tacrolimus	tacrolimus	NOUN
dpc-3736	273	20	and	and	CCONJ
dpc-3736	273	21	clotrimazole	clotrimazole	NOUN
dpc-3736	273	22	in	in	ADP
dpc-3736	273	23	the	the	DET
dpc-3736	273	24	treatment	treatment	NOUN
dpc-3736	273	25	of	of	ADP
dpc-3736	273	26	pityriasis	pityriasis	NOUN
dpc-3736	273	27	versicolor	versicolor	NOUN
dpc-3736	273	28	:	:	PUNCT
dpc-3736	273	29	a	a	DET
dpc-3736	273	30	single	single	ADJ
dpc-3736	273	31	blind	blind	ADJ
dpc-3736	273	32	,	,	PUNCT
dpc-3736	273	33	randomised	randomise	VERB
dpc-3736	273	34	clinical	clinical	ADJ
dpc-3736	273	35	trial	trial	NOUN
dpc-3736	273	36	.	.	PUNCT
dpc-3736	274	1	mycoses	mycose	NOUN
dpc-3736	274	2	.	.	PUNCT
dpc-3736	275	1	2017;60(5):338	2017;60(5):338	NUM
dpc-3736	275	2	-	-	SYM
dpc-3736	275	3	342	342	NUM
dpc-3736	275	4	.	.	PUNCT
dpc-3736	276	1	doi:10.1111	doi:10.1111	NOUN
dpc-3736	276	2	/myc.12598	/myc.12598	PROPN
dpc-3736	276	3	.	.	PUNCT
dpc-3736	277	1	pmid	pmid	NOUN
dpc-3736	277	2	:	:	PUNCT
dpc-3736	277	3	28120351	28120351	NUM
dpc-3736	277	4	.	.	PUNCT
dpc-3736	278	1	of	of	ADP
dpc-3736	278	2	relative	relative	ADJ
dpc-3736	278	3	risk	risk	NOUN
dpc-3736	278	4	and	and	CCONJ
dpc-3736	278	5	risk	risk	NOUN
dpc-3736	278	6	difference	difference	NOUN
dpc-3736	278	7	estimates	estimate	NOUN
dpc-3736	278	8	,	,	PUNCT
dpc-3736	278	9	adjusted	adjust	VERB
dpc-3736	278	10	to	to	PART
dpc-3736	278	11	account	account	VERB
dpc-3736	278	12	for	for	ADP
dpc-3736	278	13	potential	potential	ADJ
dpc-3736	278	14	confounding	confound	VERB
dpc-3736	278	15	effects	effect	NOUN
dpc-3736	278	16	of	of	ADP
dpc-3736	278	17	age	age	NOUN
dpc-3736	278	18	,	,	PUNCT
dpc-3736	278	19	sex	sex	NOUN
dpc-3736	278	20	,	,	PUNCT
dpc-3736	278	21	lesion	lesion	NOUN
dpc-3736	278	22	extent	extent	NOUN
dpc-3736	278	23	,	,	PUNCT
dpc-3736	278	24	and	and	CCONJ
dpc-3736	278	25	lesion	lesion	NOUN
dpc-3736	278	26	site	site	NOUN
dpc-3736	278	27	,	,	PUNCT
dpc-3736	278	28	did	do	AUX
dpc-3736	278	29	not	not	PART
dpc-3736	278	30	yield	yield	VERB
dpc-3736	278	31	significant	significant	ADJ
dpc-3736	278	32	results	result	NOUN
dpc-3736	278	33	in	in	ADP
dpc-3736	278	34	our	our	PRON
dpc-3736	278	35	study	study	NOUN
dpc-3736	278	36	.	.	PUNCT
dpc-3736	279	1	thus	thus	ADV
dpc-3736	279	2	,	,	PUNCT
dpc-3736	279	3	it	it	PRON
dpc-3736	279	4	appears	appear	VERB
dpc-3736	279	5	that	that	SCONJ
dpc-3736	279	6	the	the	DET
dpc-3736	279	7	therapeutic	therapeutic	ADJ
dpc-3736	279	8	efficacy	efficacy	NOUN
dpc-3736	279	9	of	of	ADP
dpc-3736	279	10	these	these	DET
dpc-3736	279	11	antifungal	antifungal	ADJ
dpc-3736	279	12	agents	agent	NOUN
dpc-3736	279	13	is	be	AUX
dpc-3736	279	14	independent	independent	ADJ
dpc-3736	279	15	of	of	ADP
dpc-3736	279	16	patients	patient	NOUN
dpc-3736	279	17	age	age	NOUN
dpc-3736	279	18	,	,	PUNCT
dpc-3736	279	19	gender	gender	NOUN
dpc-3736	279	20	,	,	PUNCT
dpc-3736	279	21	and	and	CCONJ
dpc-3736	279	22	the	the	DET
dpc-3736	279	23	location	location	NOUN
dpc-3736	279	24	of	of	ADP
dpc-3736	279	25	skin	skin	NOUN
dpc-3736	279	26	lesions	lesion	NOUN
dpc-3736	279	27	.	.	PUNCT
dpc-3736	280	1	there	there	PRON
dpc-3736	280	2	are	be	VERB
dpc-3736	280	3	several	several	ADJ
dpc-3736	280	4	limitations	limitation	NOUN
dpc-3736	280	5	to	to	ADP
dpc-3736	280	6	our	our	PRON
dpc-3736	280	7	study	study	NOUN
dpc-3736	280	8	that	that	PRON
dpc-3736	280	9	should	should	AUX
dpc-3736	280	10	be	be	AUX
dpc-3736	280	11	considered	consider	VERB
dpc-3736	280	12	.	.	PUNCT
dpc-3736	281	1	first	first	ADV
dpc-3736	281	2	,	,	PUNCT
dpc-3736	281	3	there	there	PRON
dpc-3736	281	4	are	be	VERB
dpc-3736	281	5	various	various	ADJ
dpc-3736	281	6	diseases	disease	NOUN
dpc-3736	281	7	that	that	PRON
dpc-3736	281	8	share	share	VERB
dpc-3736	281	9	similar	similar	ADJ
dpc-3736	281	10	manifestations	manifestation	NOUN
dpc-3736	281	11	to	to	ADP
dpc-3736	281	12	pityriasis	pityriasis	NOUN
dpc-3736	281	13	versicolor	versicolor	NOUN
dpc-3736	281	14	and	and	CCONJ
dpc-3736	281	15	must	must	AUX
dpc-3736	281	16	be	be	AUX
dpc-3736	281	17	differentiated	differentiate	VERB
dpc-3736	281	18	,	,	PUNCT
dpc-3736	281	19	including	include	VERB
dpc-3736	281	20	seborrheic	seborrheic	PROPN
dpc-3736	281	21	dermatitis	dermatitis	NOUN
dpc-3736	281	22	,	,	PUNCT
dpc-3736	281	23	secondary	secondary	ADJ
dpc-3736	281	24	syphilis	syphili	NOUN
dpc-3736	281	25	,	,	PUNCT
dpc-3736	281	26	pityriasis	pityriasis	NOUN
dpc-3736	281	27	rosea	rosea	NOUN
dpc-3736	281	28	,	,	PUNCT
dpc-3736	281	29	pityriasis	pityriasis	NOUN
dpc-3736	281	30	alba	alba	PROPN
dpc-3736	281	31	,	,	PUNCT
dpc-3736	281	32	vitiligo	vitiligo	VERB
dpc-3736	281	33	,	,	PUNCT
dpc-3736	281	34	erythrasma	erythrasma	PROPN
dpc-3736	281	35	,	,	PUNCT
dpc-3736	281	36	and	and	CCONJ
dpc-3736	281	37	malassezia	malassezia	NOUN
dpc-3736	281	38	furfur	furfur	NOUN
dpc-3736	281	39	[	[	X
dpc-3736	281	40	29	29	NUM
dpc-3736	281	41	]	]	PUNCT
dpc-3736	281	42	.	.	PUNCT
dpc-3736	282	1	while	while	SCONJ
dpc-3736	282	2	we	we	PRON
dpc-3736	282	3	relied	rely	VERB
dpc-3736	282	4	on	on	ADP
dpc-3736	282	5	the	the	DET
dpc-3736	282	6	standard	standard	ADJ
dpc-3736	282	7	koh	koh	PROPN
dpc-3736	282	8	examination	examination	NOUN
dpc-3736	282	9	for	for	ADP
dpc-3736	282	10	confirmation	confirmation	NOUN
dpc-3736	282	11	of	of	ADP
dpc-3736	282	12	mycologic	mycologic	ADJ
dpc-3736	282	13	cure	cure	NOUN
dpc-3736	282	14	,	,	PUNCT
dpc-3736	282	15	the	the	DET
dpc-3736	282	16	lack	lack	NOUN
dpc-3736	282	17	of	of	ADP
dpc-3736	282	18	color	color	NOUN
dpc-3736	282	19	contrast	contrast	NOUN
dpc-3736	282	20	in	in	ADP
dpc-3736	282	21	the	the	DET
dpc-3736	282	22	koh	koh	PROPN
dpc-3736	282	23	mount	mount	PROPN
dpc-3736	282	24	may	may	AUX
dpc-3736	282	25	have	have	AUX
dpc-3736	282	26	affected	affect	VERB
dpc-3736	282	27	the	the	DET
dpc-3736	282	28	visualization	visualization	NOUN
dpc-3736	282	29	and	and	CCONJ
dpc-3736	282	30	accuracy	accuracy	NOUN
dpc-3736	282	31	of	of	ADP
dpc-3736	282	32	the	the	DET
dpc-3736	282	33	results	result	NOUN
dpc-3736	282	34	.	.	PUNCT
dpc-3736	283	1	the	the	DET
dpc-3736	283	2	use	use	NOUN
dpc-3736	283	3	of	of	ADP
dpc-3736	283	4	additional	additional	ADJ
dpc-3736	283	5	staining	staining	ADJ
dpc-3736	283	6	techniques	technique	NOUN
dpc-3736	283	7	,	,	PUNCT
dpc-3736	283	8	such	such	ADJ
dpc-3736	283	9	as	as	ADP
dpc-3736	283	10	methylene	methylene	ADJ
dpc-3736	283	11	blue	blue	ADJ
dpc-3736	283	12	stain	stain	NOUN
dpc-3736	283	13	,	,	PUNCT
dpc-3736	283	14	ink	ink	NOUN
dpc-3736	283	15	blue	blue	ADJ
dpc-3736	283	16	stain	stain	NOUN
dpc-3736	283	17	,	,	PUNCT
dpc-3736	283	18	or	or	CCONJ
dpc-3736	283	19	swartz	swartz	PROPN
dpc-3736	283	20	-	-	PUNCT
dpc-3736	283	21	medrik	medrik	PROPN
dpc-3736	283	22	stain	stain	NOUN
dpc-3736	283	23	,	,	PUNCT
dpc-3736	283	24	could	could	AUX
dpc-3736	283	25	have	have	AUX
dpc-3736	283	26	improved	improve	VERB
dpc-3736	283	27	the	the	DET
dpc-3736	283	28	diagnostic	diagnostic	ADJ
dpc-3736	283	29	accuracy	accuracy	NOUN
dpc-3736	283	30	.	.	PUNCT
dpc-3736	284	1	another	another	DET
dpc-3736	284	2	limitation	limitation	NOUN
dpc-3736	284	3	is	be	AUX
dpc-3736	284	4	the	the	DET
dpc-3736	284	5	absence	absence	NOUN
dpc-3736	284	6	of	of	ADP
dpc-3736	284	7	long	long	ADJ
dpc-3736	284	8	-	-	PUNCT
dpc-3736	284	9	term	term	NOUN
dpc-3736	284	10	follow	follow	NOUN
dpc-3736	284	11	-	-	PUNCT
dpc-3736	284	12	up	up	ADP
dpc-3736	284	13	care	care	NOUN
dpc-3736	284	14	in	in	ADP
dpc-3736	284	15	our	our	PRON
dpc-3736	284	16	study	study	NOUN
dpc-3736	284	17	.	.	PUNCT
dpc-3736	285	1	pityriasis	pityriasis	PROPN
dpc-3736	285	2	versicolor	versicolor	NOUN
dpc-3736	285	3	is	be	AUX
dpc-3736	285	4	known	know	VERB
dpc-3736	285	5	for	for	ADP
dpc-3736	285	6	its	its	PRON
dpc-3736	285	7	tendency	tendency	NOUN
dpc-3736	285	8	to	to	PART
dpc-3736	285	9	recur	recur	VERB
dpc-3736	285	10	,	,	PUNCT
dpc-3736	285	11	and	and	CCONJ
dpc-3736	285	12	longer	long	ADJ
dpc-3736	285	13	-	-	PUNCT
dpc-3736	285	14	term	term	NOUN
dpc-3736	285	15	assessments	assessment	NOUN
dpc-3736	285	16	would	would	AUX
dpc-3736	285	17	have	have	AUX
dpc-3736	285	18	provided	provide	VERB
dpc-3736	285	19	valuable	valuable	ADJ
dpc-3736	285	20	insights	insight	NOUN
dpc-3736	285	21	into	into	ADP
dpc-3736	285	22	the	the	DET
dpc-3736	285	23	durability	durability	NOUN
dpc-3736	285	24	of	of	ADP
dpc-3736	285	25	treatment	treatment	NOUN
dpc-3736	285	26	outcomes	outcome	NOUN
dpc-3736	285	27	.	.	PUNCT
dpc-3736	286	1	additionally	additionally	ADV
dpc-3736	286	2	,	,	PUNCT
dpc-3736	286	3	our	our	PRON
dpc-3736	286	4	study	study	NOUN
dpc-3736	286	5	design	design	NOUN
dpc-3736	286	6	only	only	ADV
dpc-3736	286	7	included	include	VERB
dpc-3736	286	8	patients	patient	NOUN
dpc-3736	286	9	with	with	ADP
dpc-3736	286	10	limited	limited	ADJ
dpc-3736	286	11	skin	skin	NOUN
dpc-3736	286	12	involvement	involvement	NOUN
dpc-3736	286	13	,	,	PUNCT
dpc-3736	286	14	which	which	PRON
dpc-3736	286	15	may	may	AUX
dpc-3736	286	16	limit	limit	VERB
dpc-3736	286	17	the	the	DET
dpc-3736	286	18	generalizability	generalizability	NOUN
dpc-3736	286	19	of	of	ADP
dpc-3736	286	20	our	our	PRON
dpc-3736	286	21	findings	finding	NOUN
dpc-3736	286	22	to	to	ADP
dpc-3736	286	23	cases	case	NOUN
dpc-3736	286	24	with	with	ADP
dpc-3736	286	25	more	more	ADV
dpc-3736	286	26	extensive	extensive	ADJ
dpc-3736	286	27	or	or	CCONJ
dpc-3736	286	28	severe	severe	ADJ
dpc-3736	286	29	disease	disease	NOUN
dpc-3736	286	30	.	.	PUNCT
dpc-3736	287	1	further	further	ADJ
dpc-3736	287	2	studies	study	NOUN
dpc-3736	287	3	involving	involve	VERB
dpc-3736	287	4	a	a	DET
dpc-3736	287	5	broader	broad	ADJ
dpc-3736	287	6	range	range	NOUN
dpc-3736	287	7	of	of	ADP
dpc-3736	287	8	patients	patient	NOUN
dpc-3736	287	9	,	,	PUNCT
dpc-3736	287	10	including	include	VERB
dpc-3736	287	11	those	those	PRON
dpc-3736	287	12	with	with	ADP
dpc-3736	287	13	more	more	ADV
dpc-3736	287	14	severe	severe	ADJ
dpc-3736	287	15	or	or	CCONJ
dpc-3736	287	16	widespread	widespread	ADJ
dpc-3736	287	17	pityriasis	pityriasis	NOUN
dpc-3736	287	18	versicolor	versicolor	NOUN
dpc-3736	287	19	,	,	PUNCT
dpc-3736	287	20	are	be	AUX
dpc-3736	287	21	needed	need	VERB
dpc-3736	287	22	to	to	PART
dpc-3736	287	23	evaluate	evaluate	VERB
dpc-3736	287	24	the	the	DET
dpc-3736	287	25	potential	potential	ADJ
dpc-3736	287	26	dose	dose	NOUN
dpc-3736	287	27	-	-	PUNCT
dpc-3736	287	28	dependent	dependent	ADJ
dpc-3736	287	29	adverse	adverse	ADJ
dpc-3736	287	30	reactions	reaction	NOUN
dpc-3736	287	31	associated	associate	VERB
dpc-3736	287	32	with	with	ADP
dpc-3736	287	33	topical	topical	ADJ
dpc-3736	287	34	amphotericin	amphotericin	ADP
dpc-3736	287	35	b	b	NOUN
dpc-3736	287	36	and	and	CCONJ
dpc-3736	287	37	to	to	PART
dpc-3736	287	38	assess	assess	VERB
dpc-3736	287	39	its	its	PRON
dpc-3736	287	40	efficacy	efficacy	NOUN
dpc-3736	287	41	in	in	ADP
dpc-3736	287	42	diverse	diverse	ADJ
dpc-3736	287	43	populations	population	NOUN
dpc-3736	287	44	.	.	PUNCT
dpc-3736	288	1	in	in	ADP
dpc-3736	288	2	conclusion	conclusion	NOUN
dpc-3736	288	3	,	,	PUNCT
dpc-3736	288	4	our	our	PRON
dpc-3736	288	5	study	study	NOUN
dpc-3736	288	6	demonstrates	demonstrate	VERB
dpc-3736	288	7	that	that	SCONJ
dpc-3736	288	8	the	the	DET
dpc-3736	288	9	topical	topical	ADJ
dpc-3736	288	10	application	application	NOUN
dpc-3736	288	11	of	of	ADP
dpc-3736	288	12	liposomal	liposomal	NOUN
dpc-3736	288	13	amphotericin	amphotericin	ADP
dpc-3736	288	14	b	b	PROPN
dpc-3736	288	15	0.4	0.4	NUM
dpc-3736	288	16	%	%	NOUN
dpc-3736	288	17	is	be	AUX
dpc-3736	288	18	comparable	comparable	ADJ
dpc-3736	288	19	in	in	ADP
dpc-3736	288	20	efficacy	efficacy	NOUN
dpc-3736	288	21	to	to	ADP
dpc-3736	288	22	topical	topical	ADJ
dpc-3736	288	23	clotrimazole	clotrimazole	NOUN
dpc-3736	288	24	1	1	NUM
dpc-3736	288	25	%	%	NOUN
dpc-3736	288	26	for	for	ADP
dpc-3736	288	27	the	the	DET
dpc-3736	288	28	treatment	treatment	NOUN
dpc-3736	288	29	of	of	ADP
dpc-3736	288	30	pityriasis	pityriasis	NOUN
dpc-3736	288	31	versicolor	versicolor	NOUN
dpc-3736	288	32	.	.	PUNCT
dpc-3736	289	1	these	these	DET
dpc-3736	289	2	findings	finding	NOUN
dpc-3736	289	3	suggest	suggest	VERB
dpc-3736	289	4	that	that	SCONJ
dpc-3736	289	5	topical	topical	ADJ
dpc-3736	289	6	liposomal	liposomal	NOUN
dpc-3736	289	7	amphotericin	amphotericin	ADP
dpc-3736	289	8	b	b	NOUN
dpc-3736	289	9	can	can	AUX
dpc-3736	289	10	serve	serve	VERB
dpc-3736	289	11	as	as	ADP
dpc-3736	289	12	a	a	DET
dpc-3736	289	13	viable	viable	ADJ
dpc-3736	289	14	alternative	alternative	ADJ
dpc-3736	289	15	treatment	treatment	NOUN
dpc-3736	289	16	option	option	NOUN
dpc-3736	289	17	for	for	ADP
dpc-3736	289	18	pityriasis	pityriasis	NOUN
dpc-3736	289	19	versicolor	versicolor	NOUN
dpc-3736	289	20	.	.	PUNCT
dpc-3736	290	1	however	however	ADV
dpc-3736	290	2	,	,	PUNCT
dpc-3736	290	3	it	it	PRON
dpc-3736	290	4	is	be	AUX
dpc-3736	290	5	important	important	ADJ
dpc-3736	290	6	to	to	PART
dpc-3736	290	7	note	note	VERB
dpc-3736	290	8	that	that	SCONJ
dpc-3736	290	9	based	base	VERB
dpc-3736	290	10	on	on	ADP
dpc-3736	290	11	our	our	PRON
dpc-3736	290	12	current	current	ADJ
dpc-3736	290	13	findings	finding	NOUN
dpc-3736	290	14	,	,	PUNCT
dpc-3736	290	15	we	we	PRON
dpc-3736	290	16	do	do	AUX
dpc-3736	290	17	not	not	PART
dpc-3736	290	18	recommend	recommend	VERB
dpc-3736	290	19	topical	topical	ADJ
dpc-3736	290	20	liposomal	liposomal	NOUN
dpc-3736	290	21	amphotericin	amphotericin	ADP
dpc-3736	290	22	b	b	PROPN
dpc-3736	290	23	as	as	ADP
dpc-3736	290	24	the	the	DET
dpc-3736	290	25	primary	primary	ADJ
dpc-3736	290	26	treatment	treatment	NOUN
dpc-3736	290	27	choice	choice	NOUN
dpc-3736	290	28	for	for	ADP
dpc-3736	290	29	pv	pv	NOUN
dpc-3736	290	30	.	.	PUNCT
dpc-3736	291	1	further	further	ADJ
dpc-3736	291	2	research	research	NOUN
dpc-3736	291	3	is	be	AUX
dpc-3736	291	4	needed	need	VERB
dpc-3736	291	5	to	to	PART
dpc-3736	291	6	better	well	ADV
dpc-3736	291	7	understand	understand	VERB
dpc-3736	291	8	the	the	DET
dpc-3736	291	9	potential	potential	ADJ
dpc-3736	291	10	consequences	consequence	NOUN
dpc-3736	291	11	and	and	CCONJ
dpc-3736	291	12	safety	safety	NOUN
dpc-3736	291	13	profile	profile	NOUN
dpc-3736	291	14	of	of	ADP
dpc-3736	291	15	using	use	VERB
dpc-3736	291	16	liposomal	liposomal	NOUN
dpc-3736	291	17	amphotericin	amphotericin	ADP
dpc-3736	291	18	b	b	NOUN
dpc-3736	291	19	in	in	ADP
dpc-3736	291	20	the	the	DET
dpc-3736	291	21	long	long	ADJ
dpc-3736	291	22	term	term	NOUN
dpc-3736	291	23	,	,	PUNCT
dpc-3736	291	24	as	as	ADV
dpc-3736	291	25	well	well	ADV
dpc-3736	291	26	as	as	ADP
dpc-3736	291	27	its	its	PRON
dpc-3736	291	28	comparative	comparative	ADJ
dpc-3736	291	29	effectiveness	effectiveness	NOUN
dpc-3736	291	30	and	and	CCONJ
dpc-3736	291	31	cost	cost	NOUN
dpc-3736	291	32	-	-	PUNCT
dpc-3736	291	33	effectiveness	effectiveness	NOUN
dpc-3736	291	34	compared	compare	VERB
dpc-3736	291	35	to	to	ADP
dpc-3736	291	36	other	other	ADJ
dpc-3736	291	37	treatment	treatment	NOUN
dpc-3736	291	38	options	option	NOUN
dpc-3736	291	39	.	.	PUNCT
dpc-3736	292	1	references	reference	NOUN
dpc-3736	292	2	1	1	NUM
dpc-3736	292	3	.	.	PUNCT
dpc-3736	293	1	gupta	gupta	PROPN
dpc-3736	293	2	a	a	DET
dpc-3736	293	3	k	k	NOUN
dpc-3736	293	4	,	,	PUNCT
dpc-3736	293	5	foley	foley	PROPN
dpc-3736	293	6	k	k	PROPN
dpc-3736	293	7	a.	a.	PROPN
dpc-3736	293	8	antifungal	antifungal	PROPN
dpc-3736	293	9	treatment	treatment	NOUN
dpc-3736	293	10	for	for	ADP
dpc-3736	293	11	pityriasis	pityriasis	NOUN
dpc-3736	293	12	versicolor	versicolor	NOUN
dpc-3736	293	13	.	.	PUNCT
dpc-3736	294	1	j	j	PROPN
dpc-3736	294	2	fungi	fungi	PROPN
dpc-3736	294	3	(	(	PUNCT
dpc-3736	294	4	basel	basel	PROPN
dpc-3736	294	5	)	)	PUNCT
dpc-3736	294	6	.	.	PUNCT
dpc-3736	295	1	2015;1(1):13	2015;1(1):13	NUM
dpc-3736	295	2	-	-	SYM
dpc-3736	295	3	29	29	NUM
dpc-3736	295	4	doi:10.3390	doi:10.3390	NOUN
dpc-3736	295	5	/jof1010013	/jof1010013	PUNCT
dpc-3736	295	6	.	.	PUNCT
dpc-3736	296	1	pmid	pmid	NOUN
dpc-3736	296	2	:	:	PUNCT
dpc-3736	296	3	29376896	29376896	NUM
dpc-3736	296	4	.	.	PUNCT
dpc-3736	297	1	pmcid	pmcid	NOUN
dpc-3736	297	2	:	:	PUNCT
dpc-3736	297	3	pmc5770013	pmc5770013	NOUN
dpc-3736	297	4	.	.	PUNCT
dpc-3736	298	1	2	2	X
dpc-3736	298	2	.	.	X
dpc-3736	298	3	shahid	shahid	PROPN
dpc-3736	298	4	j	j	PROPN
dpc-3736	298	5	,	,	PUNCT
dpc-3736	298	6	ihsan	ihsan	PROPN
dpc-3736	298	7	z	z	PROPN
dpc-3736	298	8	,	,	PUNCT
dpc-3736	298	9	khan	khan	PROPN
dpc-3736	298	10	s.	s.	PROPN
dpc-3736	298	11	oral	oral	ADJ
dpc-3736	298	12	fluconazole	fluconazole	NOUN
dpc-3736	298	13	in	in	ADP
dpc-3736	298	14	the	the	DET
dpc-3736	298	15	treatment	treatment	NOUN
dpc-3736	298	16	of	of	ADP
dpc-3736	298	17	pityriasis	pityriasis	NOUN
dpc-3736	298	18	versicolor	versicolor	NOUN
dpc-3736	298	19	.	.	PUNCT
dpc-3736	299	1	j	j	PROPN
dpc-3736	299	2	dermatolog	dermatolog	PROPN
dpc-3736	299	3	treat	treat	NOUN
dpc-3736	299	4	.	.	PUNCT
dpc-3736	300	1	2000;11(2):101	2000;11(2):101	NUM
dpc-3736	300	2	-	-	PUNCT
dpc-3736	300	3	103	103	NUM
dpc-3736	300	4	.	.	PUNCT
dpc-3736	301	1	doi:10.1080/09546630050517496	doi:10.1080/09546630050517496	NOUN
dpc-3736	301	2	.	.	PUNCT
dpc-3736	302	1	original	original	ADJ
dpc-3736	302	2	article	article	NOUN
dpc-3736	302	3	|	|	ADV
dpc-3736	302	4	dermatol	dermatol	ADJ
dpc-3736	302	5	pract	pract	NOUN
dpc-3736	302	6	concept	concept	NOUN
dpc-3736	302	7	.	.	PUNCT
dpc-3736	303	1	2024;14(1):e2024083	2024;14(1):e2024083	NUM
dpc-3736	303	2	9	9	NUM
dpc-3736	303	3	25	25	NUM
dpc-3736	303	4	.	.	PUNCT
dpc-3736	304	1	khatter	khatter	PROPN
dpc-3736	304	2	nj	nj	PROPN
dpc-3736	304	3	,	,	PUNCT
dpc-3736	304	4	khan	khan	PROPN
dpc-3736	304	5	mab	mab	PROPN
dpc-3736	304	6	.	.	PUNCT
dpc-3736	304	7	clotrimazole	clotrimazole	PROPN
dpc-3736	304	8	.	.	PUNCT
dpc-3736	305	1	2023	2023	NUM
dpc-3736	305	2	jul	jul	PROPN
dpc-3736	305	3	10	10	NUM
dpc-3736	305	4	.	.	PUNCT
dpc-3736	306	1	in	in	ADP
dpc-3736	306	2	:	:	PUNCT
dpc-3736	306	3	statpearls	statpearl	NOUN
dpc-3736	307	1	[	[	X
dpc-3736	307	2	internet	internet	NOUN
dpc-3736	307	3	]	]	PUNCT
dpc-3736	307	4	.	.	PUNCT
dpc-3736	308	1	treasure	treasure	NOUN
dpc-3736	308	2	island	island	NOUN
dpc-3736	308	3	(	(	PUNCT
dpc-3736	308	4	fl	fl	PROPN
dpc-3736	308	5	):	):	PUNCT
dpc-3736	308	6	statpearls	statpearl	NOUN
dpc-3736	308	7	publishing	publishing	NOUN
dpc-3736	308	8	;	;	PUNCT
dpc-3736	308	9	2023	2023	NUM
dpc-3736	308	10	.	.	PUNCT
dpc-3736	309	1	pmid	pmid	NOUN
dpc-3736	309	2	:	:	PUNCT
dpc-3736	309	3	32809478	32809478	NUM
dpc-3736	309	4	.	.	PUNCT
dpc-3736	310	1	26	26	NUM
dpc-3736	310	2	.	.	PUNCT
dpc-3736	310	3	faustino	faustino	PROPN
dpc-3736	310	4	c	c	PROPN
dpc-3736	310	5	,	,	PUNCT
dpc-3736	310	6	pinheiro	pinheiro	PROPN
dpc-3736	310	7	l.	l.	PROPN
dpc-3736	310	8	lipid	lipid	PROPN
dpc-3736	310	9	systems	system	NOUN
dpc-3736	310	10	for	for	ADP
dpc-3736	310	11	the	the	DET
dpc-3736	310	12	delivery	delivery	NOUN
dpc-3736	310	13	of	of	ADP
dpc-3736	310	14	amphotericin	amphotericin	ADP
dpc-3736	310	15	b	b	NOUN
dpc-3736	310	16	in	in	ADP
dpc-3736	310	17	antifungal	antifungal	ADJ
dpc-3736	310	18	therapy	therapy	NOUN
dpc-3736	310	19	.	.	PUNCT
dpc-3736	311	1	pharmaceutics	pharmaceutic	NOUN
dpc-3736	311	2	.	.	PUNCT
dpc-3736	312	1	2020;12(1):29	2020;12(1):29	NUM
dpc-3736	312	2	.	.	PUNCT
dpc-3736	312	3	doi	doi	NOUN
dpc-3736	312	4	:	:	PUNCT
dpc-3736	312	5	10.3390	10.3390	NUM
dpc-3736	312	6	/	/	SYM
dpc-3736	312	7	pharmaceutics12010029	pharmaceutics12010029	PROPN
dpc-3736	312	8	.	.	PUNCT
dpc-3736	313	1	pmid	pmid	NOUN
dpc-3736	313	2	:	:	PUNCT
dpc-3736	313	3	31906268	31906268	NUM
dpc-3736	313	4	.	.	PUNCT
dpc-3736	314	1	pmcid	pmcid	NOUN
dpc-3736	314	2	:	:	PUNCT
dpc-3736	314	3	pmc7023008	pmc7023008	NOUN
dpc-3736	314	4	.	.	PUNCT
dpc-3736	315	1	27	27	NUM
dpc-3736	315	2	.	.	PUNCT
dpc-3736	316	1	frézard	frézard	PROPN
dpc-3736	316	2	f	f	PROPN
dpc-3736	316	3	,	,	PUNCT
dpc-3736	316	4	aguiar	aguiar	NOUN
dpc-3736	316	5	m	m	NOUN
dpc-3736	316	6	m	m	VERB
dpc-3736	316	7	g	g	NOUN
dpc-3736	316	8	,	,	PUNCT
dpc-3736	316	9	ferreira	ferreira	PROPN
dpc-3736	316	10	l	l	PROPN
dpc-3736	316	11	a	a	PROPN
dpc-3736	316	12	m	m	PROPN
dpc-3736	316	13	,	,	PUNCT
dpc-3736	316	14	ramos	ramos	PROPN
dpc-3736	316	15	g	g	PROPN
dpc-3736	316	16	s	s	PROPN
dpc-3736	316	17	,	,	PUNCT
dpc-3736	316	18	santos	santos	PROPN
dpc-3736	316	19	t	t	PROPN
dpc-3736	316	20	t	t	PROPN
dpc-3736	316	21	,	,	PUNCT
dpc-3736	316	22	borges	borge	VERB
dpc-3736	316	23	g	g	PROPN
dpc-3736	316	24	s	s	PROPN
dpc-3736	316	25	m	m	PROPN
dpc-3736	316	26	,	,	PUNCT
dpc-3736	316	27	et	et	PROPN
dpc-3736	316	28	al	al	PROPN
dpc-3736	316	29	.	.	PROPN
dpc-3736	316	30	liposomal	liposomal	PROPN
dpc-3736	316	31	amphotericin	amphotericin	ADP
dpc-3736	316	32	b	b	NOUN
dpc-3736	316	33	for	for	ADP
dpc-3736	316	34	treatment	treatment	NOUN
dpc-3736	316	35	of	of	ADP
dpc-3736	316	36	leishmaniasis	leishmaniasis	NOUN
dpc-3736	316	37	:	:	PUNCT
dpc-3736	316	38	from	from	ADP
dpc-3736	316	39	the	the	DET
dpc-3736	316	40	identification	identification	NOUN
dpc-3736	316	41	of	of	ADP
dpc-3736	316	42	critical	critical	ADJ
dpc-3736	316	43	physicochemical	physicochemical	ADJ
dpc-3736	316	44	attributes	attribute	NOUN
dpc-3736	316	45	to	to	ADP
dpc-3736	316	46	the	the	DET
dpc-3736	316	47	design	design	NOUN
dpc-3736	316	48	of	of	ADP
dpc-3736	316	49	effective	effective	ADJ
dpc-3736	316	50	topical	topical	ADJ
dpc-3736	316	51	and	and	CCONJ
dpc-3736	316	52	oral	oral	ADJ
dpc-3736	316	53	formulations	formulation	NOUN
dpc-3736	316	54	.	.	PUNCT
dpc-3736	317	1	pharmaceutics	pharmaceutic	NOUN
dpc-3736	317	2	.	.	PUNCT
dpc-3736	318	1	2022;15(1):99	2022;15(1):99	X
dpc-3736	318	2	.	.	PUNCT
dpc-3736	318	3	doi	doi	NOUN
dpc-3736	318	4	:	:	PUNCT
dpc-3736	318	5	10	10	NUM
dpc-3736	318	6	.3390	.3390	NOUN
dpc-3736	318	7	/	/	SYM
dpc-3736	318	8	pharmaceutics15010099	pharmaceutics15010099	VERB
dpc-3736	318	9	.	.	PUNCT
dpc-3736	319	1	pmid	pmid	NOUN
dpc-3736	319	2	:	:	PUNCT
dpc-3736	319	3	36678729	36678729	NUM
dpc-3736	319	4	.	.	PUNCT
dpc-3736	320	1	pmcid	pmcid	NOUN
dpc-3736	320	2	:	:	PUNCT
dpc-3736	320	3	pmc9864876	pmc9864876	NOUN
dpc-3736	320	4	.	.	PUNCT
dpc-3736	321	1	28	28	NUM
dpc-3736	321	2	.	.	PUNCT
dpc-3736	322	1	muddasani	muddasani	PROPN
dpc-3736	322	2	s	s	PART
dpc-3736	322	3	,	,	PUNCT
dpc-3736	322	4	peck	peck	VERB
dpc-3736	322	5	g	g	NOUN
dpc-3736	322	6	,	,	PUNCT
dpc-3736	322	7	fleischer	fleischer	NOUN
dpc-3736	322	8	a	a	DET
dpc-3736	322	9	b.	b.	PROPN
dpc-3736	322	10	systemic	systemic	ADJ
dpc-3736	322	11	ketoconazole	ketoconazole	PROPN
dpc-3736	322	12	continues	continue	VERB
dpc-3736	322	13	to	to	PART
dpc-3736	322	14	be	be	AUX
dpc-3736	322	15	prescribed	prescribe	VERB
dpc-3736	322	16	despite	despite	SCONJ
dpc-3736	322	17	an	an	DET
dpc-3736	322	18	fda	fda	PROPN
dpc-3736	322	19	warning	warning	NOUN
dpc-3736	322	20	.	.	PUNCT
dpc-3736	323	1	j	j	PROPN
dpc-3736	323	2	dermatolog	dermatolog	PROPN
dpc-3736	323	3	treat	treat	NOUN
dpc-3736	323	4	.	.	PUNCT
dpc-3736	324	1	2022;33(3):1787	2022;33(3):1787	NUM
dpc-3736	324	2	-	-	SYM
dpc-3736	324	3	1788	1788	NUM
dpc-3736	324	4	.	.	PUNCT
dpc-3736	325	1	doi:10.1080/09546634.2020.18	doi:10.1080/09546634.2020.18	PROPN
dpc-3736	325	2	36308	36308	NUM
dpc-3736	325	3	.	.	PUNCT
dpc-3736	326	1	pmid	pmid	NOUN
dpc-3736	326	2	:	:	PUNCT
dpc-3736	326	3	33076731	33076731	NUM
dpc-3736	326	4	.	.	PUNCT
dpc-3736	327	1	29	29	NUM
dpc-3736	327	2	.	.	PUNCT
dpc-3736	328	1	leeming	leeming	PROPN
dpc-3736	328	2	j	j	PROPN
dpc-3736	328	3	p	p	PROPN
dpc-3736	328	4	,	,	PUNCT
dpc-3736	328	5	notman	notman	PROPN
dpc-3736	328	6	f	f	PROPN
dpc-3736	328	7	h.	h.	PROPN
dpc-3736	328	8	improved	improve	VERB
dpc-3736	328	9	methods	method	NOUN
dpc-3736	328	10	for	for	ADP
dpc-3736	328	11	isolation	isolation	NOUN
dpc-3736	328	12	and	and	CCONJ
dpc-3736	328	13	enumeration	enumeration	NOUN
dpc-3736	328	14	of	of	ADP
dpc-3736	328	15	malassezia	malassezia	NOUN
dpc-3736	328	16	furfur	furfur	NOUN
dpc-3736	328	17	from	from	ADP
dpc-3736	328	18	human	human	ADJ
dpc-3736	328	19	skin	skin	NOUN
dpc-3736	328	20	.	.	PUNCT
dpc-3736	329	1	j	j	PROPN
dpc-3736	329	2	clin	clin	PROPN
dpc-3736	329	3	microbiol	microbiol	PROPN
dpc-3736	329	4	.	.	PUNCT
dpc-3736	330	1	1987;25(10):2017	1987;25(10):2017	NUM
dpc-3736	330	2	-	-	SYM
dpc-3736	330	3	2019	2019	NUM
dpc-3736	330	4	.	.	PUNCT
dpc-3736	331	1	doi:10.1128	doi:10.1128	NOUN
dpc-3736	331	2	/	/	SYM
dpc-3736	331	3	jcm.25.10.2017	jcm.25.10.2017	PROPN
dpc-3736	331	4	-2019.1987	-2019.1987	NOUN
dpc-3736	331	5	.	.	PUNCT
dpc-3736	332	1	pmid	pmid	NOUN
dpc-3736	332	2	:	:	PUNCT
dpc-3736	332	3	3667925	3667925	NUM
dpc-3736	332	4	.	.	PUNCT
dpc-3736	333	1	pmcid	pmcid	NOUN
dpc-3736	333	2	:	:	PUNCT
dpc-3736	333	3	pmc269393	pmc269393	ADJ
dpc-3736	333	4	.	.	PUNCT
dpc-3736	334	1	19	19	NUM
dpc-3736	334	2	.	.	X
dpc-3736	334	3	khosravi	khosravi	VERB
dpc-3736	334	4	a	a	DET
dpc-3736	334	5	r	r	NOUN
dpc-3736	334	6	,	,	PUNCT
dpc-3736	334	7	shokri	shokri	NOUN
dpc-3736	334	8	h	h	NOUN
dpc-3736	334	9	,	,	PUNCT
dpc-3736	334	10	darabi	darabi	NOUN
dpc-3736	334	11	m	m	NOUN
dpc-3736	334	12	h	h	NOUN
dpc-3736	334	13	,	,	PUNCT
dpc-3736	334	14	kashani	kashani	VERB
dpc-3736	334	15	a	a	PRON
dpc-3736	334	16	,	,	PUNCT
dpc-3736	334	17	mansouri	mansouri	PROPN
dpc-3736	334	18	p	p	NOUN
dpc-3736	334	19	,	,	PUNCT
dpc-3736	334	20	naser	naser	PROPN
dpc-3736	334	21	a.	a.	PROPN
dpc-3736	334	22	comparative	comparative	PROPN
dpc-3736	334	23	study	study	NOUN
dpc-3736	334	24	on	on	ADP
dpc-3736	334	25	the	the	DET
dpc-3736	334	26	effects	effect	NOUN
dpc-3736	334	27	of	of	ADP
dpc-3736	334	28	a	a	DET
dpc-3736	334	29	new	new	ADJ
dpc-3736	334	30	antifungal	antifungal	ADJ
dpc-3736	334	31	lotion	lotion	NOUN
dpc-3736	334	32	(	(	PUNCT
dpc-3736	334	33	artemisia	artemisia	NOUN
dpc-3736	334	34	sieberi	sieberi	PROPN
dpc-3736	334	35	essential	essential	ADJ
dpc-3736	334	36	oil	oil	NOUN
dpc-3736	334	37	)	)	PUNCT
dpc-3736	334	38	and	and	CCONJ
dpc-3736	334	39	a	a	DET
dpc-3736	334	40	clotrimazole	clotrimazole	NOUN
dpc-3736	334	41	lotion	lotion	NOUN
dpc-3736	334	42	in	in	ADP
dpc-3736	334	43	the	the	DET
dpc-3736	334	44	treatment	treatment	NOUN
dpc-3736	334	45	of	of	ADP
dpc-3736	334	46	pityriasis	pityriasis	NOUN
dpc-3736	334	47	versicolor	versicolor	NOUN
dpc-3736	334	48	.	.	PUNCT
dpc-3736	335	1	j	j	PROPN
dpc-3736	335	2	mycol	mycol	PROPN
dpc-3736	335	3	med	me	VERB
dpc-3736	335	4	.	.	PUNCT
dpc-3736	336	1	2009;19(1):17	2009;19(1):17	NUM
dpc-3736	336	2	-	-	SYM
dpc-3736	336	3	21	21	NUM
dpc-3736	336	4	.	.	PUNCT
dpc-3736	337	1	doi	doi	NOUN
dpc-3736	337	2	:	:	PUNCT
dpc-3736	337	3	10.1016	10.1016	NUM
dpc-3736	337	4	/	/	SYM
dpc-3736	337	5	j.mycmed.2008.12.001	j.mycmed.2008.12.001	PROPN
dpc-3736	337	6	.	.	PROPN
dpc-3736	338	1	20	20	NUM
dpc-3736	338	2	.	.	PUNCT
dpc-3736	339	1	rezvani	rezvani	PROPN
dpc-3736	339	2	,	,	PUNCT
dpc-3736	339	3	sm	sm	PROPN
dpc-3736	339	4	,	,	PUNCT
dpc-3736	339	5	sefid	sefid	ADJ
dpc-3736	339	6	gar	gar	PROPN
dpc-3736	339	7	s.	s.	PROPN
dpc-3736	339	8	efficacy	efficacy	PROPN
dpc-3736	339	9	of	of	ADP
dpc-3736	339	10	terbinafine	terbinafine	ADJ
dpc-3736	339	11	1	1	NUM
dpc-3736	339	12	%	%	NOUN
dpc-3736	339	13	cream	cream	NOUN
dpc-3736	339	14	versus	versus	ADP
dpc-3736	339	15	clotrimazole	clotrimazole	NOUN
dpc-3736	339	16	1	1	NUM
dpc-3736	339	17	%	%	NOUN
dpc-3736	339	18	cream	cream	NOUN
dpc-3736	339	19	in	in	ADP
dpc-3736	339	20	the	the	DET
dpc-3736	339	21	treatment	treatment	NOUN
dpc-3736	339	22	of	of	ADP
dpc-3736	339	23	pityriasis	pityriasis	NOUN
dpc-3736	339	24	versicolor	versicolor	NOUN
dpc-3736	339	25	.	.	PUNCT
dpc-3736	340	1	j	j	PROPN
dpc-3736	340	2	babol	babol	PROPN
dpc-3736	340	3	univ	univ	PROPN
dpc-3736	340	4	med	med	PROPN
dpc-3736	340	5	sci	sci	PROPN
dpc-3736	340	6	.	.	PUNCT
dpc-3736	341	1	2006;8(2):42	2006;8(2):42	NUM
dpc-3736	341	2	-	-	SYM
dpc-3736	341	3	46	46	NUM
dpc-3736	341	4	.	.	PUNCT
dpc-3736	342	1	21	21	NUM
dpc-3736	342	2	.	.	PUNCT
dpc-3736	343	1	budimulja	budimulja	PROPN
dpc-3736	343	2	u	u	PROPN
dpc-3736	343	3	,	,	PUNCT
dpc-3736	343	4	paul	paul	PROPN
dpc-3736	343	5	c.	c.	PROPN
dpc-3736	343	6	one	one	NUM
dpc-3736	343	7	-	-	PUNCT
dpc-3736	343	8	week	week	NOUN
dpc-3736	343	9	terbinafine	terbinafine	NOUN
dpc-3736	343	10	1	1	NUM
dpc-3736	343	11	%	%	NOUN
dpc-3736	343	12	solution	solution	NOUN
dpc-3736	343	13	in	in	ADP
dpc-3736	343	14	pityriasis	pityriasis	NOUN
dpc-3736	343	15	versicolor	versicolor	NOUN
dpc-3736	343	16	:	:	PUNCT
dpc-3736	343	17	twice	twice	ADV
dpc-3736	343	18	-	-	PUNCT
dpc-3736	343	19	daily	daily	ADJ
dpc-3736	343	20	application	application	NOUN
dpc-3736	343	21	is	be	AUX
dpc-3736	343	22	more	more	ADV
dpc-3736	343	23	effective	effective	ADJ
dpc-3736	343	24	than	than	ADP
dpc-3736	343	25	once	once	ADV
dpc-3736	343	26	-	-	PUNCT
dpc-3736	343	27	daily	daily	NOUN
dpc-3736	343	28	.	.	PUNCT
dpc-3736	344	1	j	j	PROPN
dpc-3736	344	2	dermatolog	dermatolog	PROPN
dpc-3736	344	3	treat	treat	NOUN
dpc-3736	344	4	.	.	PUNCT
dpc-3736	345	1	2002;13(1):39	2002;13(1):39	NUM
dpc-3736	345	2	-	-	SYM
dpc-3736	345	3	40	40	NUM
dpc-3736	345	4	.	.	PUNCT
dpc-3736	346	1	doi:10.1080/09546630252775243	doi:10.1080/09546630252775243	NOUN
dpc-3736	346	2	.	.	PUNCT
dpc-3736	347	1	pmid	pmid	NOUN
dpc-3736	347	2	:	:	PUNCT
dpc-3736	347	3	12006138	12006138	NUM
dpc-3736	347	4	.	.	PUNCT
dpc-3736	348	1	22	22	NUM
dpc-3736	348	2	.	.	PUNCT
dpc-3736	348	3	lakshmitatavarthin	lakshmitatavarthin	PROPN
dpc-3736	348	4	,	,	PUNCT
dpc-3736	348	5	b.	b.	PROPN
dpc-3736	348	6	,	,	PUNCT
dpc-3736	348	7	ramachandra	ramachandra	PROPN
dpc-3736	348	8	,	,	PUNCT
dpc-3736	348	9	b.v	b.v	PROPN
dpc-3736	348	10	.	.	PROPN
dpc-3736	348	11	,	,	PUNCT
dpc-3736	348	12	subbarao	subbarao	PROPN
dpc-3736	348	13	,	,	PUNCT
dpc-3736	348	14	d.v	d.v	PROPN
dpc-3736	348	15	.	.	PROPN
dpc-3736	348	16	,	,	PUNCT
dpc-3736	348	17	srinivasulu	srinivasulu	ADV
dpc-3736	348	18	,	,	PUNCT
dpc-3736	348	19	g.	g.	PROPN
dpc-3736	348	20	clinical	clinical	ADJ
dpc-3736	348	21	evaluation	evaluation	NOUN
dpc-3736	348	22	of	of	ADP
dpc-3736	348	23	efficacy	efficacy	NOUN
dpc-3736	348	24	of	of	ADP
dpc-3736	348	25	sertaconazole	sertaconazole	NOUN
dpc-3736	348	26	2	2	NUM
dpc-3736	348	27	%	%	NOUN
dpc-3736	348	28	cream	cream	NOUN
dpc-3736	348	29	in	in	ADP
dpc-3736	348	30	treatment	treatment	NOUN
dpc-3736	348	31	of	of	ADP
dpc-3736	348	32	pityriasis	pityriasis	NOUN
dpc-3736	348	33	versicolor	versicolor	NOUN
dpc-3736	348	34	and	and	CCONJ
dpc-3736	348	35	a	a	DET
dpc-3736	348	36	comparison	comparison	NOUN
dpc-3736	348	37	with	with	ADP
dpc-3736	348	38	that	that	PRON
dpc-3736	348	39	of	of	ADP
dpc-3736	348	40	clotrimazole	clotrimazole	NOUN
dpc-3736	348	41	1	1	NUM
dpc-3736	348	42	%	%	NOUN
dpc-3736	348	43	cream	cream	NOUN
dpc-3736	348	44	.	.	PUNCT
dpc-3736	349	1	j	j	PROPN
dpc-3736	349	2	evol	evol	NOUN
dpc-3736	349	3	med	med	PROPN
dpc-3736	349	4	dent	dent	PROPN
dpc-3736	349	5	sci	sci	PROPN
dpc-3736	349	6	.	.	PUNCT
dpc-3736	349	7	2015;4:4668	2015;4:4668	PROPN
dpc-3736	349	8	-	-	PUNCT
dpc-3736	349	9	4675	4675	NUM
dpc-3736	349	10	.	.	PUNCT
dpc-3736	350	1	doi:10.14260	doi:10.14260	PROPN
dpc-3736	350	2	/	/	SYM
dpc-3736	350	3	jemds/2015/675	jemds/2015/675	PROPN
dpc-3736	350	4	.	.	PROPN
dpc-3736	350	5	23	23	NUM
dpc-3736	350	6	.	.	PUNCT
dpc-3736	351	1	hibbett	hibbett	PROPN
dpc-3736	351	2	d	d	PROPN
dpc-3736	351	3	s	s	PROPN
dpc-3736	351	4	,	,	PUNCT
dpc-3736	351	5	donoghue	donoghue	PROPN
dpc-3736	351	6	m	m	PROPN
dpc-3736	351	7	j.	j.	PROPN
dpc-3736	351	8	integrating	integrate	VERB
dpc-3736	351	9	phylogenetic	phylogenetic	ADJ
dpc-3736	351	10	analysis	analysis	NOUN
dpc-3736	351	11	and	and	CCONJ
dpc-3736	351	12	classification	classification	NOUN
dpc-3736	351	13	in	in	ADP
dpc-3736	351	14	fungi	fungi	PROPN
dpc-3736	351	15	.	.	PUNCT
dpc-3736	351	16	mycologia	mycologia	NOUN
dpc-3736	351	17	.	.	PUNCT
dpc-3736	352	1	1998;90:347	1998;90:347	NUM
dpc-3736	352	2	-	-	PUNCT
dpc-3736	352	3	356	356	NUM
dpc-3736	352	4	.	.	PUNCT
dpc-3736	353	1	24	24	NUM
dpc-3736	353	2	.	.	PUNCT
dpc-3736	353	3	zaini	zaini	PROPN
dpc-3736	353	4	f	f	PROPN
dpc-3736	353	5	,	,	PUNCT
dpc-3736	353	6	a.	a.	PROPN
dpc-3736	353	7	mehbod	mehbod	PROPN
dpc-3736	353	8	,	,	PUNCT
dpc-3736	353	9	and	and	CCONJ
dpc-3736	353	10	m.	m.	PROPN
dpc-3736	353	11	emami	emami	PROPN
dpc-3736	353	12	.	.	PUNCT
dpc-3736	354	1	comprehensive	comprehensive	ADJ
dpc-3736	354	2	medical	medical	ADJ
dpc-3736	354	3	mycology	mycology	NOUN
dpc-3736	354	4	.	.	PUNCT
dpc-3736	355	1	tehran	tehran	PROPN
dpc-3736	355	2	:	:	PUNCT
dpc-3736	355	3	tehran	tehran	PROPN
dpc-3736	355	4	university	university	NOUN
dpc-3736	355	5	publications	publication	NOUN
dpc-3736	355	6	;	;	PUNCT
dpc-3736	355	7	2013	2013	NUM
dpc-3736	355	8	;	;	PUNCT
dpc-3736	355	9	9:632	9:632	NUM
dpc-3736	355	10	-	-	SYM
dpc-3736	355	11	635	635	NUM
dpc-3736	356	1	[	[	X
dpc-3736	356	2	book	book	NOUN
dpc-3736	356	3	in	in	ADP
dpc-3736	356	4	persian	persian	PROPN
dpc-3736	356	5	]	]	PUNCT
dpc-3736	356	6	.	.	PUNCT